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ABSTRACT 
Anna Marie Belle:  EXPLORING LOCAL NEURONAL CIRCUITRY WITH CONTROLLED 
IONTOPHORESIS 
(Under the direction of R. Mark Wightman) 
 
Understanding how neurochemical messengers propagate neuronal signals and 
ensure delivery of nutrients to fuel this process is the first step to proper treatment and 
prevention of disorders involving neurological dysregulation.  Here, the technique of 
controlled iontophoresis is coupled to electrochemical detection of dopamine, serotonin, and 
molecular oxygen (O2) and concurrent monitoring of cell firing to begin to probe the 
mechanics of local neural circuits.  Iontophoresis is a drug delivery technique where 
application of current causes charged molecules to migrate through a glass capillary.  In 
controlled iontophoresis these capillaries are coupled to a carbon-fiber microelectrode and 
ejections are monitored electrochemically.  The ability to control and modify iontophoretic 
ejections in real-time makes controlled iontophoresis a significant advancement over 
previous iterations of iontophoresis as explained and demonstrated herein.  Use of this 
technique first established that we can in fact selectively modulate electrically evoked 
dopamine release in the striatum of anesthetized rats with local application of an 
autoreceptor antagonist.  Then, the technique was used to examine functional hyperemia, 
the link between cerebral blood flow and neurochemical release, by monitoring local 
changes in O2.  Direct glutamate application, known to cause vasodilation, increased local 
O2 concentration linking these O2 changes to blood flow.  Additionally, with controlled 
iontophoresis the relative concentrations of glutamate applied could be compared.  This led 
to the discovery that application of high concentrations of glutamate induced ionic 
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oscillations that are attributed to calcium.  Next, the role of serotonin in functional hyperemia 
is examined in two regions with different serotonergic topography.  Unlike glutamate, 
serotonin application is shown have a much more complex role in functional hyperemia, 
inducing increases, decreases, and no change in O2.  Finally, in order to really understand 
neuronal signaling, it must be given a context.  This work concludes with collection of 
concurrent electrochemical/electrophysiological data while controlled iontophoresis is used 
to selectively modulate dopamine release and cell firing in freely-moving animals engaged in 
behavioral tasks.  Preliminary application of this technique has confirmed the existence of 
subpopulations of medium spiny neurons in the nucleus accumbens and shown that each of 
these subpopulations plays a unique role in intracranial self-stimulation. 
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Chapter 1 
 
Monitoring and modulating dopamine release and unit activity in real-time 
 
INTRODUCTION 
 
A vital step in creating effective treatments for addiction and learning disorders is to 
understand the neuronal circuitry that drives voluntary reward-directed behaviors and how 
drugs may hinder, help or hijack this system.  Intracranial self stimulation (ICSS) is a well 
established behavioral paradigm in which an animal learns to press a lever to stimulate a 
region in their own brain and is considered a robust method to study learning and reward 
(Olds and Milner, 1954).  Use of this technique combined with selective lesions and 
pharmacological manipulation of selected brain regions has indicated that the nucleus 
accumbens (NAc) is an important junction for the transmission of information during ICSS 
(Saddoris et al., 2013).   
The role of dopamine in circuits that control learning, goal-oriented behaviors, and 
addiction has been of interest to neuroscientists for many decades.  It is known that 
dopaminergic neurons, many of which terminate in the NAc, change their firing patterns in 
response to rewards and cues that predict reward (Mirenowicz and Schultz, 1994) and that 
dopamine neurotransmission is vital for reinforcing a behavior (Di Chiara and Imperato, 
1988).  However, these discoveries were made using electrophysiology to monitor the firing 
pattern of neurons or microdialysis to look at prolonged changes in extracellular dopamine 
concentration, not dopamine concentration changes on the timescale of cell firing.  
Dopaminergic neurons generally fire several times per second with periodic bursts of 
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increased frequency (Grace and Bunney, 1984) so a technique that can distinguish changes 
in dopamine concentration on this timescale is essential.  
Fast-scan cyclic voltammetry (FSCV) can measure changes in local dopamine 
concentrations up to 60 times per second (Kile et al., 2012), making it the perfect technique 
to monitor dopamine release in freely moving animals (Garris et al., 1997; Rebec et al., 
1997, Robinson and Wightman, 2007).  Thanks to technical advances over the past decade 
FSCV can now be combined with electrophysiological recordings and iontophoresis, 
allowing researchers to monitor and manipulate pre- and postsynaptic activity during 
behavior.  The technical considerations and resulting discoveries from the combination of 
these techniques are discussed here. 
 
DOPAMINE NEUROTRANSMISSION 
 
Neurons are brain cells responsible for the integration and transmission of 
information throughout the brain; they receive, process, and transmit information to and from 
discrete populations of neurons within specific circuits in the brain.  Classic 
neurotransmission occurs when the activation of receptors on dendrites of a cell begins a 
cascade of intracellular processes that often include the generation and propagation of an 
action potential, a voltage difference across the neuronal membrane.  The frequency of the 
firing of action potentials of a cell is referred to as its unit activity, and the modulation of unit 
activity is the way in which information is encoded.  When an action potential propagates 
along the neuron’s axon to its terminals, it triggers the release of neurotransmitter into the 
extracellular space.  There the neurotransmitters can bind to specific receptors on a 
proximal neuron.  The modulation of target neurons via neurotransmitter release is central to 
the regulation of an organism’s behavior. 
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Dopamine release in the NAc plays an extensive role in governing motivated 
behaviors (Salamone and Correa, 2012) and we have shown that its release coincides with 
learned associations for rewarding stimuli and drugs of abuse (Phillips et al., 2003; 
Robinson and Wightman, 2007; Owesson-White et al., 2009; Beyene et al., 2010; Day et al., 
2010).  There is a high density of dopamine cell bodies in the ventral tegmental area (VTA) 
that send their axonal projections to many regions of the brain including the striatum.  The 
ventral striatum is divided into two subregions: the NAc core and NAc shell.  In both NAc 
subregions, dopamine terminals form synapses onto spines found on the dendrites of 
medium spiny neurons (MSNs) (Yung et al., 1995).  MSNs comprise 95% of the cell bodies 
in the NAc and release GABA, an inhibitory neurotransmitter, upon firing (Chang and Kitai, 
1985).  Neurons with cell bodies located in regions other than the VTA, including other NAc 
MSNs, also synapse onto these MSNs, making their activation a complex process known to 
be essential for movement, learning, and motivation, and that is facilitated by dopamine 
release in the region.   
When dopamine is released from terminals it can then bind to any of the 5 types of 
dopamine receptors (D1-D5).  The predominant dopamine receptors in the NAc, are the D1 
receptor (D1R) and D2 receptor (D2R).  Both of these receptors are G-protein linked, but 
D1Rs activate G-proteins that stimulate adenylyl cyclase while D2Rs activate G-proteins that 
inhibit adenylyl cyclase.  D1Rs also have a lower binding affinity for dopamine than D2Rs.  
This difference in binding affinities supports the idea that normal basal levels of dopamine in 
the brain constantly ensure the activation of the majority of D2Rs, while sudden phasic 
increases in dopamine release activate D1Rs (Dugast et al., 1997; Berke and Hyman, 
2000). 
D2Rs are found on both pre- and postsynaptic terminals.  Pre-synaptic receptors are 
commonly referred to as D2 autoreceptors (Roth, 1979) and are found to have inhibitory 
effects on DA release from terminals.  D2-autoreceptors have been linked to short term 
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modulation of dopamine release (Kita et al., 2007) making them an ideal target when 
attempting to manipulate evoked dopamine release quickly.  Additionally, there are 
biochemical (Helmreich et al., 1982; Martin et al., 1982; Claustre et al., 1985), 
electrophysiological (Skirboll et al., 1979), and behavioral (Bradbury et al., 1984) data 
suggesting that dopamine agonists exhibit greater potency at D2 autoreceptors than at 
postsynaptic D2Rs.  While both pre- and postsynaptic D2 receptors exhibit similar 
pharmacology (Elsworth and Roth, 1997), they differ in the G-proteins they use to inhibit 
adenylyl cyclase (Montmayeur et al., 1993; Guiramand et al., 1995).  Functionally, this 
means more binding may be required at post-synaptic receptors to elicit comparable 
adenylyl cylase inhibition.  The net effect of dopamine release on MSNs is dependent on a 
balance between the binding of D1Rs, postsynaptic D2Rs and D2 autoreceptors.  Indeed, it 
appears that the more we know about dopamine neurotransmission the more subtle and yet 
complex its signaling capabilities seem. 
While the different effects of D1R and D2R activation on MSNs has long been 
recognized, it was recently discovered that D1Rs and D2Rs are in fact segregated onto two 
different MSN populations (Valjent et al., 2009; Gerfen and Surmeier, 2011).  In the dorsal 
striatum approximately half of MSNs contain D1Rs and project axons to the output nuclei of 
the basal ganglia (substantia nigra and internal capsule of the globus pallidus).  These D1 
MSNs are termed the “direct pathway.”  Other MSNs contain exclusively D2Rs and project 
to the external capsule of the globus pallidus.  These D2 MSNs are termed the “indirect 
pathway” because they synapse with neurons that also project back to the output nuclei.  
Although this circuitry was originally characterized in the dorsal striatum, it is also found in 
the NAc (Ikemoto, 2007). 
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EVOLUTION OF A WAVEFORM 
 
A number of electrochemical techniques can be used to detect neurotransmitters in 
vivo (Robinson et al., 2008) but cyclic voltammetry has the unique ability to provide a distinct 
current trace (cyclic voltammogram) for the oxidation and/or reduction of electroactive 
compounds.  This allows identification and quantification of compounds, a critical feature 
that prevents incorrect conclusions about the role of a substance in a particular behavior 
(Wightman and Robinson, 2002).  FSCV has become the electrochemical technique of 
choice for monitoring changes in neurotransmitter levels in the brain because it adds high 
temporal resolution to the chemical selectivity and high sensitivity of cyclic voltammetry 
(Millar et al., 1985).  The detection of monoamines with FSCV has been optimized over the 
years to allow detection of low nanomolar concentrations of dopamine (Keithley et al., 
2011).  However, the detection limit is not the only factor that must be considered when 
deciding on a waveform.  By varying the rate and range of potentials applied to the carbon-
fiber microelectrode the detection limit of a neuroactive species and the temporal response 
of the electrode can be optimized. 
 The first studies in freely moving rats detected dopamine with a waveform that held 
the carbon fiber at -0.4 V, increased linearly up to 1.0 V and back to -0.4 V in 9.3 ms once 
every 100 ms.  This potential waveform is less frequently used today for the detection of 
neurotransmitters in freely moving animals because of its lack of sensitivity.  However, many 
important discoveries were made with its use because of its temporal resolution.  These 
include studies of rapid dopamine release in response to reward delivery and how the 
magnitude of the dopamine changes as an animal learns a behavior (Garris et al., 1999; 
Kilpatrick et al., 2000).  This high speed recording of dopamine release during behavioral 
tasks supported the hypothesis that dopamine release is required for learning a rewarding 
task, but it does  not signal the reward itself. 
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The lack of sensitivity of the original waveform used for dopamine detection limited 
FSCV to the measurement of “extracellular dopamine changes after electrical stimulation of 
cell bodies in the substantia nigra compact, rather than spontaneous or gradual changes in 
extracellular dopamine” (Budygin et al., 2001).  Fortunately, extension of the original 
waveform increased dopamine sensitivity 9-fold in vivo allowing detection of 5 nM, a level 
seen for some naturally occurring changes in dopamine (Heien et al., 2003).  The improved 
detection limit was achieved by holding the electrode at -0.6 V and linearly increasing 
voltage to 1.4 V and back to -0.6 V in 10 ms once every 100 ms.  Increased sensitivity 
resulted from two consequences of this extended waveform:  adsorptive pre-concentration 
of dopamine occurs when the electrode is held at a more negative potential between scans, 
and the reactive carbon fiber surface is constantly cleaned as a consequence of over-
oxidation of its functional groups.  This extended waveform decreased the temporal 
response of the technique by 1.2 s, however, and decreased the selectivity of the electrode 
for the oxidation and reduction of dopamine over other species.  Thus this waveform is most 
useful for experiments carried out in regions where only a single electroactive compound is 
present and when the detection limit of dopamine is of higher priority than the electrode’s 
temporal response.  This waveform allowed monitoring of naturally occurring increases in 
dopamine release the NAc (Phillips et al., 2003) and allowed detection of basal dopamine 
level changes over 90 s periods (Heien et al., 2005). 
The waveform now used for dopamine detection in vivo combines the detection limit 
of the extended waveform and the temporal response of the original waveform.  The scan 
starts at -0.4 V and linearly increases to 1.3 V at the same rate as the extended waveform, 
taking 8.5 ms to complete (Heien et al., 2004).  This is repeated every 100 ms.  This 
“dopamine waveform” allows detection of 8 nM DA without the sacrifice in temporal 
response seen with pre-adsorption at -0.6 V.  This is the waveform of choice in experiments 
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where FSCV is used to monitor dopamine or norepinephrine and pH changes in the brain of 
freely-moving animals. 
With the development of methods to quantitatively measure the dynamics of several 
analytes simultaneously (Heien et al., 2004) and to display thousands of cyclic 
voltammograms simultaneously to qualitatively monitor the temporal dynamics of each 
analyte (Michael et al., 1998), we were able to begin to ask and answer increasingly 
complex questions about dopamine signaling dynamics in behavior.  One of these questions 
was how the dynamics of dopamine signaling affected the balance between cerebral blood 
flow and metabolism in a region.  A waveform was designed that allows for the reduction of 
oxygen at the carbon fiber when biased to a negative potential (-1.4 V).  By scanning up to 
1.0 V we can also see the oxidation of dopamine and any changes in hydrogen ion 
concentrations within the same scan, but the sensitivity of this waveform for monoamines is 
greatly reduced due to the reduced magnitude of the positive scan and a holding potential of 
0.0 V (Zimmerman and Wightman, 1991; Kennedy et al., 1992).  Monitoring oxygen, pH, 
and dopamine simultaneously has allowed the discoveries that dopamine seems to have 
little effect on the balance between cerebral blood flow (oxygen changes) and metabolism 
(pH changes) in both anesthetized (Zimmerman and Wightman, 1991; Venton et al., 2003) 
and awake animals (Cheer et al., 2006; Ariansen et al., 2012).  The information about 
metabolic dynamics during neurotransmission that this waveform allows us to monitor also 
allowed us to be the first to show with the temporal and spatial resolution of our 
microelectrodes that the endocannabinoid CB1 receptor mediates changes in the balance 
between cerebral blood flow and metabolism in the brain of awake animals (Cheer et al., 
2006).  This finding has implications for the development of new treatments for cerebral 
vascular disorders and is an excellent example of the sorts of questions FSCV can answer 
about the brain. 
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SEEING THE BRAIN COMMUNICATE:  A COMBINATION OF MEASUREMENT 
PROCEDURES 
 
Development of the FSCV method that is optimized for monitoring neuronal 
processes was a task that analytical chemists with an interest in neuroscience could 
confidently undertake.  However, the design of small animal behavioral experiments to 
probe the role of dopamine dynamics encompassed concepts far beyond those normally 
addressed by chemists.  We employed a number of unconventional stimuli such as the 
popping of bubble wrap outside of cages to monitor the startle response of rats (Robinson 
and Wightman, 2004).  We made the unanticipated discovery that the presence of female 
rats induced subsecond dopamine increases in male rats.  We also discovered that these 
dopamine transients were unrelated to sexual differentiation (Rebec et al., 1997; Robinson 
et al., 2001; Robinson et al., 2002).  Nevertheless, the initial attempts at behavioral 
experiments turned out to be excellent proof-of-concept for this new measurement 
technique in freely moving rats.   
In 2000, the Wightman lab partnered with the lab of Dr. Regina Carelli, a 
psychologist with demonstrated proficiency in small animal behavior.  Carelli was known for 
using electrophysiology to monitor cell firing in behaviors involving reward-based learning 
and drugs of abuse (Carelli and Deadwyler, 1997; Carelli, 2000; Carelli, 2002).  Extracellular 
electrophysiological recordings monitor voltage changes in the space around a cell that 
result from potential changes arising from propagation of an action potential.  Carelli and 
coworkers had focused on the electrophysiology responses of dopaminergic neurons in rats 
and thus it was relatively straight forward to reexamine the same behaviors while monitor 
changes in dopamine release with FSCV (Carelli, 2002).  The combined expertise brought 
by psychologists and chemists working in parallel allowed significant breakthroughs in 
understanding the dynamics of dopamine transmission in behavior and addiction.  The 
temporal resolution of FSCV resolves distinct dopamine increases coinciding with the cue 
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indicating imminent lever availability from those that occur at the lever presentation 2 s later 
(Stuber et al., 2005a; Day et al., 2007).  In addition, the temporal resolution of FSCV 
showed that the dopamine release occurred before the reward was presented once the 
animal knew to expect lever presentation at a fixed interval (Cheer et al., 2007).  This 
directly supported earlier theories that hypothesized that dopamine is responsible for reward 
prediction or its expectation instead of being a component of the hedonistic aspect (Schultz, 
1998).   
The early experiments used a fixed time between lever availability so it was unclear 
whether dopamine was playing a role in the measurement of elapsed time or was signaling 
that the lever was present.  We now use a variable time-out period between lever 
presentations to avoid teaching the animal that the timing of cue presentation is predictable 
(Owesson-White et al., 2008).  FSCV used in a variety of reward-based behavioral 
paradigms established that in the NAc, dopamine release occurs during behavioral tasks 
with the same rapid dynamics as changes in cell firing (Phillips et al., 2003; Roitman et al., 
2004; Stuber et al., 2005b; Stuber et al., 2005a; Owesson-White et al., 2008; Jones et al., 
2010; Sugam et al., 2012).   
Combining Electrochemistry with Electrophysiology 
 
In a 2004 review, Carelli and Wightman reviewed the microcircuitry in the NAc 
involved in drug addiction (Carelli and Wightman, 2004).  The review contained a single 
figure in which data from two separate experiments in two separate animals were overlaid to 
show cell firing and dopamine changes both rapidly occurred at the administration of 
cocaine.  The modulation of cell firing in NAc MSNs during behavioral tasks appeared to be 
dopamine-dependent (Yun et al., 2004) but the relationship between the two was (and still 
is!) not fully understood.  While the Wightman lab had previously ventured into simultaneous 
electrochemistry and single-unit recordings experiments in anesthetized preparations 
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(Ewing et al., 1983; Kuhr et al., 1987), the two techniques were carried out at separate 
electrodes positioned 500 µm apart (Ewing et al., 1983) or in completely different brain 
regions (Kuhr et al., 1987).  The development of the electronics and methods to combine the 
two techniques on a single electrode in a freely-moving animal was first accomplished by 
the lab in 2005 (Cheer et al., 2005) and has been an ongoing area of research (Owesson-
White et al., 2009; Cacciapaglia et al., 2011; Takmakov et al., 2011; Belle et al., 2013). 
The key to this combined technique is the ability to use a carbon-fiber microelectrode 
both for electrochemistry and electrophysiology.  This concept was first developed by Julian 
Millar and coworkers in anesthetized animals (Armstrong-James and Millar, 1979, 1988; 
Stamford et al., 1993).  Several advantages arise from using the same electrode for both 
measurements, including the ability to measure action potentials from the neurons that are 
being influenced by the local neurotransmitter release sensed at the electrode (Su et al., 
1990), the minimization of tissue damage, and the decreased complexity of surgeries.  
Rapidly alternating between these two techniques without glitches or artifacts requires 
complex circuitry and modified experimental parameters to freely-moving systems (Garris et 
al., 1997), a project that required the collaboration of chemists, neurobiologists, and 
electrical engineers (Cheer et al., 2005; Takmakov et al., 2011).   
A switch is used to alternate the carbon fiber between a current amplifier for 
electrochemical detections and a voltage follower for single-unit recording.  The headstage 
where this first stage of signal modification is completed is located on the rats’ head within a 
few centimeters of the electrode, minimizing the noise in the amplified signal.  Figure 1 
shows the timing and output when switching between the two circuits.  When the voltage 
follower is connected, voltage changes occurring at the carbon fiber are recorded.  
Alternatively when the current amplifier is connected to the carbon fiber, it is ramped through 
a potential window and the resulting currents recorded.  The original design of this 
experiment included a solid-state switch that unfortunately would sometimes allow 
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electrochemical voltages to leak over into the single-unit recordings (Cheer et al., 2005).  
While these voltage changes looked distinct from unit activity, they often overwhelmed the 
recordings making it difficult to elicit firing changes in the unit of interest.  Two improvements 
were made to help prevent this leakage.   
The first modification was to the electrical circuit.  There is now a new solid-state 
relay chosen for its low leakage, low charge transfer, low and matched input capacitance, 
low resistance (10 Ω), and fast (<1 µs) switching time (Takmakov et al., 2011).  These 
characteristics prevent excess charging currents during the switch and current leakage 
between the two circuits.  The second modification that helped prevent leakage of voltage 
between the two systems was the timing of the voltammetric scan to the carbon fiber.  The 
unit-recording interval always has a 20 ms gap every 180 ms during which the 8.5 ms 
voltammetric scan occurs.  In initial applications of this technique, the potential scan 
occurred at the very end of this 20 ms interval.  This was done to maximize the adsorption of 
dopamine to the electrode while it was held at a negative potential; however, this resulted in 
current fluctuations when the electrode was switched over to electrophysiology.  These 
fluctuations would manifest as large voltage changes in the single-unit data.  To correct for 
this, a potential of -0.4 V is applied for pre-concentration of dopamine and current 
stabilization of the electrode for only the first 5 ms of the 20 ms interval.  The electrode is 
then ramped to 1.3 V and back to -0.4 V where it remains for ~5 ms before the mode is 
switched.  This timing is shown in Figure 1.1.  The ability to look at these changes 
concurrently and with respect to external stimuli or behavioral patterns allows us 
to begin to directly tease apart the effects of dopamine neurotransmission by monitoring 
dopamine release from terminals and the unit-activity of the cell with dopamine receptors in 
the vicinity.  The required modifications of the dopamine waveform result in some sacrifices 
in electrochemical detection however.  The sampling rate is doubled to once every 200 ms  
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Figure 1.1.  Data output from combined fast-scan cyclic voltammetry/electrophysiology 
experiments.  A) The output of the carbon-fiber electrode was connected to a voltage 
follower to monitor cell firing, seen at voltage changes over time (upper circuitry).  The lines 
above the voltage read out indicate regions of the 180 ms recording interval that have been 
expanded above.  The dark grey spikes are firing of the MSN of interest.  The light grey 
spikes are an example of an excluded event.  Every 200 ms the electrode was switched 
from the electrophysiology circuit to the lower voltammetry circuitry for 20 ms.  In this 
position, the amplifier controlled the electrode potential and the current was monitored.  
When the lower circuit was completed, the electrode was held at -0.4 V then over 8.5 ms 
scanned from to +1.3 V and back to -0.4 V.  During this time, there were no voltage changes 
seen in the electrophysiology (when circuit was open but program still recorded data). 
B) The cyclic voltammograms resulting from changes each of the three sequential potential 
scans.  C) The simultaneous presentation of electrophysiological and electrochemical data.  
The histogram shows the frequency with which the cell fired during the 200 ms bins and the 
trace superimposed over the graph shows changes in the concentration of dopamine 
detected over the same time period.  
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and the dopamine detection limit is only 62% of the traditional dopamine waveform (Cheer 
et al., 2005). 
This dual technique’s first discovery was to show that in the same location dopamine 
release and changes in cell firing were both synchronized to lever pressing in trained 
animals.  MSNs that showed increases OR decreases at lever press (and electrical 
stimulation), showed a simultaneous increase in dopamine (Cheer et al., 2005).  This study 
also showed that cell firing (but not dopamine release) changed with the administration of 
GABAergic antagonists; supporting the idea that dopamine altered the probability of a cell 
firing but was not the neurotransmitter directly responsible for NAc MSNs firing.  Later work 
demonstrated a positive correlation between the concentration of dopamine and magnitude 
of cell firing change and observed that dopamine release was seen in all locations with 
MSNs responsive to behavioral stimuli (Owesson-White et al., 2009).  MSNs that were 
unresponsive during the behavior were all in locations with no dopamine release during the 
behavior (Owesson-White et al., 2009; Cacciapaglia et al., 2012).  The difference between 
correlation of dopamine release and cell firing in the two subregions of the NAc, the core 
and the shell, was also investigated.  Dopamine in the core was closely timelocked to the 
reinforced response of the lever press.  In the shell, dopamine was released over a longer 
duration and did not coincide as greatly with lever pressing (Owesson-White et al., 2009).  
The same subregion specific dopamine dynamics were seen for natural rewards as well 
(Cacciapaglia et al., 2012).  These results demonstrate the heterogeneity of dopamine 
release and suggest this release is positioned to selectively modulate specific MSNs. 
 After establishing the link between dopamine release and cell firing during ICSS 
(Cheer et al., 2005; Cheer et al., 2007; Owesson-White et al., 2009), we investigated 
whether this link was also seen with natural rewards (Cacciapaglia et al., 2011).  Rats were 
trained to press a lever for a sucrose pellet instead of a direct electrical stimulation.  The 
lever was made available at a variable interval and preceded by a 2 s cue.  Locations with a 
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surge in dopamine concentration at the onset of the cue and (to a lesser extent) with lever 
press, showed one of four alterations in MSN firing:  inhibition at cue presentation, excitation 
at cue presentation, inhibition at lever press, and excitation at lever press.  To see if this 
surge of dopamine was in fact responsible for the coincident changes in cell firing, NMDA 
receptors were blocked in the VTA attenuating the burst firing of dopamine cells in the 
region (Chergui et al., 1993).  This decreased dopamine release in the NAc.  MSNs that 
showed an excitation to the cue onset or lever press became non-phasic, while cells that 
were inhibited at either the cue or the lever press were unaffected by the diminished in 
dopamine release.  This showed dopamine’s ability to selectively modulate discrete 
pathways within the NAc and suggested that this was a selective modulation of the direct 
(D1 MSNs) or indirect (D2 MSNs) pathway. 
Controlled Iontophoresis 
 
Iontophoresis is a technique that uses current to induce the migration of a solution of 
ions through a glass pipette.  It was developed in the early 1950s by W.L. Natsuk, a student 
of A.L. Hodgkin (Nastuk, 1953).  While attempting to understand how ions contributed to the 
actions of acetylcholine at the neuromuscular junction, he noticed that acetylcholine would 
naturally leak out of a glass pipette pulled to a fine tip and that application of current to the 
pipette solution ejected even more acetylcholine onto the junction (Hicks, 1984).  From 
there, iontophoresis increased in popularity and extensive studies on the technique were 
carried out (Krnjevic et al., 1963a; Krnjevic et al., 1963b; Crawford and Curtis, 1964; Curtis 
and Nastuk, 1964; Bradley and Candy, 1970; Bloom, 1974; Simmonds, 1974; Freedman et 
al., 1975; Purves, 1977, 1979).  The technique’s popularity for studying receptor dynamics in 
vivo is due to the fact that drugs can be quickly, selectively, and locally delivered to the site 
of action with minimal disruption of tissue.  Systemic drug administration is only useful for 
drugs that can pass the blood-brain barrier without metabolic degradation.  Even in cases 
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where the drug can cross the blood-brain barrier, the drug affects the entire brain making it 
difficult to study discrete brain region effects (Bloom, 1974).  Additionally, systemic drug 
administration can alter animal behavior, making it difficult to look at the drug effects in the 
brain during behavior (Hernandez and Cheer, 2012).  These problems are avoided by using 
iontophoresis to study the pharmacology of the brain. 
A drawback to iontophoresis was the inability to monitor or quantify the amount of 
drug delivered.  This made it impossible to differentiate a null response to drug application 
from a clogged glass pipette.  Additionally, too little drug delivered could result in a false 
negative whereas excessive application could lead to nonspecific effects.  Applied pump 
currents are commonly used to compare ejections (Pierce and Rebec, 1995; Kiyatkin and 
Rebec, 1996, 1999b), but the same pump current ejects different drug concentrations from 
barrel to barrel (Herr et al., 2008).  Modifications to the design of Millar and co-workers, 
which coupled iontophoresis barrels to carbon-fiber microelectrodes, allow detection of 
electroactive compounds ejected with iontophoresis at the neighboring electrode 
(Armstrong-James et al., 1981). 
Using these coupled iontophoresis probes, electroosmosis was found to contribute 
significantly to the observed drug delivery (Herr et al., 2008).  Electroosmosis is a 
phenomenon caused by the attraction between the cations in solution and the ionizable 
silanol groups on the glass capillary surface.  When a positive current is applied to the 
capillary, the cations along the wall migrate toward the anode, inducing a bulk movement of 
solution, termed electroosmotic flow.  The variability in iontophoretic ejections is associated 
with variability of electroosmotic flow from barrel to barrel, while electrophoretic mobility 
(ionic migration) for a given species is consistent.  Using an electroactive neutral molecule 
as an internal standard to monitor the variability in electroosmotic flow, and subsequently 
the amount of drug delivered from different barrels, allows us to control for this variability.  
These insights into iontophoresis enable quantitative delivery of electroactive and 
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electroinactive drugs by monitoring the coejection of an electroactive molecule from the 
same barrel (Herr et al., 2008).  When the relative mobilities of the coejected substances are 
known, monitoring the concentration of the electroactive molecule with the carbon-fiber 
electrode provides an indirect measure of the relative concentration of the coejected 
nonelectroactive substance (Herr et al., 2008; Herr et al., 2010).   
While FSCV had previously been coupled to iontophoresis to monitor modulation of 
cell firing by electroactive compounds (Kiyatkin and Rebec, 1996, 1997; Rebec, 1998; 
Kiyatkin and Rebec, 1999a, b; Kiyatkin et al., 2000; Kiyatkin and Rebec, 2000), it was not 
until 2010 that the technique was used in vivo to alter release from dopamine terminals in 
the region of drug application (Herr et al., 2010).  These papers established that controlled 
iontophoresis could be used to quickly (<60 s) modulate dopamine release by affecting 
D2 autoreceptors and the dopamine transporter in anesthetized (Herr et al., 2010) and 
freely-moving animals (Belle et al., 2013).  Monitoring iontophoresis ejections eliminates the 
fear of ionic and electrical artifacts from the ejection current altering the neuronal 
environment as well.  With controlled iontophoresis coupled to the simultaneous 
electrochemistry/electrophysiology technique we can watch for these problems during an 
experiment.  While changes to the neuronal environment are not seen from ejection of 
saline or the electroactive marker molecule, if the ejection current is seen to affect the 
electrode, electrical connections can be altered or a different barrel on the probe used to 
prevent any data collection problems (Belle et al., 2013).   
With the discovery of the discrete location of D1Rs and D2Rs on separate 
populations of MSNs (Valjent et al., 2009; Gerfen and Surmeier, 2011) came a huge 
breakthrough in how neuronal networks in the brain work together in reward, behavior and 
addiction.  In the NAc core, only 6% of MSNs have both D1Rs and D2Rs, while 53% of 
MSN’s have D1Rs exclusively (D1 MSNs) and 41% of MSNs have D2Rs exclusively (D2 
MSNs) (Valjent et al., 2009).  While the role each receptor during learning and reward has 
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been investigated (Surmeier et al., 2007), direct electrophysiological evidence has been 
lacking, partly because of the difficulties in differentiating D1 MSNs and D2 MSNs in vivo 
(Venance and Glowinski, 2003).   
Coupling controlled iontophoresis to the same microelectrode in a combined FSCV 
and single-unit recording experiment allows for pharmacological identification of MSNs 
based on their responses to D1R and D2R antagonists (Belle et al., 2013).  The firing rates 
of NAc MSNs in awake animals were monitored before, during and after a 15 s iontophoretic 
ejection of specific dopamine receptor antagonist.  Changes in response to these 
antagonists were seen both immediately and on a prolonged timescale (as an overall 
change in the firing rate of a neuron after application).  Looking at prolonged changes, 40% 
of MSNs increased their firing rate after local application of a D2R antagonist, 46% of MSNs 
exhibited a decreased firing rate after local application of the D1R antagonist, and only 11% 
of MSNs responded to both antagonists.  These results are in agreement with previously 
reported distributions for dopamine receptor subtypes on MSNs (Valjent et al., 2009) 
supporting the method as a way to discriminate between and selectively modulate D1 MSNs 
and D2 MSNs in vivo. 
 
CONCLUSIONS 
 
As our knowledge of the subtle and complex signaling required for the brain to encode 
reward-directed behaviors increases, the ability to selectively modulate and monitor 
dopamine release and MSN firing in freely-moving animals engaged in behavioral tasks 
becomes even more essential.  The development of a technique to monitor subsecond 
dopamine fluctuations in freely-moving animals has allowed the study of naturally and 
electrically evoked dopamine during reward-motivated tasks and provided the ability to 
watch slower, tonic changes in dopamine.  Furthermore, combining this ability with 
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concurrent observation of cell firing patterns in vivo is essential for understanding 
neurotransmission.  The technique has shown that MSNs alter their firing during a 
behavioral task, receive dopaminergic inputs during the behavior and that dopamine release 
is required for excitations of MSNs during behavior.  This combined technique is a passive 
way to ‘listen in’ on neurotransmission and the ability to selectively and locally modulate this 
neuronal conversation will allow an even greater understanding of the purpose of 
dopaminergic pathways in learning and reward. 
 
DISSERTATION OVERVIEW 
 
 While the final two chapters of this dissertation directly report the development and 
first insights from the combined electrochemical/electrophysiological with iontophoretic 
modulation discussed here, other applications of controlled iontophoresis in anesthetized 
animals are first discussed in Chapters 2, 3 and 4.  These Chapters lay the ground work for 
further iontophoretic investigations in awake animals.  Chapter 2 presents the utility and 
methodology of controlled iontophoresis for pharmacological manipulation of 
neurotransmission.  Controlled iontophoresis is then used to probe the relationship between 
cerebral metabolism (neurotransmission) and blood flow.  First, in Chapter 3 this relationship 
is examined for glutamate, a neurotransmitter with a known vasoactive role in the brain.  
Then, in Chapter 4 methodology from Chapter 3 is used to investigate the role of serotonin 
in regulation of cerebral blood flow.  Finally, controlled iontophoresis is modified for use in 
conscious animals (Chapter 5) to elicit the role of dopamine in ICSS (Chapter 6).  These 
projects all demonstrate the utility and improvements of controlled iontophoresis to look at 
the inner workings of neurotransmission in whole, conscious animals.   
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Chapter 2 
Iontophoresis for quantitative modulation of the D2 autoreceptor 
 
INTRODUCTION 
 
Drug Receptor Theory 
 
Neurons transport information through the brain via the release and detection of 
neurotransmitters by specific receptors at synaptic junctions.  The mechanisms behind the 
transport of information from neuron to neuron can be investigated with the use of 
compounds that can block or activate particular receptors.  Here, D2 dopamine receptor 
(D2R) subtype occupancy was modulated with dopamine (DA) and other drugs to determine 
effects on extracellular DA.  D2Rs are found on pre- and post-synaptic terminals.  The pre-
synaptic D2Rs are commonly referred to as D2-autoreceptors (Roth, 1979) and are found to 
have an inhibitory effect on DA release.  Additionally, there are biochemical (Helmreich et 
al., 1982; Martin et al., 1982; Claustre et al., 1985), electrophysiological (Skirboll et al., 
1979), and behavioral (Bradbury et al., 1984) data that suggest that DA agonists exhibit 
greater potency at D2 autoreceptors than at post-synaptic D2Rs. Therefore, in the low-
dosage range the autoreceptor-mediated effects of DA and other agonists will predominate.  
D2 autoreceptors have also been linked to short term modulation of DA release (Kita et al., 
2007) making them the ideal target when attempting to manipulate evoked DA release 
quickly.   
The negative feedback that these autoreceptors provide on the release of DA at a 
synapse can also be blocked with the use of antagonists specific for this receptor.  
Antagonists are drugs that bind a receptor with high affinity but have no intrinsic efficacy to 
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the receptor, and thus effectively “block” the receptor.  Conversely, an agonist interacts with 
a receptor in a way that mimics the neurotransmitter expected to activate the receptor.  This 
gives the illusion of increased concentration of a neurotransmitter at the synapse and 
increases the response at the synapse to the neurotransmitter.  The illusion of increased DA 
binding to D2 autoreceptors would signal the decreased release of DA from the pre-synaptic 
terminal, resulting in a decrease in extracellular DA levels when agonist binds to the 
receptor.   
In pharmacology, dose-response curves serve as a guide to determine relative 
affinity of drugs for a receptor or efficacy for the onset of a given response.  In 1927, A.J. 
Clark put forth Occupational Theory to explain drug-receptor interactions (Clark, 1926, 1927, 
1937).  This theory assumes that responses, whether quantified in terms of behavior or 
evoked release of a given neurotransmitter, are a result of reversible receptor occupation by 
an agonist and that the magnitude of the response is proportional to the number of receptors 
occupied by agonist.  This theory is particularly useful where the magnitude of response to a 
drug rather than receptor occupancy from direct binding studies is a more practical piece of 
information both in terms of results and experimental procedure.  Dose response curves are 
often used to examine this relationship for several reasons including the large range of drug 
concentrations that can be examined.  The relationship between response and the logarithm 
of drug concentration is almost completely linear between 20% and 80% of the maximum 
response.  On these curves the concentration of a drug that causes 50% of the maximum 
effect is referred to as the EC50.  Potency (but not necessarily affinity) of a drug at a given 
receptor can be determined from the EC50 value.   
Competitive antagonism, as modeled here, occurs when both the agonist and 
antagonist bind to the same site(s) on a receptor and compete for binding at those sites 
when both are present.  While this is a simplified model that does not necessarily hold true 
for many cases in vivo, it is good for initial modeling (Wyllie and Chen, 2007).  The binding 
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of the antagonist can be eliminated by increasing the concentration of the agonist.  This is 
exactly what we observed when a high concentration of the agonist quinelorane was locally 
ejected into the brain.  Then, as quinelorane diffused away from the ejection point, its 
concentration in the synapses around the electrode decreases and haloperidol, the 
antagonist, once again dominates the competition for binding to the receptor.  
Drug Delivery Methods 
 
 Traditional drug delivery tools such as intraperitoneal (i.p.) or intravenous injections 
affect the system as a whole and potentially activate additional mechanisms on both sides of 
the blood-brain barrier that can affect the observed results.  Systemic drug application also 
comes with the disadvantages of time delay, potential side effects and toxicity (Hicks, 1984).  
Localized drug manipulations are therefore necessary to break the system down into 
individual parts and study each in isolation.  With respect to the brain, this leaves 
researchers with the options of microinjection, pressure ejection and iontophoresis.  
Microinjection, while more selective than a systemic injection, still provides relatively large 
injection volumes that can affect multiple, neighboring regions of the brain or specific 
pathways not under study.  Pressure ejection methods are prone to leakage and can disturb 
tissue at the ejection site. 
Fortunately, iontophoresis can deliver incredibly small volumes of concentrated 
solutions without leakage.  Iontophoresis allows for localized drug ejections directly into 
brain regions of interest by inducing the migration of ions with the application of a current to 
the solution of interest. Additionally by coupling iontophoresis barrels to a carbon-fiber 
microelectrode, a novel method by which iontophoresis can be quantified has been 
developed based on the original design of Armstrong-James and co-workers (Armstrong-
James et al., 1981; Herr et al., 2008) and presented in the schematic in Figure 2.1.  With 
this probe, the same microelectrode that is used to sense changes in neurotransmitter   
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Figure 2.1.  Schematic of an iontophoresis probe coupled to a carbon-fiber microelectrode. 
A positive or negative current is applied to the iontophoresis probe by an external DC power 
supply.  This current causes the migration of the solution within the barrel.  From Herr, N.R.; 
Kile, B.K.; Carelli, R.M.; and Wightman, R.M. (2008) Anal. Chem. 80,8635-8641.  
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release can also be used to confirm and quantify the iontophoretic ejection with fast-scan 
cyclic voltammetry (FSCV).  This makes iontophoresis an appealing technique for use in 
pharmacological studies involving specific brain regions.  
Iontophoresis 
 
Iontophoresis allows for the ejection of both charged and neutral molecules through 
a combination of migration and electroosmosis. In glass capillaries pulled to a sharp tip a 
few microns in diameter, the migration of ions is induced with the application of a current to 
the solution of interest.  The linear velocity of a solution ejected by iontophoresis ( obsυ ) is 
defined by 
epeoobs υυυ +=      (2.1) 
where eoυ is the velocity of electroosmotic flow and epυ is the rate of migration.   These terms 
are further defined as  
EEζ eoeo µη
ευ =−=       (2.2) 
Eepep µυ =        (2.3) 
where epµ and eoµ are  the migration and electroosmotic mobilities respectively.  E is the 
applied electric field, ε is the permittivity, ζ is the ζ -potential at the interface of the glass 
capillary and solution, and η  is the viscosity of the solution (Herr et al., 2008). 
 Classically, the moles of a species ejected with a given current in iontophoresis has 
been determined by  
zF
iTnM =       (4) 
where n is the transport number, i is the applied current, T is the ejection time, z is the 
charge, and F is Faraday’s constant (Stone, 1985).  Unfortunately, there is often a huge 
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difference between the moles predicted by equation 2.4 and the moles in an actual ejection 
since the equation only takes the electrophoretic mobility of compounds into account.  
While, iontophoresis has been used in the past as a general approach for localized drug 
delivery in vivo, it has been limited in use as a non-quantitative technique (Curtis, 1964; 
Bloom, 1974; Purves, 1980) until recently (Herr et al., 2008).  The inability of equation 2.4 to 
accurately predict the concentration of drug delivered means that the only way to account 
for all forces contributing to an ejection and accurately determine ejection concentrations is 
through direct measurement of individual ejections.   
Radioactive labels (Bevan et al., 1981), fluorescent detection (Purves, 1979) and 
electrochemical detection (Armstrong-James et al., 1981) have all been used to attempt 
quantification of iontophoretic ejections.  The cumbersome task of radiolabelling compounds 
or limiting the technique to use only with fluorescent or electroactive molecules made each 
method too impractical for widespread use however. 
Electrochemical techniques allow for the quantitative monitoring of the concentration 
of an ejection based on the oxidation and reduction of the ejected compound.  One major 
limitation to this method of monitoring ejection molarity is that the drug of interest must be 
electroactive.  So, while the idea of monitoring iontophoretic ejections with electrochemistry 
was initially proposed in the early 1980’s (Armstrong-James et al., 1981) and has been used 
to examine catecholamine diffusion and rates of DA clearance (Rice and Nicholson, 1989; 
Kiyatkin et al., 2000) it has until recently (Herr et al., 2008) not been practical to use this 
technique for localized drug delivery.  The ability to only monitor the ejection of electroactive 
compounds has been overcome with the use of a neutral, electroactive marker molecule 
that can be co-ejected with nonelectroactive drugs of interest.  Using a neutral molecule has 
further reinforced the long held belief that electroosmosis plays some role in iontophoretic 
ejections (Curtis, 1964; Bloom, 1974; Purves, 1979; Purves, 1980; Bevan et al., 1981; Pikal 
and Shah, 1990; Scott et al., 1993; Volpato et al., 1995; Bath et al., 2000; Guy et al., 2000).  
33 
 
By making the neutral marker for electroosmotic flow (EOF) electroactive, the carbon-fiber 
microelectrode coupled to the iontophoresis probe can be used to quantify directly just how 
much of the marker is ejected and to indirectly calculate how much of the nonelectroactive 
drug of interest is concurrently co-ejected.  Additionally, the contribution of EOF to 
iontophoretic ejections allows for the ejection of neutral or even negatively charged 
compounds with the application of a positive ejection current.  
Iontophoresis ejections are controlled by the same combination of migration of 
charged particles and electroosmotic flow that is seen in capillary electrophoresis.  The 
similarities of these two techniques allows a comparison between retention times for 
electroactive and nonelectroactive compounds in capillary electrophoresis to serve as an 
indicator of the iontophoretic flow rate of nonelectroactive compounds in relation to a neutral 
electroactive marker.  The electrophoretic mobilities of AP and other drugs of interest can be 
used to determine the concentration of other electrochemically inactive charged or neutral 
drugs co-ejected with AP.  A ratio of electrophoretic mobilities of drugs of interest with 
respect to AP can be determined by capillary electrophoresis where the electrophoretic 
mobility (µep) of each compound is calculated as  












=
V
L
t
L t
r
epµ       (2.5) 
where L is the distance between the inlet and the detector, tr is the time required for the 
analyte to reach the detector, V is the applied voltage, and Lt is the total length of the 
capillary (Skoog, 1998). 
Using electrochemistry to monitor iontophoretic ejections, it has been established 
that while there is large variability in ejection concentration from barrel to barrel for a given 
current, there is a direct relationship between ejection current and amount of drug ejected 
for each individual barrel (Figure 2.2).  The reproducibility of a series of ejections from a 
single barrel is excellent however as shown in Figure 2.3.  Additionally, while the quantity of   
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Figure 2.2.  The direct relationship between ejection current and amount of drug ejected with 
iontophoresis. For all barrels, 5 mM AP was ejected for 30 s with the requested current 
which varied from 5 nA to 55 nA.  Barrels 1-3 were attached to different carbon fiber 
electrodes while barrels 4 & 5 were attached to the same electrode.  
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Figure 2.3.  The reproducibility of iontophoresis ejections from a single barrel (n=4).   All 
ejections were normalized to the first ejection for that particular barrel ([AP]/[AP]i).  
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drug ejected for a given current does vary greatly from barrel to barrel the quantity of AP 
ejected can be monitored and manipulated in real time to reproducibly administer a 
quantitative amount of drug, regardless of the behavior of a particular barrel.  
While the coupled use of electrochemistry and iontophoresis is not common, 
iontophoresis has been utilized in tandem with electrophysiology to yield important results 
on the direct effects of small amounts of drug on the firing of single neurons.  White and 
Wang combined single-unit electrophysiology and iontophoresis in anesthetized rats to 
show that D1R and D2R are found post-synaptically on neurons in the nucleus accumbens, 
and that these neurons have differential responses to D1R and D2R drugs (White and 
Wang, 1986).  By using iontophoresis for drug delivery, White and Wang were able to 
monitor similar cells, with the same electrode and in the same animal, unquestionably 
showing the presence of differentiated D1R and D2Rs.  The use of iontophoresis allows for 
drug ejections so small that they dilute to insignificant quantities as they diffuse away from 
the ejection point.  Additionally, ejections only affect an area a few hundred microns across 
meaning that relocating the probe gives access to a brain region completely free of 
previously ejected drugs.  If systemic drug delivery were used, only one drug could be used 
per animal since complete washout from the brain of an anesthetized animal is unlikely.  
Other groups have used a similar approach in awake animals to show the roles that 
exogenous glutamate and DA play on dopaminergic cell firing (Rebec, 1998).   
The ejection reproducibility of iontophoresis when coupled to the time resolution of 
FSCV gives us the unique ability to monitor both the drug ejection and its effects on 
neurotransmitter release quantitatively, in real-time.  Dose response curves can be 
generated relating the concentration of drug iontophoresed to the modulation of extracellular 
neurotransmitter concentrations in vivo.  These dose response curves provide researchers 
with the opportunity to begin linking receptor occupancy and DA release in specific brain 
regions with behavior in freely-moving animals.  Ideally, these dose response curves can be 
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constructed in freely moving rats to manipulate the concentration of a given neurotransmitter 
and monitor the affects these changes have on behavior.  
General Overview 
 
While our lab has previously adapted a method to quantitatively monitor 
iontophoretic ejections, the technique had until recently not been applied in vivo to modulate 
electrically evoked release of DA in anesthetized rats.  A neutral, electroactive marker 
molecule that is ejected purely by EOF was used to monitor indirectly the ejection of 
nonelectroactive dopaminergic drugs (raclopride, quinpirole, quinelorane, and nomifensine).  
The modulation of stimulated release in an anesthetized animal using a 30 s ejection of 
quinelorane is demonstrated and changes in evoked DA release are seen 30 s from the 
conclusion of the ejection.  Presented here are the first attempts at creating dose-response 
curves that monitor changes in electrically evoked DA due to the introduction of DA agonists 
and antagonists.  Coupling iontophoresis and FSCV allows quantitative relationships 
between receptor occupancy to be linked with millisecond temporal resolution for the first 
time.  This technique allows for more reproducible ejections from barrel to barrel and with 
these more accurate measurements of drug ejections, more precise dose response curves 
were constructed. 
Presented here are the first attempts at creating dose-response curves monitoring 
changes in electrically evoked DA due to the introduction of DA agonists and antagonists.  
Coupling iontophoresis and FSCV allows quantitative relationships between receptor 
occupancy to be linked with millisecond temporal resolution for the first time.  Here dose-
response curves were created as quinelorane replaces haloperidol at the D2 autoreceptors.   
Quinelorane has a higher affinity for the D2R than DA (Bates et al., 1991; Mercier et al., 
2001) making it an excellent drug with which to begin this modeling.  The high brain 
concentration of haloperidol after i.p. administration and its high affinity for the D2 
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autoreceptor ensures that after an ejection haloperidol will once again occupy the 
autoreceptors when quinelorane diffuses away.  Haloperidol has been found to accumulate 
22 times more in the brain compared to serum (Tsuneizumi et al., 1992) and to have an 
affinity 20 times greater for the D2R over the D3 (Sokoloff et al., 1990).  So administration of 
haloperidol by i.p. injection before other drugs are locally injected into the brain ensures that 
all receptors are occupied and allows for the use of the model of competitive antagonism to 
be used when constructing dose response curves. This is important because changes in 
tonic DA concentration are not accounted for in the current model and cannot be monitored 
or quantified using FSCV (Wightman et al., 2007). 
Recently, the Wightman lab (Herr et al., 2010) presented the first use of quantitative 
iontophoresis for modulation of DA release in the striatum of anesthetized rats.  Results 
presented here indicate that pharmacologically active cations such as nomifensine, 
quinpirole and raclopride are ejected at approximately twice the rate of AP, the neutral EOF 
marker.  We also established that the applied current and the EOF marker did not affect 
evoked DA release or uptake, validating the method’s assumption that only the drug of 
interest is responsible for any change in evoked DA concentration after an ejection.  Here 
the D2 autoreceptor agonist quinelorane is iontophoretically ejected to modulate 
extracellular DA levels in the striatum of anesthetized rats that have received systemic 
ejections of haloperidol.  Results show that modulation is rapid, with the onset of the drug 
effect occurring in less than 30 s.   
Going even further, the extent to which the DA signal is modified can be quantified 
and used to create dose-response curves that show just how much quinelorane is required 
to cause a given percent decrease in electrically evoked DA release.  Initial results show this 
technique allows the construction of sigmoidal dose response curves that are reproducible 
at multiple locations along the dorsal ventral axis in the striatum of a single animal.  
However, variations in sensitivity to drug dosage are seen from animal to animal lending 
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credence to the theory of biological variation from animal to animal both in terms of drug 
sensitivity and DA receptor density (Mandt et al., 2008; Mandt et al., 2009; Mandt and 
Zahniser, 2010).  This work lays the foundation for future experiments in freely-moving 
animals where localized drug ejections can be associated with the study of reward-seeking 
behaviors.   
 
MATERIALS & METHODS 
 
Chemicals 
 
Unless otherwise noted, all chemicals were purchased from Sigma-Aldrich (St. Louis, 
MO) and used as received. Solutions were prepared using doubly distilled deionized water 
(Megapure system, Corning, NY).  A physiological buffer solution, pH 7.4, (15 mM TRIS, 126 
mM NaCl, 2.5 mM KCl, 25 mM NaHCO3, 2.4 mM CaCl2, 1.2 mM NaH2PO4, 1.2 mM MgCl2, 
2.0 mM Na2SO4) was used in all electrochemical experiments.  
Construction of Iontophoresis Probes 
 
 Iontophoresis probes were constructed by filling one barrel of multibarrel (three or 
four) fused glass capillaries (Stoelting Co., Wood Dale, IL) with a single glass barrel (A-M 
Systems, Carlsborg, WA) already containing a single carbon fiber (Thornel T-650, Amoco 
Corp., Greenville, SC).  The filaments aid in the filling of the iontophoresis barrels with 
solution while the addition of the extra, filament free single glass barrel around the carbon 
fiber (CF) helps eliminate cross-talk between barrels and ensures the filament of the outer 
barrel does not interfere with the quality of the carbon fiber-glass seal.  Heat shrink was then 
applied to the ends of each multibarrel glass capillary before being pulled on a vertical 
micropipette puller (Narashige, Tokyo, Japan) in a two step process. The electrode was then 
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cut so the length of exposed carbon fiber was 20-50 µm and the barrel backfilled with an 
electrolyte solution (4 M KC2H3O2, 150 M KCl).  A three barrel probe is seen in Figure 2.4.    
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Figure 2.4.  Scanning electron microscopy image of a carbon-fiber iontophoresis probe.  
Carbon-fiber iontophoresis probes are made starting with three barrel glass.  The carbon 
fiber is in one of the barrels leaving two empty barrels for iontophoresis.  Modified from Herr, 
N.R.; Kile, B.K.; Carelli, R.M.; and Wightman, R.M. (2008)  Anal Chem 80, 8635-8641.  
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Electrochemistry 
 
FSCV was performed using locally constructed hardware and software (Michael et 
al., 1999).  A triangle waveform (-0.4 V to 1.3 V) was applied to the carbon fiber at a scan 
rate of 400 V/s at a frequency of 60 Hz for pre-conditioning and 10 Hz for data acquisition.  
The potential was held at -0.4 V between scans.  The generated current was filtered at a 
frequency of 2 kHz.   
Iontophoresis Ejections 
 
Ejections were carried out via a 30 s application of a positive current (1 nA to 
250 nA) to the iontophoresis barrel containing the solution to be ejected.  All currents were 
generated using a NeuroPhore BH-2 (Harvard Apparatus, Medical Systems Research 
Products, Holliston, MA).   
Ejected solutions were composed of 0 mM to 20 mM quinelorane and 5 mM AP 
dissolved in a 5 mM NaCl solution, pH 5.5, to help promote electroosmotic flow.  For all 
quantitative ejection experiments, a current of 0 nA was applied to barrels between 
ejections.   
Anesthetized Rat Surgery  
 
In vivo experiments were carried out using male Sprague-Dawley Rats (300-500 g, 
Charles River Laboratories, Wilmington, MA) anesthetized with 1.5 g/kg urethane (50% 
urethane/50% saline, w/w).  Urethane has been established, with respect to other 
anesthetics, to minimally inhibit brain metabolism, neuronal activity, and response to stimuli 
(Buzsaki et al., 1983).  Using bregma as a reference, holes were drilled through the skull for 
placement of the working electrode in the striatum (AP +1.2 mm, ML +2.0 mm,  DV -4.0 to -
6.0 mm) and bipolar stimulating electrode  in the medial forebrain bundle (MFB) (AP -2.8 
mm, ML +1.7 mm,  DV -7.0 to -9.0 mm).  A reference electrode (Ag/AgCl) was implanted in 
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the posterior half of the contralateral hemisphere.  Biphasic stimulation of the MFB was 
performed with an analog stimulus isolator (A-M Systems, Sequim, WA) and in house 
software (Tarheel CV).  All experiments were performed with a 60 Hz, 40 pulse, 300 µA 
biphasic stimulation.  Stimulations were applied between potential scans to avoid electrical 
interference in the cyclic voltammograms (CVs). 
Calibration Procedure 
 
 At the conclusion of each experiment, electrodes were calibrated in vitro for 
sensitivity to both DA and AP using a four point calibration procedure over the range of 
0.5 µM to 4000 µM.  Calibrations were carried out using a flow injection apparatus as 
previously described by Kristensen (Kristensen et al., 1986) and the same calibration 
method used with iontophoresis probes by Herr et al. (Herr et al., 2008).  Here, a loop 
injector was mounted on an actuator (Rheodyne model 7010 valve and 5701 actuator) that 
was used with a 12 V DC solenoid valve kit (Rheodyne, Rohnert Park, CA) to introduce 
either DA or AP to the outlet of a six-port rotary valve where is the electrode is positioned 
(Kristensen et al., 1986).  The linear flow velocity (1.0 cm s-1) was controlled with a syringe 
infusion pump (Harvard Apparatus model 940, Holliston, MA).  
Capillary Electrophoresis 
 
Capillary electrophoresis experiments were carried out on a custom built system 
constructed in-house that consisted of a 30 kV power supply (Spellman CZE 1000R, East 
Tambaram, Chennai, India) and an absorbance detector (Linear UVIS 200, Hauppauge, 
NY).  Absorbance was measured at 193 nm in all experiments.  All separations were 
performed on a 50 µm (inner diameter) fused silica capillary with a total length (Lt) of 
96.0 cm and a distance of 87.5 cm between the inlet and the UV detector (L).  All 
experiments were carried out in cationic mode with the outlet acting as the cathode.  Data 
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was collected and analyzed using a custom LabVIEW program (courtesy of Dr. James 
Jorgensen, UNC-CH) and IGOR Pro (WaveMetrics, Inc., Lake Oswego, OR).  Samples 
contained approximately 100 µM of each compound in 5 mM phosphate buffered saline 
(PBS), pH 5.5.  This was consistent with the pH and buffer composition of the drug solutions 
ejected in the iontophoresis experiments.   
Very similar to iontophoretic ejections (equation 2.1) the electrophoretic mobility (µep) 
of each compound in the capillary electrophoresis experiments was calculated using:  
eoappep µµµ −=      (2.6) 
Where the mobility due to the applied current (µapp) and the mobility due to electroosmosis 
(µeo) were determined from capillary electrophoresis specific variations on equation 2.5 and 
calculated as:   
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L is the distance from the inlet to the detection point, tr is the time required for the analyte to 
reach the detection point, tneutral is the time required for the neutral species (AP) to reach the 
detection point, V is the applied voltage, and Lt is the total length of the capillary. 
In Vivo Protocol 
 
In each animal, a “hot-spot” for the stimulated release of DA (Moquin and Michael, 
2009) was found within the previously listed range of dorsal-ventral surgical coordinates and 
then stimulated every 120 s.  When a stable level of stimulated DA release was seen for 10 
consecutive stimulations, haloperidol (0.5 mg/kg rat unless otherwise noted) was 
administered i.p.  Haloperidol was dissolved in bacteriostatic water with citric acid at pH ~2 
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and then brought back up to a pH of 5.5 to 6.0 with 0.1 M NaOH.  The DA signal was then 
recorded every 120 s until the signal stabilized for 5 consecutive stimulations (normally 9-15 
stimulations or 18 to 30 min).  At this point, manipulation of the DA signal with 30 s ejections 
of quinelorane was initiated.  Stimulations were carried out every 120 s to ensure that a 
depletion of intracellular DA was in no way affecting the observed stimulated release.  The 
30 s drug ejections were timed to occur in the 120 s interval between stimulations, so the 
timing of the stimulations was not interrupted.  Additionally, the first post-ejection stimulation 
took place about 30 s after the cessation of the ejection.  While quinpirole is more often 
used in experiments that involve modulation of the D2 autoreceptors and as such is better 
characterized, quinelorane was used in these experiments due to its greater binding affinity 
and specificity for the receptor (Foreman et al., 1989; Storey et al., 1995).  Finally, the probe 
was lowered 400 µm further into the brain to a region unaffected by previous ejections 
where the protocol could be repeated (Herr et al., 2010). 
Construction of Dose Response Curves 
 
 Dose response curves were generated using the variable slope sigmoidal dose 
response curve and single site binding hyperbola regressions in GraphPad Prism 4.02 
(GraphPad Software, Inc., San Diego, CA).  The variable slope sigmoid equation was used: 
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where y is the percent change in DA response, x is the logarithm of the quantity of 
quinelorane administered, t is the maximal response (set to 0% in this case), and b is the 
response seen in the absence of the drug (always set to 100%).  The program then 
determines logEC50, the drug dose that would give a 50% change in DA release and H is a 
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measure of the slope of the linear region of the curve.  For dose response curves with an 
arithmetic dosage scale the following one site binding hyperbola equation was used: 
xK
xBy
d +
= max
      (2.10)
 
where x and y are quantity of drug administered and resulting percent change in DA release 
respectively, Bmax is the drug concentration at maximal binding and Kd is the drug 
concentration required for half of maximal binding. 
 
RESULTS & DISCUSSION 
Determination of relative iontophoretic mobility 
 
 Relative iontophoretic mobilities, normalized to the mobility of a neutral molecule 
have been reported previously for DA, uric acid, and AP using electrochemical detection in 
co-ejection experiments and used to establish both the role of electroosmosis in 
iontophoresis and the similarities in ejection forces in iontophoresis and CE (Herr et al., 
2008).  In those experiments, mobilities were determined electrochemically as the relative 
ejection amounts in a series of experiments where DA, uric acid and AP were co-ejected 
with 2-(4-nitrophenoxy) ethanol (NPE).  Unfortunately the use of electrochemical detection 
with this coejection technique limits its use to electroactive compounds, so an indirect 
method must be used to determine the relative iontophoretic mobility with respect to a 
neutral marker of nonelectroactive compounds of interest.  Overall, iontophoretic mobility at 
a capillary tip and electrophoretic mobility through a capillary column are both governed by a 
combination of migration of charged ions and electroosmosis so capillary electrophoresis 
can be used to calculate electrophoretic mobilities.  Evidence of a linear correlation between 
iontophoretic and electrophoretic mobilities in capillary electrophoresis experiments has 
previously been established (Herr et al., 2008) and here will be used to indirectly determine 
the iontophoretic mobilities of nonelectroactive compounds. 
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Use of UV-VIS detection instead of electrochemical in the capillary electrophoresis 
experiments allowed the retention times of both electroactive and nonelectroactive 
compounds to be determined.  A representative electropherogram measured for DA, 
nomifensine, quinelorane, quinpirole, raclopride, AP, and uric acid is shown in Figure 2.5.  
The relative retention time of each compound with respect to AP was then used to 
determine the contribution of electrophoretic mobility to the migration of each compound 
through the CE.   
These mobilities were then used along with relative co-ejection rates to create the 
coordinates to graph uric acid, AP and DA in Figure 2.6.  These three points were then used 
create the linear regression that was used to determine the iontophoretic ejection rates 
relative to EOF based on the electrophoretic mobilities of the nonelectroactive compounds 
from the CE experiments.  The relative iontophoretic ejection rates extrapolated from Figure 
2.6 are summarized in Table 2.1.  Data from a previous version of this experiment (Herr et 
al., 2010) indicated that raclopride will be ejected at a rate 1.75 times as fast as AP and 
quinpirole ejected at a rate 2.18 times as fast as AP, lending credence to the reproducibility 
of both the ratio of iontophoretic to electroosmotic flow and our laboratory’s method to 
determine this ratio. 
With the relative iontophoretic mobilities in hand, electrochemical techniques can be 
utilized to quantitatively monitor the ejection of nonelectroactive compounds.  In this 
procedure, a known concentration of AP was coejected with a known concentration of a 
neuroactive, but not electroactive, drug of interest, here quinelorane.  During the 
iontophoretic ejection, the oxidation and reduction current from AP was monitored.  The 
voltammetric signal measured for AP was then directly related to the amount of drug ejected 
via the relative iontophoretic mobilities with respect to a neutral species and the relative 
concentration of the drugs in the solution.   
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Figure 2.5.  Representative electropherogram  from the capillary electrophoresis experiment 
used to determine contribution of EOF and relative electrophoretic mobility of compounds.  
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Figure 2.6.  Relationship between iontophoretic and electrophoretic mobility.  Black squares 
() represent the electroactive compounds uric acid (U), AP, and DA plotted using 
previously reported  iontophoretic ejection rates relative to EOF (taken to correspond to the 
amount of the neutral ejected) and  electrophoretic mobilities determined here with CE.  
These points were then used to construct the linear regression seen.  The open green 
squares (□) represent raclopride (R), quinelorane (QL) , quinpirole (QP), and nomifensine 
(N) which were then plotted along the linear regression based on their electrophoretic 
mobilities calculated from the capillary electrophoresis experiments to determined the 
relative iontophoretic ejection rate relative to EOF.  
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Table 2.1.  Rate of iontophoretic delivery relative to electroosmotic mobility of 
acetaminophen (AP) 
Compound  
Concentration Ejected  
Relative to AP 
Nomifensine  2.24 
Quinpirole  2.18 
Quinelorane  1.85 
Raclopride  1.68 
 
 
  
51 
 
Localization of iontophoretic ejections 
 
Substances dilute into the surrounding environment primarily by diffusion when 
ejected from the iontophoretic barrel (Rice and Nicholson, 1989).  Taking this diffusion into 
account helps to better estimate the concentration of drug at receptors responsible for the 
change in evoked release of DA in response to a drug ejection.  Figure 2.7A shows a 
schematic of an iontophoresis barrel with an attached carbon fiber electrode along with 
circles modeling the diffusion sphere of compounds from the point at which they are ejected.  
For a substance nondestructively monitored by voltammetry at the carbon fiber, the 
amplitude of the voltammetric current is expected to increase as the ejected substance 
diffuses from the ejection point down the length of the fiber, and to remain constant once the 
diffusion distance exceeds the electrode length.  As such, the rise time of the voltammetric 
current should be related to the length of the electrode, with longer electrodes having longer 
rise times because of the greater time required for the diffusion sphere to fully encompass 
the electrode.  Additionally, diffusion can be considered not only the when looking at how 
long it takes for a particular carbon fiber to sense a constant concentration of drug but also 
to look at how long a compound stays in the vicinity of the carbon fiber at the cessation of 
the ejection.  Figure 2.7B shows a representative color plot collected during a 30 s 
iontophoretic delivery of AP into agarose gel and for 120 s after the ejection.  Figure 2.7C 
shows examples of the current traces for two different 30 s ejections of AP into agarose gel 
along with the decay of the current monitored for an additional 120 s at the conclusion of the 
ejection.  These particular ejections put out such a large concentration of AP that adsorption 
to the electrode may also be playing a role in the lingering AP current, but the larger 
ejections clearly illustrate the diffusion of drug away from the ejection point.  While the 
ejection of additional material from the iontophoretic barrel stopped as soon as a current 
was no longer applied to the barrel, the ejected material did not suddenly disappear but   
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 Figure 2.7.  Spatial distribution of an iontophoretic ejection.  (A)  Tip of iontophoresis probe 
and attached exposed carbon fiber superimposed on two-dimensional representation of 
ejection spheres 25 µm (green), 36 µm (blue), and 100 µm (tan) to illustrate the sphere size 
for a carbon fiber of that length to experience a constant concentration.  The green line 
shows the time required for an ejection sphere of a given size to develop as a function of 
diameter.  (B)  Representative color plot for a 30 s iontophoretic ejection that reaches steady 
state at 56 nA AP.  At the conclusion of the ejection, CVs were collected for an additional 
120 s to demonstrate the diffusion of AP away from the carbon fiber after an ejection.  (C) 
Current traces for two different 30 s ejections of AP into agarose gel along with the decay of 
the current monitored for an additional 120 s at the conclusion of the ejection.  
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instead diffused away from the ejection point.  This can help to tell us approximately how 
much of our drug of interest, here quinelorane, was present 30, 60, 90, or 120 s after the 
ejection giving an idea of how much of the drug is actually working on receptors around the 
carbon fiber at these later times when the  release of DA was once again evoked.  
The average concentration of AP still present at the carbon fiber after the cessation 
of the iontophoretic ejection is listed in Table 2.2  as a percentage of the concentration of 
the AP delivered during the ejection (n=7).  In our calculations, the percent of drug detected 
60 s after the ejection was used to determine the concentration of quinelorane causing the 
observed decrease in DA stimulated release.  While Table 2.2 shows the combined 
averages for diffusion of an ejection into agarose gel and into the brains of anesthetized 
animals, this same experiment can be carried out in the brain of an anesthetized animal at 
the start of an experiment to account for the diffusion characteristics of the ejection point 
source, the specific carbon fiber, and the brain of the animal.  Experiments carried out in 
vivo showed similar diffusion times and have been factored into the averages in Table 2.2. 
Effects of iontophoresed reagents on dopamine sensitivity  
 
The concentration of AP sensed by the carbon fiber is in fact an average 
concentration of AP present along the length of the carbon fiber.  The drug concentration at 
the portion of the carbon fiber closest to the iontophoresis tip is orders of magnitude greater 
than this average concentration and presumed to be very near the drug concentration inside 
the barrel (5 mM).  Exposure of the carbon fiber microelectrode to high drug concentrations 
during iontophoretic ejections could potentially alter the sensitivity of the electrode to DA as 
reported for nomifensine in similar experiments and GBR 12909 (Davidson et al., 2000).  A 
series of carbon-fiber iontophoresis probes were calibrated before and after iontophoretic 
ejections to determine if any loss in DA sensitivity occurs.  One of the iontophoresis barrels 
was loaded with 10 mM of AP or 10 mM AP plus 10 mM of the drug of interest.  While   
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Table 2.2.  Concentration of acetaminophen at the carbon fiber after ejection current is turned off.  
 
Time after ejection 
(seconds) 10 30 60 90 120 
Drug present  
(% of ejection 
concentration) 
19.94 ± 4.55 7.43 ± 2.05 3.26 ± 1.32 1.95 ± 1.04 1.34 ± 0.83 
 
  
55 
 
electrochemically monitoring the response of AP, the loaded solution was ejected into buffer 
for 40 min at a current sufficient to continuously deliver approximately 10 µM of AP 
(generally between 10-15 nA).  The results from these experiments are presented in 
Table 2.3 as the average and standard deviation of three separate experiments.  The 
neutral EOF markers AP and NPE did not significantly alter DA sensitivity.  Pharmacological 
agents, such as nomifensine, quinpirole, and raclopride, have slight effects on the 
electrodes’ response to DA, but the ejection times and concentrations used during these 
sensitivity experiments were considerably longer than would be used in most in vivo 
experiments.  Given the small effect observed even with these prolonged iontophoresis 
conditions, the iontophoresis of these drugs during in vivo experiments should not 
significantly affect the DA sensitivity of the carbon fiber. 
Effects of large ejection currents on stimulated dopamine release in anesthetized 
animals 
 
Iontophoretic literature has discussed that current artifacts can be seen neurophysiologically 
due to the introduction of Na+ and Cl- that are present in a drug solution (Curtis, 1964; 
Stone, 1985).  While cell firing was not monitored in these experiments it was still important 
to determine if currents applied by the iontophoresis pump for an ejection altered the 
stimulated release of DA.  The stimulated release of DA was monitored before and after the 
ejection of NaCl with currents up to +505 nA, double the maximum currents used even in 
very large ejections in in vivo experiments.  An example of this experiment can be seen in 
Figure 2.8.  A representative baseline trace is shown in Figure 2.8A.  To test the effects of 
large currents on DA release, NaCl was iontophoresed for 30 s using large pump currents 
following stimulation.  This current trace cannot be quantitatively linked to a concentration of 
saline ejected, but it does serve to confirm the occurrence of an ejection.  Stimulation was 
repeated after the ejection of saline with excessive current, and the maximum amplitude of 
released DA and its time course remained the same.  Measurements were repeated every   
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Table 2.3.  Effect of Drugs on Carbon Fiber Sensitivity for Dopamine 
Compound(s) Ejected Post Ionto/Pre Ionto Sensitivity (nA/nM)  
AP 1.00 ± 0.10  
AP + NPE  1.01 ± 0.07  
AP + Nomifensine  0.86 ± 0.08  
AP + Quinpirole 0.91 ± 0.08  
AP+ Raclopride 0.87 ± 0.07  
AP+ Quinelorane 0.94 ± 0.07 
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Figure 2.8.  Effect of current on stimulated dopamine release. The panels show current as a 
function of time.  (A) A representative baseline current trace for the stimulated release of 
dopamine.  (B)  Representation of iontophoretic ejection of 2 nA saline. (C)  Current trace for 
stimulated release after ejection seen in B.  There is no change in the extracellular 
concentrations of dopamine seen in A and C elicited with a stimulation indicated by the red 
bar at t=0 for each trace.  
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120 s for a total of 30 min with no significant change in the amount of DA released or rate of 
uptake observed as shown in Fig 2.8C (n=4 animals with three release sites tested in each 
animal for 12 total locations). The ejection of NaCl was confirmed electrochemically as the 
combination of an acidic pH shift and increased capacitance in the double layer at the 
electrode’s surface.  As Figure 2.9 illustrates, increased capacitance was also seen in a 
NaCl injection in the flow cell, but as the trace in Figure 2.9B shows, this is not the only 
factor contributing to the in vivo saline CV.  The NaCl ejected with large currents does alter 
the double layer of the carbon fiber, although this is not seen with the lower ejection currents 
typically used.   
Effects of EOF marker on stimulated dopamine release  
 
Before this technique was used to investigate the effect of DA agonists at 
autoreceptors on electrically stimulated DA release, it was important to ensure that AP did 
not affect stimulated DA release.   Figure 2.10 shows the results of a representative 
experiment in an anesthetized rat.  A carbon-fiber iontophoresis probe was lowered into the 
striatum and a ‘hot-spot’ for the stimulated release of DA found.  A representative baseline 
trace and color plot are shown in Figure 2.10A.  To test the effects of the EOF marker on DA 
release, AP was iontophoresed for 30 s following stimulation.  The amount of AP delivered 
was monitored electrochemically, and the concentration vs. time trace and color plot are 
shown in Figure 2.10B.  The stimulation was repeated after AP delivery.  The maximum 
amplitude of released DA and its time course remained the same.  Measurements were 
repeated every 2 min for a total of 30 min, and no significant change in the amount of DA 
released or rate of uptake was observed as shown in Fig 2.10C (n = 9, p > 0.01).  The same 
experiment was performed for NPE, with no measurable difference observed from control 
(Herr et al., 2010).  The experiment was also carried out in anesthetized rats after the i.p. 
administration of haloperidol with no significant change in electrically evoked DA release   
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Figure 2.9.  Comparison of NaCl CVs in vitro and in vivo.  (A)  The CV and colorplot for an in 
vitro injection of NaCl.  The colorplot shows a 5 s injection of 27 mM NaCl into Tris buffer at 
pH 7.4.  CVs were taken at the times indicated with a white dashed line in the colorplots.  
The rectangular shape of the CV, while still keeping sharp features, indicates an increase in 
capacitance at the surface of the electrode.  (B)  Representative CV and color plot for an in 
vivo ejection of NaCl.  The color plot is a 30 s ejection of 5 mM NaCl at pH 5.8 into the brain 
of an anesthetized animal and the CV was taken at the time indicated with a white dashed 
line in the colorplot.   While this CV also shows the broadening characteristic of increased 
capacitance, there is also a shape change in part associated with acidic pH.  
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Figure 2.10.  Effect of AP on stimulated dopamine release. The top panels show current as 
a function of time while the lower panels are two-dimensional colorplots where current is 
shown in false color on the potential vs. time axes.  (A)  A representative baseline current 
trace and colorplot for the stimulated release of DA.  (B)  Representation of iontophoretic 
ejection of 3 µM AP.  The white dashed line (t=0) indicates application of a positive current 
to the barrel.   (C)  Current trace and colorplot for stimulated release immediately after 
ejection seen in B.  There is no change in the extracellular concentrations of DA seen in A 
and C elicited with a stimulation indicated by the red bar and t=0 for each trace.  
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observed.  This ensured that AP did not interact with haloperidol or the D2 autoreceptor in a 
way that altered electrically evoked DA release in the striatum.   
Effect of systemic administration of haloperidol on the stimulated dopamine release  
 
In vivo the amount of DA released per stimulation remains fairly constant during the 
stimulation of the MFB (May et al., 1988).  Additionally, the increase in stimulated DA 
release stays more or less constant with haloperidol administered i.p. (Wiedemann et al., 
1992).  A 0.5 mg/kg challenge of haloperidol given i.p. was previously established to 
increase stimulated extracellular DA levels four-fold in approximately 40 min and from there 
slowly decay to half of the pre-challenge levels over the course of nine hours (Wiedemann 
et al., 1992).  In this study, a similar dose of haloperidol caused approximately a 2.5-fold 
increase in extracellular DA and remained at this elevated level for at least an hour (though 
usually much longer) in all cases before slowly decaying back down to below the initial DA 
concentration in the same manner described previously.  Figure 2.11 shows the electrically 
evoked DA release recorded at 120 s intervals over the course of four hours both with and 
without the i.p. administration of haloperidol at 20 min (indicated by the arrow).  Without the 
administration of haloperidol, the signal decays 10% over the first 2 to 2.5 hours with about 
a 30% decrease seen after 4 hours and a 50% decay in signal after 5 hours of stimulations.  
In the presence of haloperidol, stimulated release reaches a maximum level one hour into 
recording (40 minutes after i.p. injection) at 2.3-times the initial baseline concentration.  The 
signal then decreases 33% over the next four hours, showing a decay trend consistent with 
evoked release in the absence of haloperidol.   
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Figure 2.11.  Temporal response (•) of extracellular DA concentration induced by electrical 
stimulation of the medial forebrain bundle of a rat given haloperidol (0.5 mg/kg, i.p.) at 
20 min (arrow). DA response to repeated stimulations in rat without haloperidol on board is 
represented with ▲.  Stimulations were repeated every 2 min.  
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Modulation of stimulated release of dopamine with quinelorane can be monitored 
over several hours for multiple ejections 
 
 It was previously established that localized ejections of drugs that interact with 
D2 autoreceptors affect stimulated DA release in the same manner as systemic ejections 
but on a much faster timescale (Herr et al., 2010).  The timecourse for the effects of 
localized drug ejections on stimulated DA release had not yet been explored however.  
Here, quinelorane was used to decrease the stimulated release of DA.  Figure 2.12 shows 
the current versus time traces and color plots for the stimulated release of DA before and 
after the quinelorane ejection (Figure 2.12B).  In the example shown in Figure 2.12A, there 
was approximately 1.03 µM DA released in response to the stimulus indicated by the 
dashed white line.  After a 6.5 µM quinelorane ejection (Figure 2.12), 0.754 µM DA was 
detected at the electrode in response to the stimulus (Figure 2.12C), a 22.7% decrease in 
the electrically evoked release of DA after the local ejection.  The time course of both the 
onset and recovery of the drugs affects was then monitored for trends between the 
concentration of drug administered and duration and extent of modulation to the DA signal.  
In Figure 2.12, and in all other experiments, the concentration of quinelorane during 
the time of the ejection was determined from the plateau current for AP seen during the 
ejection.  This current was converted into an AP concentration using the data from post-
experiment calibration of the carbon fiber for AP sensitivity.  Finally, using the relative 
iontophoretic mobility from Table 2.1 along with a ratio of the relative concentrations of AP 
and quinelorane in the ejection solution, the concentration of quinelorane during the ejection 
was indirectly determined.  Again, this reported quinelorane concentration at the time of the 
ejection measured the maximum output of drug during the ejection.  As the data in Table 2.2 
reports, this concentration quickly decays away at the cessation of an ejection.  In order to 
account for this rapid decay of drug that occurs before DA is once again electrically evoked, 
the percentage of the ejection concentration of the drug remaining at 60 s after the ejection   
64 
 
 
 
 
 
 
Figure 2.12.  Stimulated dopamine release in an anesthetized animal before and after a 
localized ejection of solution containing both AP and quinelorane.  The top panels show 
current as a function of time while the lower panels are two dimensional colorplots where 
current is shown in false color on the potential vs. time axes.  (A)  A representative baseline 
current trace and colorplot for the stimulated release of dopamine.  (B)  Representation of 
iontophoretic ejection of 30.6 µM AP and 6.5 µM quinelorane.  The white dashed line (t=0) 
indicates the onset of current application to the barrel.  Note that quinelorane cannot be 
seen in the color plots or current as a function of time traces.   (C)  Current trace and 
colorplot for stimulated release after ejection seen in B.  The extracellular concentration of 
DA seen in C less than 50% of that evoked in A.  In both A and C the time of stimulation is 
indicated by the white dashed line at t=0. 
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was reported as the concentration of quinelorane present at the first post-ejection electrical 
stimulation of DA. 
Figure 2.13 shows the typical time course for the repeated iontophoretic ejection of 
quinelorane into the striatum of an anesthetized rat after the systemic i.p. administration of 
haloperidol.  Again, each point represents the release of DA in response to an electrical 
stimulation.  Stimulation events occurred every 120 s.  An increase in the concentration of 
quinelorane administered resulted in further depression of the stimulated release of DA.  
Regardless of quinelorane concentration, depression of the DA signal occurred during the 
stimulation immediately following the iontophoretic ejection, which occurred less than 30 s 
after the conclusion of the ejection.  However, the greater the concentration of quinelorane 
administered, the longer it took for the maximum depression in stimulated release to occur. 
In Figure 2.13, the 45.8 nM ejection of quinelorane causes a 21.0% decrease in the 
DA signal within the first 30 s but over the course of the next 8 min the DA signal continues 
to decrease to 59% of the pre-ejection DA signal.  Recovery times varied from animal to 
animal, but consistently increased with increasing drug concentration.  There was also 
consistently a recovery of the DA signal to the concentrations seen before the quinelorane 
ejection, at which point drug was again iontophoresed and modulation of the signal 
monitored.  These repeated ejections showed a reproducible time course and magnitude for 
similar concentrations of quinelorane indicating that recovery of the signal can also be used 
to tease out diffusion rates and relative drug affinities for the D2 autoreceptor.  The 
timecourse seen in Figure 2.13 also establishes that repeated ejections can be carried out in 
the same location in an animal over the course of 3 hours with the decay in baseline DA 
signal following the same trend seen in Figure 2.11.  This means that the same location can 
be stimulated for several hours and repeatedly modulated as long as the signal is allowed to 
recover back to the original baseline concentration before the next ejection, an act not 
possible with systemic injections.  The duration of DA modulation after a quinelorane   
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Figure 2.13.  Time course for changes in stimulated dopamine release with ejections of 
quinelorane.  Modulation of stimulated release of dopamine with quinelorane can be 
monitored over several hours for multiple ejections. 
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ejection was typically 20 min or less for changes of less than 50% to the DA signal (but 
never more than 30 min).   
Dose response curves built using the neutral marker technique instead of pump 
current as an indicator of ejected drug concentration 
 
 Iontophoretic drug ejections are typically monitored and reported as a function of the 
current applied to a barrel.  The complaints that iontophoresis is unpredictable and 
irreproducible can be traced to the use of this method to monitor ejections.  While pump 
current may serve as a decent indicator of relative ejection amounts from a single barrel, 
Figure 2.2 demonstrates that there was a large variation in the ejection from barrel to barrel 
for a given current and no way to account for this variation without actually monitoring 
ejections.  
 Here, an iontophoresis probe consisting of a single carbon fiber coupled to three 
iontophoresis barrels all containing the same drug solution (0.5 mM quinelorane and 
5 mM AP) was inserted into the striatum of an anesthetized rat.  After a stable baseline of 
stimulated release was established, a 10 nA current was applied to one of the iontophoresis 
barrels.  When the stimulated DA signal had recovered to the pre-ejection baseline, a 10 nA 
current was then applied to a different iontophoresis barrel.  This was carried out with 10, 30 
and 90 nA on all three barrels, as well as with 145 nA and 234 nA currents on the first 
barrel.  The ejection currents as well as the subsequent percent decrease in stimulated DA 
release were then plotted regardless of barrel number and a linear dose response curve 
(linear scale on both the x- and y-axes) fitted to the data (Figure 2.14A).  The three very 
different responses to the same current seen at 10 nA, 30 nA and 90 nA in Figure 2.14A 
clearly illustrate the complaint about the perceived irreproducibility of iontophoresis.  The 
variation in the changes in signal for the three points at each current once again confirms 
the claim that barrels do have individual slopes (Figure 2.2).   
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A
B
C
 Figure 2.14.  Linear dose-response curves constructed where ejected (dose) is recorded as 
the pump current compared to our technique where concentration of AP is monitored and 
used to calculate the concentration of the drug of interest.  (A)  Dose response curve for the 
change in extracellular dopamine for a given current (nA) requested on the iontophoresis 
pump for three different iontophoresis barrels in the same animal.   (B)  Dose response 
curve for the change in extracellular dopamine concentration for a given current (nA) of AP 
measured in real time during the ejection with FSCV in the same experiment displayed in A.  
The measured [AP] is shown in the top x-axis while the concentration of quinelorane 
calculated from this measured concentration is seen in the bottom x-axis.  (C)  Zoomed in 
view of the ≤50% of predrug region of the graph seen in B.   Here, the measured 
concentration of AP is once again on the top x-axis while the calculated concentrations of 
quinelorane responsible for these changes are listed on the lower x-axis.  
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Figure 2.14B then shows the subsequent dose response curve created from the 
same experiment if the calculated concentration of quinelorane ejected, instead of ejection 
current was used.  The concentration of quinelorane was determined for each individual 
ejection on all three barrels by monitoring of the oxidation and reduction of the neutral 
marker, AP, the measured concentration of which is seen on the upper x-axis.  Using the 
concentration of quinelorane instead of the ejection current as the measure of dosage 
allowed for excellent agreement between the data points acquired and a regression that fits 
the behavior of a linear dose response curve.  Additionally, using the calculated 
concentration of quinelorane instead of ejection current, nanomolar concentrations of 
quinelorane can be linked to reductions in the electrically evoked DA release seen within the 
caudate of an anesthetized animal (Figure 2.14C).   
Since quinelorane is the compound responsible for the decrease in stimulated DA 
release, the goal was to determine a method that allows quantitative ejection of this 
nonelectroactive drug.  For the curve in Figure 2.14B, quinelorane’s EC50 (which again gives 
potency but not necessarily affinity for a receptor) was 62 nM.  While a larger value than the 
EC50 value of 5.3 ± 11 nM determined for quinelorane in brain slices our calculated values 
still come within an order of magnitude of reported values (unpublished, Dissertation of C. 
Miller, 2008).  Additionally, according to tritium radiolabel binding studies in vitro on brain 
slices quinelorane bound with an incredibly high affinity (KD=1.8 nM) with very low non-
specific binding (Gackenheimer et al., 1995).  The systemic administration of haloperidol 
does have an effect on the KD of quinelorane however and the same study also confirmed 
that D2 antagonists inhibited the binding of quinelorane and specifically that haloperidol had 
a Ki of 3.1 nM for this inhibition (Gackenheimer et al., 1995).  The order of magnitude 
discrepancy between the EC50 reported here and that determined in vitro in slices in our lab 
can be attributed to two factors:  the competitive antagonism of haloperidol at the receptors 
of interest and potentially inflated calculated quinelorane concentrations at the synapses of 
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interest during stimulations. While the presence of haloperidol at the receptors definitely 
decreased the potency of quinelorane, there most likely still remains a discrepancy between 
the maximum concentration of quinelorane during the ejection and the concentration of 
quinelorane actually interacting with D2 autoreceptors at the time of evoked release that still 
needs further investigation beyond the diffusion studies carried out thus far.  But, this affects 
only the potential accuracy of the EC50 values seen on our dose response curves not the 
validity of the method for monitoring the ejection.  Finally, while the presence of haloperidol 
at receptors was needed to ensure that variations in tonic DA do not affect quinelorane 
potency at receptors, an estimated EC50 in the absence of haloperidol could potentially be 
obtained through the construction of a series of competitive antagonist dose response 
curves at various haloperidol concentrations. 
Construction of an intra-animal dose response curve 
 
While the heterogeneity of receptors from region to region and even with a single 
region in the brain has long been debated it was established to not be an issue over the 
length of a carbon fiber (Venton et al., 2003) but is still potentially an issue as the electrode 
is moved further down into the brain.  This is theorized to be a result of changes in tonic DA 
levels within a region, which unfortunately cannot be monitored over time using background-
subtracted FSCV.  The application of a D2 antagonist has been shown to eliminate or 
greatly reduce this heterogeneity in the rat striatum however (Moquin and Michael, 2009).  
This behavior supports the theory that tonic extracellular DA levels cause any differences in 
electrically evoked release from location to location or for a given dosage of drug.  With 
haloperidol occupying many of the DA autoreceptors we want to manipulate, any changes in 
tonic DA should not affect stimulated release or recovery time of the DA signal after a drug 
ejection.  Additionally, quinelorane has a higher affinity for the D2 autoreceptor than DA 
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itself (Storey et al., 1995) so the relationship explored was only competitive antagonism of 
the D2 autoreceptor between haloperidol and quinelorane.   
After stabilization of DA stimulated release with haloperidol on board, quinelorane 
(0.5 mM) and AP were co-ejected for 30 seconds as the stimulated release of DA was 
continually monitored every 120 seconds until the signal recovered to pre-drug levels.  
When stimulated release re-stabilized post-ejection, drug was once again iontophoresed 
using a larger positive ejection current.  Ejections were repeated for 5 different AP currents 
over 3 orders of magnitude had been collected in a single location in the animal’s brain.  
These drug ejections and the subsequent reductions in stimulated release of DA were then 
used to construct the sigmoidal dose response curve seen in Figure 2.15.  The probe was 
then moved a minimum of 400 µm further down into the brain until another DA hotspot was 
located.  At this new location, drug was once again iontophoresed using different positive 
currents while monitoring the ejection via AP current.  The drug ejection concentrations and 
the changes in DA stimulated release they induced were then plotted on the dose response 
curve made higher up in the brain.  This process was then repeated at 400 µm intervals 
further down into the striatum.   As Figure 2.15 shows, the dose response curve created at 
the initial location in the brain also described the dose-response relationship seen further 
down in the caudate and nucleus accumbens.  This gives credence to the homogeneity of 
the D2 autoreceptor density in the with regards to the area over which the carbon fiber 
measures average responses. 
 
CONCLUSIONS 
 
Here controlled iontophoresis was used to not only modulate the stimulated release 
of DA in vivo but to create dose response curves modeling the role of the agonist 
quinelorane at the D2 autoreceptor with stimulated release of DA.  First the relative 
iontophoretic mobilities of nonelectroactive compounds with respect to a neutral marker   
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Figure 2.15.  Sigmoidal dose response curve for quinelorane in an anesthetized animal with 
quinelorane concentrations on a logarithmic scale.  Curve was constructed using the points 
collected at the original location (▲) and the data collected at the two deeper locations (Δ 
and ○) plotted on the same graph.  R-squared value is for data points from all three locations 
in comparison to the curve created using the original location however.  
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molecule were determined using CE and UV-VIS detection.  The diffusion from the point of 
an iontophoretic ejection was then examined to better give an idea of the dose of drug 
present when “responses” were measured.  The neutral marker molecules of choice and 
large ejection currents were established to have no effect on the stimulated release of DA in 
the striatum and AP, NPE, nomefensine, raclopride, quinpirole and quinelorane were 
determined to have no significant effect on the DA sensitivity of a carbon-fiber 
microelectrode. 
After establishing that the technique itself did not modify the stimulated release of 
DA, the modulation of stimulated release in an anesthetized animal using quinelorane was 
demonstrated and carried out over several hours both in the same location in the rat brain 
and at 400 µm intervals more ventral in the brain with consistent responses to drug 
dosages.  This technique also allowed for more reproducible ejections from barrel to barrel 
and with these more accurate measurements of drug ejections, more precise dose response 
curves were constructed. 
Future works includes determining the range of magnitudes over which the sigmoidal 
dose response curves modeled here hold true and to determine the extremes to which the 
DA signal can be modulated with this technique.  Finally, while the presence of haloperidol 
at receptors was needed ensure that variations in tonic DA do not affect quinelorane 
potency at receptors, an estimated EC50 in the absence of haloperidol could potentially be 
obtained through the construction of a series of competitive antagonist dose response 
curves at various haloperidol concentrations.  
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Chapter 3 
Iontophoretic modulation of neuronal transmission and cerebral oxygen:  
Proof of principle and word of warning 
 
INTRODUCTION 
 
 The brain is composed of a complex neuronal network where neurons synapse onto 
one another to transmit information via chemical signaling.  Glucose, the raw material to fuel 
this energy intensive process, is delivered with molecular oxygen (O2) to this network via 
blood.  As Figure 3.1 shows, astrocytes serve as the intermediary between neurons and 
blood vessels of all sizes (Attwell and Laughlin 2001).  Astrocytes play a central role in 
neurometabolic coupling and cerebral blood flow (CBF) by producing lactate and ATP from 
glucose provided by blood vessels.  Lactate then fuels synaptic transmission. The tight 
coupling between CBF and neural activity is referred to as functional hyperemia and has 
been established in studies that monitor both events simultaneously (Thompson, Peterson 
et al. 2003). 
 Increased CBF delivers glucose and Ca2+ to a region and removes CO2 and H2O 
from that same region (Figure 3.1B).  While CBF can be measured directly with optical 
methods (Lauritzen 2001; Harrison, Sigler et al. 2009) or by measuring the rate at which H2 
is removed from a region (Young 1980), changes in O2 concentration also serve as an 
indicator of changes in CBF (Boutelle, Zetterstrom et al. 1990; Lowry, Boutelle et al. 1997).  
Consumption of glucose by metabolic processes in the brain is the prime reason increases   
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Figure 3.1.  How cerebral blood flow fuels neuronal signaling.  A) The neuro-vascular unit 
consists of pre- and post-synaptic neurons that synapse onto one another to transmit 
chemical signals.  Blood vessels and microcapillaries provide the raw materials to fuel this 
energy demanding neurotransmission.  The activities of vessels and neurons are mediated 
by astrocytes and glia that synapse onto both.  B)  Blood vessels deliver O2 and glucose to 
astrocytes where they are used to create the fuel for neural processes (ATP) and carry away 
the byproducts of this reaction, CO2 and H2O. 
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in CBF are seen to coincide with neuronal activity.  The simultaneously delivered O2 is not 
consumed as rapidly by the brain and thus increases in CBF are accompanied by a large 
overshoot in O2 concentration in a region (Fox, Raichle et al. 1988).  
Complex signaling cascades, involving many different chemical messengers, 
regulate all steps in functional hyperemia.  Individual chemical messengers can be 
monitored and manipulated to understand the relationship between neuronal transmission 
and CBF.  The association between local O2 and neuronal activity has primarily been 
evaluated for glutamatergic neurotransmission and is relatively well understood (Zonta, 
Angulo et al. 2003; Attwell, Buchan et al. 2010).  Glutamate stimulates aerobic glycolysis 
which results in the release of lactate from astrocytes. Lactate then contributes to the 
activity-dependent fuelling of the neuronal energy demands associated with synaptic 
transmission. Additionally, glutamate and Ca2+ intake by astrocytes can trigger a cascade of 
events that increases CBF at capillaries (Attwell, Buchan et al. 2010).   
Glutamate is involved in many neuronal pathways in the nucleus accumbens (NAc) 
(Iadecola and Nedergaard 2007) and thus its neurotransmission in this region is also well 
studied.  Because of its established ability to increase cell firing in a region, glutamate is 
commonly introduced directly into the brain with iontophoresis to modulate cell firing (White 
and Wang 1986; Kiyatkin and Rebec 1996; Kiyatkin and Rebec 1999; Kiyatkin and Rebec 
1999).  Here we use the technique of controlled iontophoresis (Belle, Owesson-White et al. 
2013) to electrochemically monitor the direct application of exogenous glutamate to the NAc.  
During this application we simultaneously monitor O2 changes electrochemically 
(Zimmerman and Wightman 1991; Zimmerman, Kennedy et al. 1992; Venton, Michael et al. 
2003) and cell firing with electrophysiology (Cheer, Heien et al. 2005) to better understand 
the relationship between glutamate release, postsynaptic signaling cascades, and functional 
hyperemia.  Finally, using this well understood relationship between glutamatergic signaling 
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and functional hyperemia we confirm the utility of this combined electrochemical technique 
to understand the role of neuroactive substances in functional hyperemia. 
METHODS 
 
Chemicals 
 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) and used as 
received.  Solutions were prepared using deionized water.  Phosphate buffered saline (PBS) 
(0.010 M), pH 7.4, was used in all calibration experiments. 
Surgeries 
 
Male Sprague-Dawley rats (350-500 g; Charles River, Wilmington, MA) were 
anesthetized with urethane (1.5 mg/kg) and placed in a stereotaxic frame (Kopf, Tujunga, 
CA).  Surgeries were performed as previously described (Herr, Daniel et al. 2010).  The 
working electrode was placed in the NAc (2.2 AP, 1.7 ML, DV 7.0-8.0) (Paxinos and Watson 
2007) and a bipolar stimulating electrode (Plastics One, Roanoke, VA) was lowered into the 
MFB (-2.8 AP, 1.7 ML, 7.8-8.6 DV).  The carbon-fiber and stimulating electrodes were 
individually adjusted in the dorsal−ventral coordinate to optimize O2 release.  A Ag/AgCl 
electrode was placed in the contralateral hemisphere and secured with a stainless steel 
screw to act as both reference for the carbon-fiber electrode and a ground for the 
iontophoresis barrels.  All procedures were approved by the Institutional Animal Care and 
Use Committee of the University of North Carolina. 
Electrochemical Data Acquisition and Presentation 
 
Electrochemical data were acquired using data-acquisition hardware and local 
software (HDCV) written in LabVIEW (National Instruments, Austin, TX).  The cyclic 
voltammetry waveform was generated and the voltammetric signal acquired with a computer 
interface board, the PCIe-6363 X Series (National Instruments).  The voltammetric 
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waveform was input into a custom-built instrument for application to the electrochemical cell 
(University of North Carolina at Chapel Hill, Department of Chemistry Electronics Facility).  
Background subtraction, signal averaging, and digital filtering (low-pass filtered at 2 kHz) 
were under software control.  To avoid distortion caused by background drift, scans used for 
background subtraction were recorded within 2 minutes of the subtracted data. 
The waveform was applied at a scan rate of 400 V/s with a rest potential of 0.0 V 
versus the Ag/AgCl reference electrode between scans.  The voltage was scanned linearly 
from the rest potential to +0.8 V, followed by a scan to -1.4 V and back to the rest potential.  
Before measurements were recorded, the carbon fiber surface was conditioned with this 
waveform repeated at 60 Hz.  After conditioning, scans were repeated every 100 ms.   
Iontophoresis Probe Preparation 
 
Three barrel iontophoresis probes with an attached carbon-fiber electrode were 
constructed as described previously (Belle, Owesson-White et al. 2013).  For application of 
glutamate, a barrel contained 200 mM L-glutamic acid, 5 mM of the electroactive marker, 
4-methylcatechol (4-MC), and 5 mM NaCl and another barrel contained just 5 mM 4-MC in 
5 mM NaCl.  The exact electrophoretic mobility of glutamate with respect to 4-MC was not 
determined due to equipment malfunctions.  Instead, the electrophoretic mobility of 
glutamate was estimated based on the experimental mobility of uric acid, an anion of similar 
charge and mass.  Uric acid has a relative electrophoretic mobility of 0.49 with respect to a 
neutral species (Herr et al., 2008) and here we use this same value to calculate glutamate 
concentrations.  For barrels containing ethylene glycol tetraacetic acid (EGTA) or calcium 
(Ca2+) bromide hydrate, 20 mM was dissolved in 5 mM NaCl.  Because EGTA adsorbs to 
the electrode surface, its signal prevented quantization.  Ejection currents were delivered by 
a constant current source designed for iontophoresis (Neurophore, Harvard Apparatus, 
Holliston, MA).  Positive current was used to eject all drugs. 
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Experimental Protocol 
 
The probe was slowly lowered to 1.0 mm above the NAc where the electrode was 
conditioned for 15 min before application of the waveform every 100 ms.  The iontophoresis 
barrels were primed as described previously (Herr, Daniel et al. 2010) and pump currents to 
deliver desired amounts of each drug were determined at this depth.  Between probes and 
from barrel to barrel, the amount of current required to achieve a desired concentration 
varied from 10 nA to 400 nA with 0 nA applied between ejections.   
The electrode was then lowered into the NAc (7.0 mm DV).  For experiments where 
chemical information and cell-firing were monitoring simultaneously the waveform was 
altered to concurrently allow FSCV and electrophysiological recordings (Owesson-White, 
Cheer et al. 2008).  A solid-state relay in the headstage alternated between the current 
amplifier for voltammetric scans and a voltage follower for unit-recording. The unit-recording 
interval had a 20 ms gap every 180 ms when voltammograms were collected.  In the first 
5 ms of this interval, a potential of -0.4 V was applied.  The potential sweep for voltammetry 
remained the same as during the initial cycling.   
Once in the NAc, data collection occurred at sites where a single unit was isolated. A 
single unit was classified as an MSN if baseline firing frequency was below 15 Hz and the 
waveform duration was less than 1.2 ms (Kish, Palmer et al. 1999; Carelli and Ijames 2001). 
After unit activity was monitored for 20 min to ensure a constant firing rate, drug was applied 
to the unit.  Units recorded at carbon-fiber electrodes were amplified (x 1,000) and band-
pass filtered (300–3,000 Hz).  All signals were digitized with commercially available software 
(DIGITIZER, Plexon, Dallas, TX) and isolation of a unit was accomplished with principal 
component analysis in commercially available software (OFFLINE SORTER, Plexon, Dallas, 
TX).  Digital outputs synchronized HDCV (FSCV) and Plexon (electrophysiology) records to 
iontophoretic ejections or electrical stimulations.   
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Data was displayed as a colorplot with the applied voltage plotted on the ordinate, 
time on the abscissa, and resulting current changes in false color.  Colorplots allow 
examination of multiple cyclic voltammograms (CVs) recorded over several seconds 
simultaneously.  O2 is reduced at -1.3 V and 4-MC is oxidized at 0.7 V. 
Flow Injection Apparatus 
 
In vitro experiments and calibration of carbon-fiber microelectrodes occurred in a 
flow injection analysis system (Kristensen, Wilson et al. 1986).  The linear flow velocity (2.0 
mL/min) was controlled with a syringe infusion pump (Harvard Apparatus model 940, 
Holliston, MA).  An injection valve, controlled by a 12 V DC solenoid, introduced analyte 
from an injection loop (volume of 0.7 mL) into an electrochemical cell. The carbon-ﬁber 
microelectrode was lowered through the electrochemical cell into the opening of the 
attached PEEK tubing.  Five concentrations between 500 nM to 1 µM were used to 
construct the 4-MC calibration curve.  O2 calibrations were carried out on an O2 
impermeable system using air (~21% O2), an O2 saturated solution and nitrogen saturated 
solution with the exact concentration of O2 in each solution calculated as described 
previously (Zimmerman and Wightman 1991).   
 
RESULTS & DISCUSSION 
 
Increased medium spiny neuron activity with local glutamate application 
 
 Here we demonstrate that extracellular glutamate concentrations influence the firing 
rate of medium spiny neurons (MSNs), neurons found post-synaptically in the NAc.  To 
examine prolonged (60 s) effects of glutamate on MSN firing, the firing rate of an isolated 
MSN was monitored for 30 minutes in an awake or urethane anesthetized animal.  This 
same MSN was then monitored for 30 minutes during which 30 15 s iontophoretic 
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applications of glutamate occurred at equally spaced intervals.  Figure 3.2A shows the firing 
rates during these two periods for a single MSN in a single awake animal.  As Figure 3.2B 
shows, MSNs fire more frequently in an awake animal.  Awake rats have more extracellular 
glutamate than those under urethane anesthesia (Windels and Kiyatkin 2006).  We also 
confirm that local application of additional glutamate increased cell firing in both basal 
glutamate conditions.  This implies that in an awake but quiescent animal, glutamatergic 
receptors are not yet saturated and demonstrates the utility of our drug delivery technique to 
apply small (but not saturating) drug concentrations to a region.   
O2 changes with local glutamate application 
 
 In addition to increasing the firing rate of MSNs, local glutamatergic activity has been 
shown to increase CBF (Lauritzen 2001; Vlassenko, Rundle et al. 2006).  CBF and O2 
changes are also directly related to one another (Boutelle et al., 1990), but the direct 
confirmation that glutamate can induce local changes in O2 has not been reported.  Here, we 
show that glutamate does induced changes in O2 and demonstrate the utility of using 
controlled iontophoresis coupled to electrochemical detection of O2 to monitor functional 
hyperemia.  Application of less than 50 µM of glutamate along with 4-MC caused an 
increase in O2 (Figure 3.3B) while ejection of 4-MC alone did not (Figure 3.3A) (n=5).  This 
result demonstrates controlled iontophoresis’ ability to monitor and modulate O2 dynamics in 
the intact brain.  While glutamate’s role in functional hyperemia has been studied 
extensively using methods that monitor CBF (Lauritzen 2001; Vlassenko, Rundle et al. 
2006), or optical techniques that monitor blood-oxygen level-dependent (BOLD) responses   
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Figure 3.2.  Glutamatergic modulation of MSN firing.  (A)  Histogram of average firing rate 
for a single MSN in an awake rat in baseline conditions (black) and with glutamate 
application (grey).  The blue bar indicates the onset and duration of glutamate application 
that began at t=0s. . (B)  The average baseline firing rate for MSNs (n=4) in animals under 
urethane anesthesia (left, dark blue) or awake (right, light blue) are shown in addition to the 
average firing rate of these same MSNs with exogenous glutamate application.  All firing 
rates are significantly different from one another (p<0.0001, 1-way ANOVA with Tukey’s 
post-test).  
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Figure 3.3.  Glutamate evoked changes in O2.  Colorplots show FSCV data collected around 
30 s ejections of 4-MC (A, light blue) or 4-MC & glutamate (B & C, orange) with time on the 
x-axis and potential sweep on the y-axis as labeled.  Oxidation of 4-MC occurs at 0.7 V and 
O2 changes are monitored just before -1.3 V.  Above each colorplot is a trace showing 
changes in O2 concentration with time extracted from the current at the potential marked 
with a white dashed line in each colorplot.  (A) ejection of 10 µM 4-MC alone, (B) ejection of 
1.5 µM 4-MC & 40 µM glutamate,  (C) ejection of 5 µM 4-MC & 100 µM glutamate. 
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(Enzi et al., 2012; Falkenberg et al., 2012), this is the first demonstration of glutamate’s 
ability to induce local changes in O2. 
 Interestingly, when ten times more glutamate was applied to the same location in the 
NAc, the expected increase in O2 no longer occurs.  Instead, decreases in [O2] of up to 
20 µM occurred a few seconds into the application of this higher concentration of glutamate 
(Figure 3.3C) (n=5).  These large decreases are of the same magnitude as the increases in 
O2 seen with electrical stimulation (Venton, Michael et al. 2003).  The decreases are likely 
due to increased metabolic activity in response to excessive glutamate application that is 
known to cause neuronal damage (Shimada, Graf et al. 1989).  Such neuronal damage has 
been shown to cause a burst in MSN firing followed by a cessation in firing activity (Paschen 
1996; Schousboe, Sonnewald et al. 1997; Mehta, Prabhakar et al. 2013).  Figure 3.3C 
displays the O2 changes that accompany this toxic overstimulation of MSNs and 
demonstrate the danger of applying too much glutamate into the brain as can happen when 
techniques other than controlled iontophoresis.   
At many locations in the NAc there are regular, ongoing fluctuations in O2 
concentration (discussed in Chapter 4) occurring in the environment around the electrode 
that can be identified as such by their CVs (Figure 3.4A).  As Figure  3.4B shows, these O2 
fluctuations look electrochemically distinct from the oscillations seen after application of 
glutamate concentrations (> 1 mM) known to cause the O2 decrease seen in Figure 3.3C.  
These oscillations appear to be ionic changes in the charging current of the electrode 
because they exhibit current spikes at the voltages where the direction of the voltage scan is 
switched.  Such behavior can occur when electrochemically inert cations can adsorb to 
functional groups on the surface of the carbon fiber changing the double-layer   
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Figure 3.4.  Changes in the environment around the carbon-fiber electrode in vivo.  (A) 
Natural O2 fluctuations and (B) ionic oscillations induced with 2 s ejection of glutamate at the 
orange bar.  CVs to the right of each colorplot are from the time(s) indicated with a vertical 
dashed white line. 
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capacitance of the electrode and thus the charging of the double layer (Bath, Michael et al. 
2000; Bard and Faulkner 2001).  This adsorption of cations results in distinct background 
subtracted CVs unique from those seen for faradaic processes. 
Several cations including Ca2+, Mg2+, K+, H+ and Na+ maintain constant extracellular 
concentrations in the brain to support ionic gradients across cell membranes.  With 
excessive metabolic activity or an occlusion of CBF, these gradients are disturbed however 
(Dreier 2011), leading to large ionic changes that may appear in CVs.  Increased glutamate 
concentrations are shown to coincide with disruption of these gradients and inducing large 
Ca2+ ‘waves’ (Butcher et al., 1990; Wahl et al., 1994).  These ‘waves’ may then alter the 
ionic gradients of other neurons as well, an event referred to as spreading depression. 
In Figure 3.4B, a decrease in current is apparent a few millivolts after the -1.4 V 
switching potential.  The presence of this current decrease at the onset of a positive scan, 
regardless of initial potential, indicates that the current arises from capacitive changes.  Ca2+ 
and Mg2+ have been characterized previously (Takmakov, Zachek et al. 2010, Jones et al., 
1994; Kume-Kick and Rice, 1998) and were shown to cause shifts in the charging current of 
the carbon-fiber electrode that appeared as unique CVs after background subtraction.  
Physiologically relevant changes (~100 µM) in both Ca2+ and Mg2+ were not detectable in 
vivo in these studies.  But, Ca2+ changes seen in response to glutamate induced 
excitotoxicity may be much larger like the Ca2+ changes seen with occlusion of blood flow 
(Pluta et al., 1988; Dohmen et al., 2005) and thus apparent in these experiments.  Here, 
ionic fluctuations induced by glutamate are in fact creating unique CVs that serve as an 
indication of neuronal damage.  The fact that these oscillations are usually not seen in vivo 
with carbon-fiber electrodes provides evidence that they do not cause spreading depression 
by causing damage to tissue.  The appearance of these oscillations in background 
subtracted electrochemical experiments, however, can serve as an indicator of potential 
neuronal dysregulation in a region.   
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CONCLUSIONS 
 
With this combined electrochemical/electrophysiological/iontophoretic method we 
monitored the effects of exogenous glutamate on cell firing, CBF (via O2), and local ionic 
gradients.  Here we presented for the first time the O2 component of glutamatergic signaling 
and excitotoxicity in the NAc.  This work shows very clearly the potential negative 
consequences of blind glutamate application on ionic gradients, cell firing, and functional 
hyperemia.  The use of controlled iontophoresis to prevent in vivo neurotoxicity of 
exogenous glutamate application was also presented.  We also discuss the likelihood that 
Ca2+ fluctuations are responsible for the ionic shifts at the electrode and that these 
fluctuations likely indicate local neuronal damage, an important thing to recognize during 
experiments.   
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Chapter 4 
Serotonergic modulation of oxygen in two distinct brain regions 
 
INTRODUCTION 
 
 Despite occupying a relatively small volume, the mammalian brain demands 
disproportionately high amounts of O2 and glucose (Armstrong, 1982; Attwell et al., 2010).  
This high energy demand requires a tightly regulated vascular network to control cerebral 
blood flow (CBF) that operates independently of systemic or arterial blood pressure 
(Paulson et al., 1995).  Astrocytes, whose end-feet encapsulate the brain’s microcapillaries, 
are the gatekeepers for O2 and glucose exchange between the capillaries and neurons. 
Neuronal activation results in extra-cellular neurochemical cascades that allow astrocytes to 
sense and therefore balance supply and demand for energy (Iadecola et al., 2007). 
Additionally, serotoninergic terminals innervate the peri-vesicular space and its receptors 
are located directly on the blood vessels (Cohen et al., 1995).  
Local increases in O2 concentration result from increases in CBF (Lauritzen et al., 
2001), whereas decreases can be a result of increased metabolism and/or decreases in 
CBF.  Thus, local O2 changes are a good indicator of dynamic metabolic events.  Local in 
vivo O2 concentrations can be monitored noninvasively with a number of techniques.  
Positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) 
with blood-O2-level-dependent (BOLD) contrast (Samanez-Larkin et al., 2010) allow imaging 
of O2 changes within the intact brain of immobile subjects.  Intrinsic optical spectroscopy 
(Harrison et al., 2009) and laser doppler flowmetry (Lauritzen et al., 2001) are used 
extensively to characterize dynamic events associated with CBF.  Laser methods, unless 
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coupled with fiber optics that can damage tissue, are restricted to cortical regions. To study 
intact deeper brain structures, smaller and less invasive probes are required. 
Electrochemistry has previously been explored as a successful option (Clark et al., 1958; 
Bartlett et al., 2008; Bolger et al., 2011; Thompson et al., 2003).  In this study, we apply fast-
scan cyclic voltammetry (FSCV) at carbon-fiber electrodes, to simultaneously monitor 
electroactive neurotransmitters and O2 fluctuations in deep brain structures in real time 
(Venton et al., 2003; Zimmerman et al., 1991) with minimal tissue damage (Peters, 2004). 
The association between local O2 and neuronal activity has primarily been evaluated 
for glutamatergic neurotransmission (Attwell et al., 2010).  However, other neurotransmitters 
such as norepinephrine (Bekar et al., 2012), GABA, acetylcholine (Hamel et al., 2006), and 
histamine (Haas et al., 2008) also regulate CBF.  Our own studies showed a role for nitric 
oxide and adenosine in the rat striatum (Venton et al., 2003). Serotonin plays an important 
role for systemic blood regulation (Cohen et al., 1996) and there are several reports 
implicating its roles in modulating CBF.  For example, serotonin neurons increase their firing 
rates in response to acidic pH shifts and increases in CO2 (Richerson et al., 2004) and 
greatly affect cerebral glucose utilization (Bonvento et al., 1991).  Furthermore, serotonin 
terminals directly contact arterioles, capillaries, and astrocytes (Cohen et al., 1995).   Finally, 
astrocytes contain membrane-bound serotonin transporters (Inazu et al., 2001) and 
serotonin receptors (Hosli et al., 1993) implicating their role as an intermediary for 
serotoninergic regulation of neurovascular coupling (Cohen, 1996). 
Here, we more fully explore serotonin’s role in regulating CBF in deep structures of 
the rat brain by monitoring O2. We targeted two brain regions with differing serotoninergic 
anatomy; the nucleus accumbens (NAc), a region primarily composed of dopaminergic 
terminals but with 10% serotonergic innervation, and the substantia nigra pars reticulata 
(SNr), a region primarily composed of serotonin terminals (Moukhles et al., 1997).  We show 
endogenous O2 fluctuations in both regions and we utilized three strategies to examine 
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serotonin’s role in modulating this O2.  First, electrical stimulation was used to release 
serotonin throughout the NAc and SNr.  Then, pharmacology was employed to modulate 
serotonin dynamics while changes in O2 were monitored.  Finally, serotonin was directly 
introduced in discrete locations within the SNr or the NAc.  The results of these 
investigations present a compelling set of evidence that serotonin plays an important role in 
modulating O2 availability in select areas of the brain.  
 
METHODS 
Chemicals 
 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) and used as 
received.  Solutions were prepared using deionized water.  Brains for slice experiments 
were stored and sliced in a sucrose slice buffer consisting of 87 mM NaCl, 2.5 mM KCl, 1.2 
mM NaH2PO4, 0.5 mM CaCl2, 7 mM MgCl2, 25 mM NaHCO3, and 75 mM sucrose, pH 7.4.  
Artificial cerebral spinal fluid (aCSF) consisting of 126 mM NaCl, 2.5 mM KCl, 1.0 mM 
NaH2PO4, 2.4 mM CaCl2, 1.2 mM MgCl2, 25 mM NaHCO3, and 11 mM D-glucose, pH 7.4 
was used in slice experiments.  A physiological buffer solution (15 mM TRIS, 126 mM NaCl, 
2.5 mM KCl, 25 mM NaHCO3, 2.4 mM CaCl2, 1.2 mM NaH2PO4, 1.2 mM MgCl2, 
2.0 mM Na2SO4), pH 7.4, was used in all calibration experiments. 
Surgeries 
 
Male Sprague-Dawley rats (350-500g; Charles River, Wilmington, MA) were 
anesthetized with urethane (1.5 mg/kg) and placed in a stereotaxic frame (Kopf, Tujunga, 
CA).  Surgeries were performed as previously described (Herr, 2010).  The working 
electrode was placed in the NAc (2.2 AP, 1.7 ML, DV 7.0-8.0) or SNr (-5.2 AP, 2.5 ML, 
DV 8.0-8.6) (Paxinos & Watson, 2007) and a bipolar stimulating electrode (Plastics One, 
Roanoke, VA) was lowered into the medial forebrain bundle (MFB) (-2.8 AP, 1.7 ML, 7.8-
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8.6 DV).  Coordinates for the bipolar stimulating electrode ensure activation of the 
dopaminergic neurons projecting to the NAc and the serotoninergic neurons projecting to 
the SNr and NAc (Hashemi et al., 2011).  The carbon-fiber and stimulating electrodes were 
individually adjusted in the dorsal−ventral coordinate to optimize O2 release.  A Ag/AgCl 
electrode was placed in the contralateral hemisphere and secured with a stainless steel 
screw to act as both reference for the carbon-fiber electrode and a ground for the 
iontophoresis barrels.  All procedures were approved by the Institutional Animal Care and 
Use Committee of the University of North Carolina. 
Slice Preparation 
 
 Male Sprague-Dawley rats (350-500g; Charles River, Wilmington, MA) were 
anesthetized with urethane (1.5 mg/kg), decapitated, and brains immediately removed and 
placed in chilled sucrose buffer solution.  The aCSF was continuously saturated with 95% 
O2/5% CO2.  The brain was then mounted on a Teflon block with Krazy Glue® and sliced on 
a NVSL vibratome (World Precision Instruments, Sarasota, FL).  Slices were 300 µm thick 
and stored at 37 ºC in sucrose slicing buffer.  A single slice was then submerged under 37ºC 
aCSF in a superfusion chamber (Warner Instruments, Hamden, CT) and aCSF continuously 
replaced in the chamber at a rate of 2 mL/min.  Each slice was allowd to equilibrate for 30 
min in the chamber before the electrode was lower with the aid of a microscope into the 
region of interest in the slice. 
 
Electrochemical Data Acquisition and Presentation 
 
Electrochemical data were acquired using data-acquisition hardware and local 
software (HDCV) written in LabVIEW (National Instruments, Austin, TX). The cyclic 
voltammetry waveform was generated and the voltammetric signal was acquired with a 
computer interface board, the PCIe-6363 X Series (National Instruments). The voltammetric 
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waveform was input into a custom-built instrument for application to the electrochemical cell 
(University of North Carolina at Chapel Hill, Department of Chemistry Electronics Facility).  
Background subtraction, signal averaging, and digital filtering (low-pass filtered at 2 kHz) 
were under software control.  To avoid distortion caused by background drift, scans used for 
background subtraction were recorded within 2 minutes of the subtracted data. 
The waveform was applied at a scan rate of 400 V/s with a rest potential of 0.0 V 
versus a Ag/AgCl reference electrode between scans.  The voltage was scanned linearly 
from the rest potential to +0.8 V, followed by a scan to -1.4 V and back to the rest potential.  
Before measurements were recorded, the carbon fiber surface was conditioned with this 
waveform repeated at 60 Hz.  After conditioning, scans were repeated every 100 ms.   
Iontophoresis Probe Preparation 
 
Three barrel iontophoresis probes attached to a carbon fiber electrode were 
constructed as described previously (Belle et al., 2013).  For application of antagonists, one 
barrel contained 5 mM methiothepin and the other barrel contained 5 mM raclopride and 5 
mM SCH 23390.  All barrels contained 5 mM 4-methylcatechol that was used as an 
electroactive marker (Herr et al., 2010) and 5 mM NaCl.  The relative electrophoretic mobility 
of ralcopride (1.68) and SCH 23390 (1.90) with respect to 4-methylcatechol was used to 
calculate the concentration of each drug ejected (Belle et al., 2013; Herr et al., 2010).  
Because methiothepin strongly adsorbs to the electrode surface, its signal prevented 
quantification as reported for other substances (Herr et al., 2010).  When directly applying 
neurotransmitters, two of the iontophoresis barrels were filled with 5 mM dopamine and 
0.6 mM serotonin, both dissolved in 5 mM NaCl.  The third barrel contained 5 mM 4-
methlcatechol in 5 mM NaCl or NaCl alone.  Ejection currents were delivered by a constant 
current source designed for iontophoresis (Neurophore, Harvard Apparatus, Holliston, MA).  
Positive current was used to eject all drugs.   
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Experimental Protocol 
 
The probe was slowly lowered to 1.0 mm above the region of interest (6.0 mm for the 
NAc and 7.0 mm for the SNr) where the electrode was conditioned for 15 min before 
application of the waveform every 100 ms.  The iontophoresis barrels were primed as 
described previously (Herr et al., 2010) and pump currents to deliver desired amounts of 
each drug were determined at this depth.  Between probes and from barrel to barrel, the 
amount of current required to achieve a desired concentration varied from 10 nA to 400 nA.  
A current of 0 nA was applied between ejections.  To ensure a barrel was not leaking 
solution, a negative current was applied to the barrel while electrochemical information 
about the area directly around the carbon-fiber was recorded.  If there was a change in the 
background of the electrode or if any compound was ejected when the current was 
increased from its negative value to 0 nA the barrel was not used and a negative retaining 
current was applied to the barrel for the duration of the experiment. The electrode was then 
lowered into the NAc (7.0 mm DV) or SNr (8.0 mm DV).  In experiments involving electrical 
stimulation of the MFB, recordings were made at sites with optimized neurotransmitter and 
O2 signals (Zimmerman et al., 1991). 
An example set of optimized voltammetric recordings in the NAc are shown in 
Figure 4.1 in which chemical events were evoked with a 2 s, 60 Hz electrical stimulation of 
the (MFB).  Each cyclic voltammogram took approximately 10 ms to record and was 
background subtracted (Figure 4.1, left panel, the background was normally taken 1 s 
before the event of interest).  Data were displayed as a color plot (Figure 4.1, middle panel), 
with the applied voltage plotted on the ordinate, time on the abscissa, and measured current 
in false color.  Color plots allow examination of multiple cyclic voltammograms recorded over 
several seconds simultaneously.  Dopamine, with an oxidation peak at 0.6 V, is released 
during the electrical stimulation.  The time course of this release can be followed by 
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examining its oxidation current in successive cyclic voltammograms (Figure 4.1, green 
trace).  O2 is reduced at -1.3 V.  It too increases in concentration after the stimulation as 
shown by the changes in its reduction current in successive voltamograms (Figure 4.1, black 
trace).   
Calibrations 
 
The response of the carbon-fiber electrode was calibrated in a flow injection analysis 
system.  The linear flow velocity (2.0 mL/min) was controlled with a syringe infusion pump 
(Harvard Apparatus model 940, Holliston, MA).  O2 calibrations were carried out on an O2 
impermeable system using air (~21% O2), an O2 saturated solution and nitrogen saturated 
solution with the exact concentration of O2 in each solution calculated as described 
previously (Zimmerman et al., 1991).  The voltammetric current was measured at the peak 
potential for each analyte at four concentrations for serotonin and dopamine. 
Histology 
 
After animal experiments were complete, 15 V (vs Ag/AgCl) was applied to the 
electrode to lesion the region around the carbon fiber.  The animals were euthanized, and 
brains were removed from the skull and stored in 10% formaldehyde for at least 3 days. 
Brains were coronally sectioned into 40−50 μm thick slices with a cryostat and the lesion 
identified visually under a stereoscope equipped with a camera.  Data were discarded if the 
histology showed the lesion was not in the desired region.    
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Figure 4.1.  Voltammetric response of dopamine (DA) and O2 in the NAc evoked by a 2 s 
electrical stimulation (red bar) of the MFB.  Every 100 ms a cyclic voltammogram was 
collected showing changes in current for the potential scan (left).  (middle) This color plot 
contains 150 cyclic voltammograms placed sequentially with current changes encoded by 
color.  The vertical white dashed line (1) indicates a time for which a single cyclic 
voltammogram can be isolated and graphed with current changes as a function of potential 
(above) or time (far left).  The horizontal black dashed line (2) indicates the potential where 
O2 reduction is monitored and the horizontal green dashed line (3) represents the potential 
where DA oxidation is monitored with concentration traces (right) showing concentration 
changes for O2 (2) and DA (3). 
 
 
 
 
  
104 
 
RESULTS 
Naturally occurring changes in the brain.  
 
While an electrical or pharmacological stimulus is generally used to evoke changes 
in monoamines and O2, here background-subtracted cyclic voltammograms reveal 
spontaneous O2 oscillations in 90 % of the locations probed in the NAc and the SNr of the 
anesthetized rat.  Examples are shown in Figure 4.2 in which fluctuations in the measured 
current reveal O2 concentration changes.  The oscillations were observed spontaneously in 
the absence of pharmacological or electrical stimulations.  In some locations, large 
infrequent O2 fluctuations (Figure 4.2A) were recorded whereas in other regions more 
frequent O2 changes (Figure 4.2B) were observed.  In 18% of locations in the SNr, signals in 
addition to the O2 oscillations were observed (Figure 4.2C).  Individual cyclic 
voltammograms recorded at such locations showed current surges at the switching apices of 
the cyclic voltammograms.  Current surges at the switching apices can arise in the presence 
of cations such as Ca2+.  Cations adsorb to the electrode’s surface altering the surface 
capacitance and generating non-oxygen or neurotransmitter signals (Takmakov et al., 
2010).  Locations with ionic fluctuations were not used for O2 measurements because of the 
overlap in signals.   
When the electrode was lowered in 200 µm intervals through a brain region, different 
oscillatory patterns were observed at each location.  This suggests that local O2 changes 
depend on the relative proximity of the electrode to blood vessels, capillaries, astrocytes, 
and neurons.   
Effect of electrical stimulation parameters on O2 release in the SNr and NAc.   
 
MFB stimulations cause dopamine and serotonin release in the NAc and the SNr 
(Hashemi et al., 2011).  We previously showed that dopamine release in the striatum was 
accompanied by a biphasic O2 change (Venton et al., 2003).  The first phase of this increase   
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Figure 4.2.  Naturally occurring O2 changes.  For all panels, the potential scan applied to the 
electrode is shown on the vertical axis of the color plot and time on the horizontal axis.  The 
white dashed line indicates the potential at which the concentration changes in O2 (blue line, 
above each color plot) were monitored.  The vertical dashed line indicates where the cyclic 
voltammograms to the right of each colorplot was taken.  A)  Representative color plot of 
naturally occurring, large, infrequent O2 changes in the brain, collected in the NAc, 5 cyclic 
voltammograms collected at 52 s were averaged and used for background subtraction.  B)  
Representative color plot of frequent changes in O2 in the SNr.  Background was taken as 
the average of 5 cyclic voltammograms collected at 55 s.  C)  Representative color plot of 
ionic changes in the SNr.  Background was taken as the average of 5 cyclic voltammograms 
collected at 95 s. 
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occurred with the onset of electrical stimulation and then dissipated; the second, slower 
increase in O2 occurred many seconds after the electrical stimulation concluded and lasted 
at least 30 s.  In this work we replicated this finding in the NAc (Figure 4.3A) and also 
showed a similar biphasic O2 response in the SNr (Figure 4.3B).  In the NAc, we measured 
dopamine and O2 simultaneously (Figure 4.3A), and the cyclic voltammograms allowed each 
to be identified.  In the SNr, serotonin and O2 responses were collected in separate 
experiments.    
To determine how maximal evoked O2 concentration ([O2]max) varied with stimulus 
frequency, we examined both peaks during stimulations at 20, 40, and 60 Hz.  At each 
frequency, 120 biphasic pulses of 350 µA were applied.  In general, neurotransmitters reach 
higher concentrations during high frequency stimulations because there is less time for 
uptake to clear neurotransmitter in the time between stimulus pulses.  The insets in 
Figure 4.3 show the results of these stimulations on [O2]max  for each peak in both the NAc 
and SNr.  A slight decrease was seen for the [O2]max  of Peak 1 with increasing stimulation 
frequency in the NAc (slope of -0.92 ± 0.11 µM O2 per 20 Hz, r2=0.9417).  Peak 2 showed 
the opposite trend in the same region, with [O2]max  decreasing with stimulation frequency at 
a rate of 0.80 ± 0.01 µM O2 per 20 Hz (r2=0.9991).  In the SNr both O2 peaks decreased with 
stimulation frequency.  In the SNr, [O2]max  for Peak 1 decreased with stimulation frequency 
at a rate of 3.10 ± 0.19 µM O2 per 20 Hz (r2=0.9851) and [O2]max  for Peak 2 decreased with 
stimulation frequency at a rate of 1.52 ± 0.42 µM O2 per 20 Hz (r2=0.7661). 
Attenuation of stimulated O2 changes with methiothepin   
 
 In the striatum, adenosine is the chemical messenger that evokes Peak 2 (Venton et 
al., 2003; Zimmerman et al., 1992) therefore the following examines Peak 1.  Stimulations 
were repeated every 4 minutes until 5 consecutive stimulations showed similar responses.  
We systemically administered selective dopamine and serotonin antagonists.  For   
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Figure 4.3.  Effect of electrical stimulation parameters on subsequent O2 release in the SNr 
and NAc.  A)  Average O2 and dopamine (DA) concentration traces in the NAc (n = 6 rats).  
B)  Average O2 and serotonin (5-HT) concentration traces in the SNr (n = 6 rats).  In both 
panels, the red bar at 0 s indicates the onset of the 2 s electrical stimulation.  The circled 
labels designate Peak 1 and Peak 2 of the O2 response.  Inset graphs show the amplitude of 
change in [O2]max as a function of the frequency at which 120 350 µA pulses were applied to 
the MFB (n = 5 rats). 
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measurements in the NAc, raclopride (2 mg/kg), a D2 receptor antagonist, and SCH 23390 
(1 mg/kg), a D1 receptor antagonist, were first administered simultaneously via 
intraperitoneal (i.p.) injection.  This combined treatment decreased [O2]max slightly 
(n = 6 rats, p < 0.001) in the NAc from a maximal value of 11.6 ± 3.0 µM to 9.0± 2.6 µM 
(Figure 4.4A).  The nonspecific serotonin receptor antagonist methiothepin (20 mg/kg) was 
then administered i.p. 2 hours after injection of the dopamine antagonists.  As shown in 
Figure 4.4A, methiothepin caused [O2]max to decrease to 28% of the original signal, 
3.2 ± 1.0 µM (n = 6 rats, p < 0.0001).  Figure 4.4C shows averaged concentration traces 
taken for O2 in the SNr (n = 6, ± SEM) before and after methiothepin.  Methiothepin caused 
a significant decrease in [O2]max from 10.6 ± 4.6 µM to 1.7 ± 2.3 µM ( p < 0.0001).  There 
was also a significant increase in serotonin, (n = 5, p < 0.0001) from 5.2 ± 1.4 nM to 
7.6 ± 0.2 nM.   
To confirm that O2 attenuation was due to local antagonism in the region adjacent to 
the electrodes, similar experiments were repeated using iontophoretic delivery of the 
antagonists.  Iontophoresis uses a current to induce the migration of these antagonists 
through a glass capillary into the brain with negligible tissue perturbation (Rebec, 1998).  
Electrical stimulation was again applied every 4 minutes for the duration of the experiment.  
After priming, the electrode was lowered to the region of interest.  After five consecutive 
stimulations showed a constant O2 response, 14.2 ± 7.3 µM raclopride and 22.6 ± 10.7 µM 
SCH 23390 were ejected for 30 s approximately 90 s before the next stimulation.  
Alterations in electrically evoked O2 were seen immediately following drug ejection.  
Ejections were repeated until responses to stimulations returned to pre-drug values.  A 
minimum of three stimulations were applied between drug ejections even if changes were 
not observed.  The same procedure was repeated for three 30 s ejections of methiothepin.    
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Figure 4.4.  Antagonism of dopamine receptors with raclopride and SCH 23390 and 
serotonin receptors with methiothepin.  A)  Average concentration changes for O2 in the NAc 
before (black) and 1 hour after i.p. administration of both SCH 23390 (1 mg/kg) and 
raclopride (2 mg/kg) (blue) and 1 hour after i.p. administration of methiothepin (20 mg/kg) 
(grey) (n = 6 rats).  B)  Average concentration changes for O2 in the NAc 60 s after 
iontophoretic application of antagonists (n = 5 rats).  C)  Average concentration over time for 
electrically stimulated O2 in the SNr before (purple) and 1 hour after i.p. administration of 
methiothepin (20 mg/kg) (grey) (n = 6 rats). D)  Average concentration changes for O2 in the 
SNr 60 s after iontophoretic application of antagonists (n = 5 rats).  In both panels, red bar at 
0 s indicates the onset and duration of stimulation.   
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 The averaged O2 responses before and after iontophoretic drug application are 
shown in Figure 4.4 in the NAc and SNr.  In the NAc (Figure 4.4B), raclopride and 
SCH 23390 did not significantly alter the concentration of electrically evoked O2 (p > 0.05) 
while methiothepin significantly attenuated [O2]max from 6.2 ± 1.9 µM to 2.4 ± 1.1 µM (n = 5, 
p < 0.01), to 35% of the pre-drug response.  In the SNr, methiothepin significantly 
attenuated the [O2]max (n = 5, p < 0.0001) to 38% of pre-drug, from 18.9 ± 5.1 µM to 
7.1 ± 3.3 µM. 
Direct application of serotonin into the NAc via iontophoresis.   
 
 To further investigate the roles of serotonin and dopamine in the regulation of local 
O2, they were directly applied to each region.  Prior work has shown that dopaminergic 
drugs do not affect O2 changes (Zimmerman et al., 1991; Venton et al., 2003) and thus its 
ejection ensures there are no O2 changes or other artifacts caused by iontophoretic 
ejections.  Here, a primed iontophoresis probe was lowered into either the SNr or NAc and 
the endogenous chemical environment recorded (Figure 4.5A).  Then dopamine was 
iontophoresed for 2 s, the same duration as electrical stimulation, at increasing 
concentrations from 500 nM to 5 µM with 5 minutes between drug applications (example 
trace shown in Figure 4.5B).  Into the same location, 20 nM serotonin was subsequently 
iontophoresed (Figure 4.5C).  The time course and relative concentrations for the ejections 
of dopamine and serotonin are compared in Figure 4.5D and the resulting O2 changes were 
compared to traces recorded before any application (Figure 4.5E).  This experiment was 
repeated at 200 µm intervals along the dorsal-ventral tract through each brain region.  At all 
locations, dopamine ejections did not affect O2 in the SNr (n = 5 rats, n = 7 locations) and 
NAc (n = 5 rats, n=6 locations).   
 To confirm that the O2 changes seen with iontophoresis were correlated to changes 
in CBF the above experiment was repeated in a slice preparation.  Brain slices lack blood   
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Figure 4.5.  Ejection of dopamine and serotonin into the NAc in an anesthetized animal.  
Color plots showing 3 averaged 60 s files for each of the following at t = 0 s:  A)  no event B) 
2 s ejection of 5 µM dopamine and C) 2 s ejection of 20 nM serotonin.  The dashed line in 
each color plot indicates the potential at which O2 changes were monitored and the solid 
lines in B and C show the potential at which dopamine and serotonin changes respectively 
were monitored.  D)  Applied concentration over time traces for the average concentration of 
dopamine (blue) and serotonin (grey) taken the potential indicated by the similarly colored 
solid lines in panels B and C respectively.  E)  O2 responses occurring naturally (black), or 
induced by iontophoretic delivery of dopamine (blue) or serotonin (grey).  Traces obtained at 
the potential for O2 reduction (white dashed line in A-C).  The red bars indicate the onset 
and duration of drug delivery.   
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flow (Iadecola et al., 2007) so any O2 changes seen in the slice experiment could not be 
attributed to CBF.  As Figure 4.6 shows, both dopamine and serotonin application caused 
no changes in O2 in the SNr (n = 4 rats, n = 8 locations, 2 slices/rat) or NAc (n = 4 rats, n=8 
locations, 2 slices/rat).   
A 2 s application of serotonin at concentrations from 10 nM to 250 nM caused O2 
changes in 77% of locations in the NAc (n = 6 rats, n = 17 locations) and 87% of locations in 
the SNr (n = 10 rats, n = 38).  While the majority of serotonin applications in the NAc (61%) 
and SNr (55%) increased O2, the responses were critically dependent on serotonin 
concentration, and did not show monotonic responses at a single location.  As the 
concentration of serotonin was increased, the response of O2 abruptly changed (examples 
in Figure 4.7A recorded in the SNr).  For measurements, in the NAc, there was no 
statistically significant correlation between the concentration of serotonin and resulting O2 
changes.  In the SNr, 20% of locations evoked O2 correlated with increasing serotonin 
(Figure 4.7B).  In these locations, O2 change varied from 11.5 ± 4.8 to 48.8 ± 20.8 nM O2 per 
nanomolar serotonin for individual locations with an average rate of 21.9 ± 8.7 nM O2 per 
nanomolar serotonin. 
To ensure that all recorded O2 changes were evoked by serotonin application; 
ejections were repeated at least twice at each location for each serotonin concentration.  
Replicate ejections caused the same O2 change.  These sites were also probed with 
dopamine ejections and had no effect as described above. Serotonin responses were not 
examined at sites with large, frequent endogenously occurring O2. 
 
DISCUSSION 
 
These experiments reveal that FSCV at microelectrodes can provide recordings of 
local O2 fluctuations and serotonin release.  The recordings provide information from a   
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Figure 4.6.  Ejection of dopamine and serotonin into the NAc in a slice preparation.  Color 
plots showing 3 averaged 60 s files for each of the following at t = 0 s:  A)  no event B) 2 s 
ejection of 10 µM dopamine and C) 2 s ejection of 70 nM serotonin.  The dashed line in 
each color plot indicates the potential at which O2 changes were monitored and the solid 
lines in B and C show the potential at which dopamine (solid blue) and serotonin (solid grey) 
changes were monitored.  The red bars indicate the onset and duration of drug delivery.  No 
significant changes in O2 were observed. 
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Figure 4.7.  O2 changes with local application of serotonin (5-HT) in the SNr.  Two different 
response behaviors were seen in a single location to application of increasing 
concentrations of 5-HT:  B) 80% of locations showed mixed changes in [O2]max (increases 
and decreases) after iontophoretic application of 5-HT.  Two example locations are shown, 
one trending positive (light blue, closed circles) and one negative (black line, open 
triangles).  Lines are drawn through responses from each location (each in a separate 
animal) to demonstrate fluctuations.  B)  20 % of locations showed only increases in [O2]max 
in response to iontophoretic application of 5-HT.  Each shape represents averaged ejections 
in a different animal and location. These increases happened at an average rate of 
21.9 ± 8.7 nM O2 per 1 nM serotonin applied (solid black line).   
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relatively small population of neurons deep within the brain and show that serotonin plays a 
dual vasoactive role in the brain.  Through interaction with receptor and transporter proteins, 
serotonin released from nerve terminals causes increases in local O2 in the SNr and NAc.  
Local application of exogenous serotonin predominantly increased O2, but decreases or no 
change were also seen at the same location.  This variability in O2 responses is not a 
property of the measurements because the measurements are reproducible with the same 
dose at a common location.  In the following sections, we postulate the physiological origins 
that underlie our observations.   
Naturally occurring O2 fluctuations in the brain 
 
 We have previously voltammetrically characterized electrically stimulated O2 in the 
brain (Venton et al., 2003).  Here, for the first time, we show that our method can detect 
rapid, naturally occurring O2 fluctuations.  It has previously been difficult to detect ambient 
O2 perturbations because O2 supply and demand is so closely maintained.  However, our 
ultra-fast, sensitive FSCV method allows tiny homeostatic adjustments of O2 to be captured. 
Recent results have revealed that natural changes in glucose occur on this time scale 
(Kiyatkin et al., 2012).  This is important because FSCV can routinely be applied in freely 
moving, behaving animals (Cheer et al., 2006; Ariansen et al., 2012).  Therefore future 
studies can probe behaviorally activated O2.  
Electrically induced O2 increases 
 
Biphasic O2 responses induced by electrical stimulation were previously investigated 
in the dorsal striatum where we applied an increasing number of pulses to the MFB over 2 s 
and reported a linear increase in [O2]max of Peak 1 and no change in [O2]max of Peak 2 
(Zimmerman et al., 1991).  Here, we instead varied the duration over which 120 pulses were 
applied by increasing frequency.  Increased frequencies result higher concentrations of 
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extracellular neurotransmitter.  Consistent with this principle, as stimulation frequency 
increased, the maximum concentration of dopamine increased (Park et al., 2011), and this 
was accompanied by an increase in [O2]max of Peak 1 in the NAc. Surprisingly, in the SNr, 
[O2]max of Peak 1 decreases with stimulation frequency suggesting different regulatory 
mechanisms.  Our own previous data showed that the primary a serotonin effect because 
MFB stimulation causes its release in the SNr with non-detectable contributions from 
dopamine (Hashemi et al., 2011).  Additionally, we previously showed that dopamine 
release does not correspond to O2 changes in the NAc (Venton et al., 2003), a finding 
confirmed here with dopamine receptor antagonists both in the NAc and in the SNr.  Peak 2, 
an event previously shown to be adenosine mediated, was relatively insensitive to changing 
stimulus parameters. 
Serotonin contributes to O2 changes in both the NAc and SNr 
 
While we cannot monitor serotonin in the NAc due to the overwhelming 
concentration of dopamine region, it is present in the NAc and could contribute to O2 effects 
(Kuczenski et al., 1995).  Instead of monitoring stimulated serotonin release in the NAc, we 
established with pharmacology that serotonin plays a role in Peak 1 in both the NAc and 
SNr.  Methiothepin increased stimulated release of serotonin in the SNr and attenuated 
[O2]max of Peak 1 in both the NAc and SNr when applied systemically.  The local effects of 
iontophoretic application of methiothepin confirmed that the O2 changes were mediated 
locally.  Methiothepin, while a potent inhibitor of the serotonin autoreceptor (Martin et al., 
1982) also antagonizes all serotonin receptor subtypes and has also been shown to 
antagonize α1-adrengeric receptors (Wikberg-Matsson et al., 1998).  Adrenergic receptors 
could play a role in the measured O2 changes because norepinephrine is released by MFB 
stimulation (Park et al., 2011), and its receptors are located on large vessels and capillaries 
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on the surface of the brain and play a role in controlling vasoconstriction on large vessels on 
the surface of the brain (Hamel et al., 2006).   
Iontophoretic application of serotonin directly into the SNr and NAc showed that 
serotonin has potent effects on local O2, a distinction not possible with systemic 
administration of drugs.  Dopamine altering agents produce no effects on O2 when 
introduced iontophoretically. Similarly, iontophoresis of another electroactive molecule, 4-
methylcatechol, did not change O2 changes (data not shown). These findings show that the 
variation in O2 following serotonin ejection is not an iontophoretic artifact.  
Variability in O2 with direct application of serotonin 
 
O2 responses to the regional release of neurotransmitters evoked by electrical 
stimulation of the MFB were consistent in both locations.  However, local application of 
serotonin elicited a variety of O2 changes in both the NAc and SNr.  A dual response profile 
evoked with local serotonin application is not surprising given the spatially heterogeneous 
distribution of its receptors and transporters throughout the brain.  While serotonin is known 
to constrict blood vessels directly via receptors (Monassier et al., 2010), a contrasting 
dilatory role has also been reported, mediated by β-receptors (Edvinsson et al., 1977).  
Additionally, serotonin receptors and transporters are found on astrocytes implying a role of 
serotonin in the indirect modulation of O2 (Cohen et al., 1996).  
Previous experiments used high concentrations of serotonin to consistently constrict 
large cerebral arteries (Lincoln, 1995).  Here local application of low concentrations (<250 
nM) of serotonin induce a variety of O2 changes in all locations in the NAc and 80% of 
locations in the SNr.  Generally, serotonin terminals do not form synapses and rely on 
volume transmission to allow serotonin to diffuse through the extracellular space to 
receptors on astrocytes and blood vessels (Fuxe et al., 2010; Cohen et al., 1995).  When 
released globally with MFB stimulation serotonin activates a consistent receptor population.  
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In contrast, iontophoresis applies a concentrated local serotonin bolus that indiscriminately 
diffuses to the nearest receptors regardless of their proximity to serotonin terminals.  As the 
concentration of ejected serotonin is increased, the size of the bolus is also increased, 
resulting in an increased number, type, and location of activated receptors (Belle et al., 
2013).  In the NAc O2 responses are highly variable, however in the SNr, a large (20%) 
fraction of locations studied exhibited monotonic increases in O2 with increasing serotonin 
concentration.  Monotonic O2 increases correlate with the greater percentage of 
serotonergic synapses in the SNr. 
 
CONCLUSIONS 
 
FSCV at carbon fiber microelectrodes provides a unique opportunity to monitor local 
functional O2 changes that arise from changes in CBF in the brain.  We show there are 
differences in O2 induced systemically with electrical stimulation, or locally with 
iontophoresis.  While the majority of direct serotonin applications resulted in increased O2, 
variability in the O2 response was also observed.  This suggests that local application affects 
a subset of receptors whose spatial sphere increases with the increased serotonin 
concentration.  This work demonstrates that serotonin plays a complex and multifaceted role 
in the functional regulation of O2 in the brain.  Serotonin is tightly regulated by efficient 
transport and metabolic processes.  Its dual role as a neurotransmitter and vasoactive agent 
are consistent with tight synaptic regulation.  Dysregulation of serotonin transmission is fatal, 
as demonstrated by serotonin syndrome. 
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Chapter 5 
Controlled iontophoresis coupled with fast-scan cyclic voltammetry/ 
electrophysiology in awake, freely-moving animals 
 
INTRODUCTION 
 
The modulation of target neurons via neurotransmitter release is central to the 
regulation of an organism’s behavior.  Dopamine plays an extensive role in governing 
motivated behaviors and our groups have shown that its release coincides with learned 
associations for rewarding stimuli and drugs of abuse (Phillips et al., 2003; Robinson and 
Wightman, 2007; Owesson-White et al., 2009; Beyene et al., 2010; Day et al., 2010).  Here, 
we describe a technique that is capable of monitoring extracellular dopamine release and 
postsynaptic cell activity in awake, behaving animals.  At a single carbon-fiber electrode of 
micron dimensions, dopamine release is detected by fast-scan voltammetry and 
postsynaptic cell activity is monitored by single-unit recordings.  The electrode is coupled to 
micropipettes that with the application of current locally deliver pharmacological agents to 
investigate the specific receptor(s) activated.  This approach was first developed by Millar 
and coworkers who used fast-scan cyclic voltammetry and single-unit recording at a single 
carbon-fiber electrode (Millar et al., 1981).  They combined these techniques with 
iontophoresis to compare the response of striatal medium spiny neurons (MSNs) to locally 
applied dopamine and endogenous dopamine released by electrical stimulation (Williams 
and Millar, 1990).  Despite the utility of this approach, it has been used only rarely in 
behaving animals (Cheer et al., 2005; Cheer et al., 2007).   Here we evaluate this approach 
in awake animals to probe the effects of dopamine in the nucleus accumbens (NAc), a 
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striatal subregion involved in reward processing, on evoked dopamine release and the 
electrical activity of MSNs. 
Establishing the nature of dopamine responses proved difficult in early studies using 
iontophoresis combined with single-unit recording for several reasons (Grenhoff and 
Johnson, 1997).  First, many of those recordings were in anesthetized animals and 
anesthesia is known to alter neuronal activity (Chiodo, 1988; Rebec, 1998).  Second, the 
amount of drug delivered by iontophoresis was not quantifiable.  Too little drug delivered 
results in a false negative whereas too much leads to nonspecific effects.  Applied pump 
currents were commonly used to compare ejections (Pierce and Rebec, 1995; Kiyatkin and 
Rebec, 1996, 1999b), but the same pump current ejected different drug concentrations from 
barrel to barrel (Herr et al., 2008).  To remedy this, we monitor the iontophoretic coejection 
of an electroactive molecule with the drug of interest from the same barrel.  When the 
relative mobilities of the coejected substances are known, monitoring the concentration of 
the electroactive molecule with the carbon-fiber electrode provides an indirect measure of 
the relative concentration of the coejected nonelectroactive substance (Herr et al., 2008; 
Herr et al., 2010).  Third, ionic and electrical artifacts can occur in iontophoresis.  Since the 
chemical and physiological environments are monitored with the combined 
voltammetry/single-unit recording probe, these problems become apparent during the 
experiment and can be corrected.  Finally, many studies were completed before the 
recognition of various subtypes of dopamine receptors and before investigators realized that 
dopamine receptors are coupled to second messenger systems that modulate the effects of 
classical neurotransmitters such as glutamate.  In addition, MSNs have “up” and “down” 
states during which the cell’s response to dopamine may differ and are not discernible with 
single-unit recordings (O'Donnell, 2003; Nicola et al., 2004; Surmeier et al., 2007). 
Interpretation of dopamine responses in prior studies were further complicated by the 
lack of understanding of the distribution of dopamine receptors.  Dopamine neurons in the 
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NAc synapse onto dendrites and spines of MSNs (Yung et al., 1995).  MSNs are GABAergic 
and comprise 95% of the cell bodies in this region (Chang and Kitai, 1985). Glutamatergic 
neurons that project from the cortex also form synapses on MSNs.  Recent anatomical 
discoveries have shown that the predominant dopamine receptors, the D1 and D2 
receptors, are segregated between two different MSN populations (Valjent et al., 2009; 
Gerfen and Surmeier, 2011).  Early studies that focused exclusively on the dorsal striatum 
showed that some MSNs project axons to the output nuclei of the basal ganglia (substantia 
nigra and internal capsule of the globus pallidus [GPi]) and are termed the “direct pathway.”  
Other MSNs project to the external capsule of the globus pallidus (GPe) and are termed the 
“indirect pathway” because they synapse with neurons that also project back to the output 
nuclei.  Although this circuitry was originally characterized in the dorsal striatum, it is also 
found in the NAc (Ikemoto, 2007).  In the NAc core 53% of MSN’s comprise the direct 
pathway and have D1 receptors exclusively.  Further, 41% of neurons in the NAc core 
comprise the indirect pathway and have D2 receptors exclusively.  Thus, an estimated 6% 
of MSNs in the NAc have both D1 and D2 receptors.   
In this work we describe the modifications made to the voltammetry/single-unit 
recording/iontophoresis probes for use in awake animals.  These improvements enable 
examination of the distribution of dopamine receptor subtypes present on MSNs in the NAc.  
In addition, we have examined the immediate and prolonged cell firing effects of 
endogenous and exogenous dopamine and dopamine antagonists on the different types of 
MSNs.  Our initial results agree with previously reported distributions of dopamine receptors 
on MSNs (Ikemoto, 2007), lending credence to our combined technique and supporting 
previous in vitro and indirect in vivo studies. 
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RESULTS & DISCUSSION 
Voltammetry/single-unit/iontophoresis measurements 
 
A diagram of the circuitry associated with these experiments is shown in Figure 5.1 
(Takmakov et al., 2011a).  In this work, the cyclic voltammograms were repeated at 5 Hz 
(once every 200 ms).  With the scan rate employed (400 V/s), a single cyclic voltammogram 
is recorded in 8.5 ms.  The total time with the current transducer connected (20 ms) includes 
5.75 ms before the triangular wave to allow for dopamine adsorption and 5.75 ms after the 
triangular wave to allow the amplifiers to settle.  For the remaining 180 ms between scans, 
the amplifier connected to the carbon-fiber electrode is switched (in <1µs) from a current 
transducer to a voltage follower to allow recording of unit activity.  Iontophoresis occurs 
continuously during the switching between voltammetry and single-unit recordings via a 
separate circuit.  The data from each measurement type is collected on separate computers 
along with time stamps allowing synchronization of the data to iontophoretic ejections or 
other events.   
In prior work we used continuous iontophoresis over multiple minutes to affect cell 
firing frequency (Cheer et al., 2007).  Shorter applications are advantageous because they 
restrict the drug to the local environment in which chemical changes and single-unit activity 
are measured.  Here, we adopted two methods to monitor ejection effects.  With the first 
method, we measured changes in cell firing or changes in electrically stimulated dopamine 
release shortly after a 15 s iontophoretic ejection.  This approach has the advantage that the 
electrochemical signal arising from the ejected internal standard does not interfere with 
endogenous chemical measurements.  With the second method we measured changes in 
cell firing during the 15 s ejections.  This method was primarily used with 
electrophysiological recordings.   
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Figure 5.1. Diagram of the electronics and outputs for combined fast-scan cyclic 
voltammetry/electrophysiology.  The same carbon-fiber electrode and reference electrode 
were used for both circuits and the reference electrode also served as ground for the 
iontophoresis circuit.  The output of the carbon-fiber electrode was connected to a voltage 
follower to monitor cell firing (upper circuitry).  Every 200 ms the carbon-fiber microelectrode 
was switched from the electrophysiology circuit to the lower voltammetry circuitry for 20 ms.  
In this position, the amplifier controlled the electrode potential and the current was 
monitored.  The synchronized outputs for both circuits are shown to the right of the circuitry.  
When the lower circuit was completed, the electrode was held at -0.4 V then over 8.5 ms 
scanned from to +1.3 V and back to -0.4 V.  The changes in current during each scan are 
indicated with arrows.  During this time, there were no voltage changes seen in the 
electrophysiology (when circuit was open but program still recorded data).  With the upper 
circuit connected, changes in voltage were monitored.  The colored marks above the voltage 
read out indicate regions of the 180 ms that have been expanded above.  Orange spikes are 
firing of the MSN of interest; purple spikes are firing that looks similar to the MSN of interest 
but are not included due to the horizontal portion at the start of the spike.  The grey spike is 
an example of an excluded event. 
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Electrode Modifications 
 
We have made several improvements to the construction of iontophoresis probes 
from the methods we previously described (Herr et al., 2008).  First, we addressed the 
electrical coupling that sometimes occurred between the iontophoresis barrels and 
voltammetric barrel due to the inherent variability in the thickness of the glass pipettes.  
When the thickness of the glass between the adjacent barrels is thin or there are 
microfractures in the capillaries, electrical coupling between the iontophoresis barrels is 
likely to occur.  Second, we improved the quality of the glass seal against the carbon fiber to 
help prevent large background currents during voltammetric recordings.  Finally, we 
modified a commercially available manipulator to facilitate use of the probes in awake 
animals. 
Reduced electrical coupling and improvements to the carbon fiber-glass seal were 
accomplished using a modified fabrication technique.  First, a carbon fiber was inserted into 
in a single glass capillary, and this assembly was inserted into one barrel of a 4-barrel pre-
fused glass assembly (Figure 5.2A).  Heat-shrink tubing was applied to the ends of each 
multi-barrel glass capillary at the location where the chuck of the pipette puller was tightened 
onto the glass.  Tack was placed at the lower end to prevent the inner glass capillary 
containing the carbon fiber from falling out.  The assembly was pulled on a vertical 
micropipette puller in a two-step process that created two electrodes of the type shown in 
Figure 5.2B.  The first pull elongated and narrowed the glass while the second pull formed 
the glass seal around the carbon fiber.  The carbon fiber was then trimmed to have an 
exposed length of 50-75 µm.  Before use, the heat-shrink was removed and an electrical 
connection to the carbon fiber was made with silver epoxy and an inserted silver wire.  
These procedures minimized the electrical coupling between the electrode and the 
iontophoresis barrels and resulted in improved carbon-glass seals.   
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Figure 5.2.  Modifications to probe construction and hardware for iontophoresis in freely 
moving animals.  (A)  4-barrel pre-fused pipette ready for pulling with heat shrink on either 
end where the glass will contact the chucks of the puller.  A smaller capillary containing a T-
650 carbon fiber is loaded into one barrel.  (B)  One of the two electrodes created from the 
2-pull electrode making technique.  The vertical bar indicates the midpoint of the pipette 
before pulling.  (C) Environmental scanning electron micrograph of the probe tip showing the 
glass iontophoresis barrels and carbon fiber.  (D)  Hardware used to attach and lower 
iontophoresis probe into the head of a freely-moving animal.  (i)  Commercially available 
Biela manipulator from Crist Instrument Co, (Part# 3-MMB-3D).  (ii)  Custom machined 
adapter that allows use of Biela manipulator with a guide cannula from Bioanalytical 
Systems, Inc.  Fabricated by UNC Physics Machine Shop (Chapel Hill, NC).  (iii)  
Commercially available guide cannula from Bioanalytical Systems. 
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To facilitate use of the voltammetry/single-unit/iontophoresis probe in awake animals 
and allow for lowering to a precise depth within the brain, the probe was inserted into a 
commercially available Biela micromanipulator (West and Woodward, 1984).  The 
manipulator contains a metal tube (Figure 5.2Di) that has 4 inner grooves to hold a four-
barrel pipette.  This inner-most piece moves up and down as the two outer-most parts screw 
together.  The Biela manipulators are designed for connection to the skull with a threaded 
guide cannula that requires a large diameter (1.5 mm) skull opening.  The large hole tends 
to become blocked with blood clots, which increases the likelihood of pipette breakage.  This 
problem is less frequent with the guide cannula that we use with single-barrel electrodes, 
which requires a 0.65 mm diameter hole (Figure 5.2Diii).  This guide cannula uses a washer 
and groove system to attach the micromanipulator to the skull.  The polyamide plastic 
cannula (2 mm long) extending beyond the hub was inserted in a hole drilled in the animal’s 
brain and permanently affixed with dental cement during surgery.  To mate the manipulator 
with the smaller diameter guide cannula, a custom-machined adapter was fabricated with 
threads to attach the adapter to the manipulator (UNC Physics Machine Shop, Chapel Hill, 
NC).  The metal ridge of the adapter (Figure 5.2Dii) mates with the groove in the guide 
cannula and the washer on the cannula locks the pieces together.  This allows for easy 
attachment on the animal’s head under brief isofluorane anesthesia.   
Modulation of dopamine evoked release by autoreceptors 
 
Because stimulated release is modulated by D2 autoreceptors (Benoit-Marand et al., 
2001; Wu et al., 2002), we used the improved probes to examine modulation of electrically 
stimulated (24 pulses, 60 Hz, 125 µA, repeated at 1 min intervals) dopamine release by 
agents active at D2 receptors in anesthetized animals.  We first used microejections of 
dopamine (16 ± 1 µM) in an attempt to activate the D2 autoreceptor, but, there was no effect 
on electrically stimulated release (N = 4 animals) with three ejections carried out 5-7 minutes 
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apart.  We then continuously delivered nomifensine (54 ± 2 µM), a dopamine transporter 
uptake inhibitor, while continuing stimulations at 1 min intervals.  Under these conditions, the 
amplitude of electrically stimulated dopamine release was inhibited by 23 ± 6% (p < 0.05, 
paired t-test).  This experiment is summarized in Figure 5.3.  A lower concentration of 
dopamine (1.7 ± 0.5 µM) was also tested in 3 of the animals and showed the same inhibition 
of electrically stimulated dopamine release only during nomifensine application.  By 
inhibiting uptake, nomifensine allowed dopamine to diffuse greater distances and remain in 
the extracellular space longer (Kelly and Wightman, 1987; Nicholson, 1995).  Additionally, 
continuous inhibition of the transporter may alter autoreceptor function (Jones et al., 1999).   
We also iontophoresed the D2 receptor antagonist raclopride in these same 
locations to ensure [DA]max responded as we previously showed to autoreceptor antagonism 
(Herr et al., 2010).  The 15 s ejection consisted of 21 ± 11 µM raclopride and terminated 10 
s before the stimulation.   Ejections were repeated three times 7-10 minutes apart during 
which electrical stimulation occurred every 60 s.  [DA]max was significantly increased by 151 
± 13% (N = 4 animals, p < 0.05, paired t-test).  Even 70 s after the ejection, [DA]max was still 
increased by 132 ± 8% but returned to pre-raclopride levels 5 minutes after the conclusion of 
the raclopride ejection.   
We also looked at the effect of autoreceptor antagonism on the amplitude of 
stimulated dopamine release in the NAc of awake, behaving animals.  Awake animals were 
trained to press a lever that delivered an electrical stimulation to the VTA.  Rats quickly learn 
this behavior termed intracranial self-stimulation (ICSS) that was discovered almost 60 years 
ago (Olds and Milner, 1954).   To ensure dopamine release was not depleted by rapid lever 
pressing (Garris et al., 1999), a variable time out (VTO) paradigm, with lever availability 18-
27s after a previous lever press was used.  This VTO allowed for a 15 s drug ejection 
between presses as well.    
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Figure 5.3.  Effect of dopamine 
transporter on exogenous dopamine 
diffusion.  (A)  A two dimensional color 
plot where current is shown in false 
color on the potential vs. time axes is 
shown for current changes in the 
nucleus accumbens (NAc).  The 
positive (green) currents are indicative 
of dopamine release.  Anesthetized 
rats received a 24 pulse, 125 µA, 60 
Hz electrical stimulation every 60 s 
and maximum dopamine concentration 
([DA]max) evoked with each stimulation 
recorded. Stimulations are indicated by 
red bars below the color plot.  (B)  In 
the same animal, the same experiment 
was carried out as in (A) but 54 ± 2 µM 
nomifensine (NOM) was constantly 
iontophoresed during the stimulations.  
(C)  Dopamine (DA) oxidation currents 
as a function of time.  Traces were 
taken from the potentials marked with 
dashed lines in panels A and B.  (D)  
15 s ejection of 16 ± 1 µM dopamine 
occurred at the vertical blue line and 
ended 10 s before electrical 
stimulation at t = 0 s.  Open triangles 
indicate dopamine ejections while 
black triangles indicate dopamine 
ejections made during constant 
application of nomifensine.  [DA]max 
evoked was greater in the presence of 
nomifensine but all data is presented 
as percent of pre-ejection [DA]max for 
each data set. 
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Data logging of [DA]max was initiated when it had reached a stable value (Owesson-
White et al., 2008).  After multiple lever-pressing trials, raclopride was ejected for 15 s and 
was terminated 3 s before the next lever extension.  This caused an immediate increase in 
the maximum concentration of evoked dopamine that was observed after each lever press 
(Figure 5.4).  This increase occurred at all locations tested, with raclopride increasing 
[DA]max at each location to 280 ± 130% the pre-raclopride [DA]max (N = 10 animals).  This 
approach is an important improvement over systemic injections of dopamine receptor 
antagonists which can alter behavior and confound investigation of receptor mechanisms; 
localized iontophoretic application of raclopride allows modulation of receptors without 
affecting an animal’s behavior (Ushijima et al., 1995).   
Modulation of cell firing with D1 and D2 receptor antagonists  
 
We did not attempt measurements of MSN unit activity in anesthetized animals 
because firing rates are so low under these conditions that investigators typically need to 
use glutamate to increase activity (White and Wang, 1986; Chiodo, 1988; Hu and Wang, 
1988).  In the awake rat, we examined the effects of the D1 antagonist, SCH 23390, the D2 
antagonist, raclopride, and dopamine on MSN firing rate (dopamine results are described 
later).  Representative histograms for responses to iontophoretic drug applications are 
shown in Figure 5.5, all measured at the same cell.  Figure 5.5A shows a sample MSN 
waveform, shape of the waveform remained constant for all test conditions.  In these 
experiments the same concentration of drug was applied to the cell for 15 s once every 60 s.  
The histograms are the average firing rate centered around these 30 drug applications with 
cell firing placed in 1.0 s bins.  Drug was introduced for 15 s starting at t=0 s, and the 
average firing rate for 15 s before and after drug delivery also shown.  The blue trace 
superimposed on each histogram is the average concentration of drug ejected over the time 
the histograms were collected.  Figure 5.5B shows the average firing rate for the MSN over   
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Figure 5.4.  Consistent modulation of electrically evoked dopamine release with raclopride 
antagonism of the pre-synaptic D2 receptor during ICSS in a behaving rat.  Stimulated 
release of dopamine occurred each time the animal pressed a lever, and the maximum 
amplitude was recorded as the maximum dopamine concentration ([DA]max).  The lever was 
made available to the animal once every 18-27 s.  Raclopride iontophoretic ejections (15 s, 
100 nM) began at 13 min.  The ejections terminated 3 s before the lever became available 
(indicated by vertical lines).   
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Figure 5.5.  Immediate response of a single 
NAc MSN to iontophoretic application of 
dopamine receptor antagonists, SCH 23390 
and raclopride, and dopamine in an awake 
animal.  (A)  Sample waveforms (150) 
shown in black with the average of the 
waveforms in grey for a NAc MSN collected 
in these experiments.  The horizontal scale 
bar represents 0.3 ms and vertical scale bar 
is 300 µV.  (B)  MSN firing with no 
iontophoretic ejections.  (C)  MSN firing 
during iontophoresis of 23 nM SCH 23390 
for 15 s starting at t = 0 s.  (D)  MSN firing 
with 40 nM raclopride iontophoresed for 15 
s starting at t = 0 s.  (E)  MSN firing with 12 
µM of dopamine iontophoresed for 15 s 
starting at t = 0 s.  Histograms are the 
average of 30 consecutive trials (60 s 
duration) and each bar is the average 
frequency recorded during the indicated 1 s 
bin.  All histograms were collected in the 
same location in the NAc of the same 
animal.  The blue traces superimposed over 
histograms are the average concentration of 
acetaminophen (AP) (C, D) or dopamine 
(DA) (E) ejected during the 45 s window 
shown for all 30 trials.  In panels C, D, and 
E iontophoretic drug delivery started at t = 0 
s and ends at t = 15 s.  Immediate changes 
in cell firing were determined by comparison 
of cell firing during a baseline period (-15 to 
0 s, solid red bar) to the average firing rate 
during the ejection (blue boxed region, 0 to 
15 s).  A quotient that differed from the 
control by ± 0.5 was taken as an immediate 
change in cell firing rate.   
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30 trials during which no drug ejections occurred.  This served to ensure that the cell was 
firing at a constant rate over a 30 minute period. 
To evaluate the immediate effect of iontophoretic drug application on MSN firing 
rates we compared firing ratios.  The firing ratio allows comparison of cell firing changes with 
respect to a defined baseline period.  Here, baseline was defined as the average firing rate 
during the 15 s interval prior to each iontophoretic application (red bars in Figure 5.5). The 
firing ratio was determined by dividing the average firing rate during 30 consecutive drug 
ejections (the region shown by the blue open bars in Figure 5.5) by the baseline. The drug 
was deemed to have an immediate effect if it caused a change in firing ratio of 50% or more, 
a change never observed without drug application.  At the location of the trials in Figure 5.5, 
the cell showed no immediate change in firing in response to application of 8.6 µM SCH 
23390 (Figure 5.5C) whereas there was an abrupt increase in firing rate (and firing ratio) 
with the application of 14 µM raclopride (Figure 5.5D).  This increase in cell firing is believed 
to be an excitation in response to blocking of the D2 mediate inhibition of MSN firing.  The 
results from multiple units are summarized in Table 5.1 and show that only 12 out of the 30 
cells that responded to one dopamine antagonist showed an immediate response.   
The time required for a change in cell firing to occur is dependent on the time needed 
for ejected drug to diffuse to receptors on the MSN as well as the time delay between 
binding and the cascade of cell signaling that modulates MSN firing.  Therefore, we also 
analyzed the data over a prolonged time scale.  For prolonged firing ratios, baseline was 
taken as the average MSN firing rate during 30 trials with no drug ejections (red bar in 
Figure 5.6A).  The prolonged firing ratio was then the average firing rate in the 15 s before 
and the 15 s after each of the 30 drug ejections (Figure 5.6B-E) divided the prolonged 
baseline.  (The prolonged firing ratio purposely excludes cell firing during the 15 s period of 
drug ejection, which was used for determination of the immediate firing ratio.)  Note that the   
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Table 5.1.  Distribution of Prolonged and 
Immediate Responses of MSNs to Dopamine 
Antagonists 
Type of 
Response 
Number of Cells (%) 
Raclopride SCH 23390 
Immediate   
Inhibitory 0 (0) 1 (3) 
Excitatory 7 (23) 4 (13) 
Prolonged   
Inhibitory 5 (17) 16 (53) 
Excitatory 9 (30) 0 (0) 
MSN = medium spiny neuron. 
MSN responses are tabulated from n = 35 cells (units) 
from 19 rats.  One cell did not respond to either drug and 
4 cells responded to both.  All 5 of these cells were 
excluded from the table. 
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-15 to 0 s period before an ejection, was also the time period 45 to 60 s after an ejection.   
Representative firing patterns of another single unit are shown in Figure 5.6 along 
with the time periods used to calculate the prolonged firing ratio.  Figure 5.6A shows the 
baseline for the prolonged measure (no drug was ejected), Figure 5.6B shows trials where 
SCH 23390 was ejected, and Figure 5.6C shows trials where raclopride was ejected. The 
immediate and prolonged firing ratios for each condition at this location are seen in 
Figure 5.6F.  At this cell, SCH 23390 had a prolonged inhibition on cell firing but no 
immediate effect (Figure 5.6B, F).  Raclopride had no significant effect on the firing ratio on 
either time scale in this MSN (Figure 5.6C, F).  These responses classify this cell as a D1 
responsive MSN. 
This analysis was repeated for 35 cells, and the results are also summarized as the 
prolonged changes in Table 5.1.  Out of 35 cells, all but one showed a prolonged response 
to receptor antagonists.  While 4 units showed a prolonged response to both antagonists, 16 
were only responsive to the D1 antagonist and 14 were only responsive to the D2 
antagonist.  This breakdown of cells is remarkably similar to the ratio of D1 and D2 cells 
established in the NAc by Girault and coworkers (Valjent et al., 2009).  The 5 prolonged 
inhibitions evoked by raclopride all exhibited a robust, immediate excitation (like the 
example in Figure 5.5).  The variability of the prolonged responses in MSNs that just 
responded to raclopride (5 out of 18 cells were inhibited while the remainder were excited) 
may have to do with the dual locations of D2 receptors (Usiello et al., 2000; Centonze et al., 
2003; Centonze et al., 2004).  Activation of D2 receptors on MSNs tends to inhibit cell firing 
whereas activation of D2 autoreceptors on dopamine neurons decreases dopamine release, 
minimizing this inhibition.   
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Modulation of cell firing with dopamine 
 
At the same locations where the effects of raclopride and SCH 23390 were 
evaluated, we also evaluated the changes in firing rate induced by iontophoretically 
delivered dopamine and dopamine released by electrical stimulation (examples shown in 
Figure 5.6D and E).  Iontophoresis of dopamine over a range of concentrations (10 nM to 20 
µM) into the NAc caused no immediate change in MSN unit activity in 36 of the 40 cells 
tested (representative example in Figure 5.5E).  However, only 18% of MSNs were 
unresponsive to either mode of dopamine delivery like the MSN in Figure 5.6.  This means 
82% of MSN showed a prolonged response to dopamine.  In Table 5.2, the cells are 
grouped according to their prolonged responses to dopamine evoked by electrical 
stimulation or iontophoresis.  Here, 75% of the MSNs monitored show the same type of 
prolonged response to both locally applied dopamine and electrical stimulation.  Our result 
contrasts with that of Millar and coworkers who found electrically stimulated dopamine could 
excite or inhibit cell firing, but iontophoresed dopamine never excited cell firing (Williams and 
Millar, 1990).  Our results also contrast with those of Gonon who found that transient 
electrical stimulations caused D1-mediated excitation of MSNs (Gonon, 1997).  However, 
both of the prior reports were in anesthetized preparations.  The changes in firing rate 
induced by increased extracellular dopamine concentration show that MSN firing rates can 
be modulated even in the absence of a coordinated surge of glutamate or GABA.  For the 
25% of the cells in which dopamine and the electrical stimulation do not cause the same 
firing rate changes, it may be that the stimulation releases other neurotransmitters besides 
dopamine that contribute to the observed effect.  For example, GABA (Steffensen et al., 
2001; Tritsch et al., 2012) and glutamate (Stuber et al., 2010) are released in conjunction 
with dopamine at some percentage of NAc synapses.   
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Figure 5.6.  Firing rates measured at 
another MSN indicating the prolonged 
analysis method.  Each histogram was 
constructed from the results of 30 trials for 
each condition,  (A)  Control where no event 
occurs (B) 15 s SCH 23390 (SCH) ejection, 
indicated by back bar (C) 15 s raclopride 
(RAC) ejection, indicated by back bar (D) 
15s dopamine (DA) ejection, indicated by 
back bar (E) 60 Hz, 24 p electrical 
stimulation (ES), indicated with dashed 
vertical lines.  The horizontal boxes above 
each histogram indicate where comparisons 
were made to determine prolonged changes 
in firing rate.  Red indicates baseline (-15 to 
30 s in panel A) and blue outlined boxes 
indicate regions compared to baseline (-15 
to 0 s and 15 to 30 s).  (F)  Summary graph 
of immediate and prolonged changes in 
firing ratio from the single unit in panels A-E.  
Prolonged firing ratios were determined by 
dividing the average firing rate during 
periods with blue boxes over them in a 
panel by the red boxed region in panel A.  
Immediate firing ratios were determined as 
described in Figure 5.5 and the text.  A 
quotient greater than 1.5 or less than 0.5 
qualified as a change in frequency of cell 
firing.  Horizontal dashed lines enclose the 
region where changes in firing ratio are less 
than 50% of the original signal.  The only 
effect seen at this cell was a prolonged 
depression to SCH23390 as indicated by 
the * in Figure 5.6F. 
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Table 5.2.  Medium Spiny Neuron Responses to 
Electrically Stimulated Dopamine and Locally  
Applied Dopamine  
Type of Prolonged 
Response 
Number of Cells (%) 
ES & DA DA onlya ES onlyb 
Excitatory 12 (30) 5 (12) 3 (8) 
Inhibitory 14 (35) 0 (0) 0 (0) 
No responsec 4 (10) -- -- 
Mixed responsed 2 (5) -- -- 
DA = locally applied dopamine; ES = electrically stimulated release. 
MSN responses are tabulated from n = 40 cells (units) from 21 rats.   
a Cells responded to DA only and had no response to ES. 
b Cells responded to ES only and had no response to DA. 
c Cells did not respond to ES or DA. 
d Cells with a mixed response responded differently to ES vs DA.  
One of the cells had an inhibitory response to ES and an 
excitatory response to DA, while the other cell had an excitatory 
response to ES and an inhibitory response to DA. 
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CONCLUSIONS 
 
Here we characterized an improved procedure to combine iontophoresis with 
voltammetric/single-unit recording that eliminates much of the unpredictability seen in earlier 
applications of this technique.  We have established that drug ejections 15 s in duration can 
alter both chemical release and cell firing on different time scales.  Previous experiments 
with iontophoresis showed that long ejections of SCH 23390 inhibited cell firing while both 
saline and raclopride caused no change in frequency of cell firing at the same cell (Cheer et 
al., 2007).  These results are in agreement with the effects observed for a portion of MSNs 
tested here.  However, for 40% of the MSNs we tested, raclopride significantly increased 
firing rate.  We also see changes in firing rate after only 15 s of drug application (vs. several 
minutes).  Additionally, we find that there are neurons that fire rapidly in response to 
raclopride and are unaffected by SCH 23390.  This agrees with many prior experiments in 
anesthetized animals showing that dopamine may be both inhibitory and excitatory (White 
and Wang, 1986).   
The results with raclopride on pre- and post-synaptic events differ in their onset time.  
Raclopride modulates dopamine release immediately and robustly after its application 
(Figure 5.3), but tends to be more effective in the prolonged modulation of MSN firing rate.  
These effects are mediated by two different isoforms of the D2 receptor that are found pre- 
and post-synaptically (Giros et al., 1989), and that exhibit similar pharmacology (Elsworth 
and Roth, 1997).  They differ in that the post-synaptic D2 receptor has a longer third 
intracellular loop that requires the presence of Gαi2 in order to inhibit adenylyl cyclase to the 
same extent that the pre-synaptic D2 receptor can with any Gαi  protein (Montmayeur et al., 
1993; Guiramand et al., 1995).  Functionally, this means more binding may be required at 
post-synaptic receptors to elicit comparable adenylyl cylase inhibitions.   
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Our results provide an interpretable view of dopamine-receptor interactions because 
of our ability to monitor the applied drug concentration.  In previous studies of dopamine’s 
actions on MSNs, the dopamine concentration was not monitored directly but based on 
barrel concentrations and applied currents.  The amount of dopamine applied in those 
experiments can be calculated to be approximately 50 times greater than the concentrations 
applied in this work (Kiyatkin and Rebec, 1999a).  In studies where dopamine was 
exclusively inhibitory, the large concentrations of dopamine applied meant that uptake by 
the dopamine transporter could not make a significant change in the applied concentration.  
Our initial iontophoresis experiments demonstrate at least three unique 
pharmacological responses that indicate the presence of different receptor populations on 
individual MSNs (Table 5.1) and these results are consistent with the current understanding 
of D1 and D2 receptors (Gerfen and Surmeier, 2011).  This also supports the classic theory 
that the effect of dopamine on MSN intrinsic and synaptic channels will be excitatory at D1R 
MSNs and inhibitory at D2R MSNs (Albin et al., 1989; DeLong, 1990; Kreitzer and Berke, 
2011).  The prolonged effect of dopamine on MSN firing was independent of the receptor 
subtypes in animals not engaged in a specific task.  The lack of immediate changes in cell 
firing with dopamine and, at some cells, with dopamine antagonists, may also be a result of 
physical distance between the tip of the iontophoresis barrel and receptors of interest.  
We have presented a technique and methodology that is uniquely designed to 
determine not only what dopamine does in an awake animal under a number of conditions 
but that also has the potential to tease apart the role of other neurotransmitters in 
conjunction with dopamine.  Characterization of this combined technique allows us to begin 
to differentiate between the function of MSNs based on their receptors.  We can now 
investigate the argument that many different circuits within the NAc fire in different patterns 
specific to the aspect of goal-directed behavior for which they encode (Carelli and 
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Wightman, 2004).  These initial data are very promising and show the potential of this 
combined technique to contribute to a broader understanding of neuronal signaling.  
 
METHODS 
Electrode Modifications 
 
A capillary (Part # 624503, 0.60 mm o.d., 0.4 mm i.d., 4” long, A-M Systems, 
Sequim, WA) was loaded with a carbon fiber (T-650, Thornel, Amoco Corp., Greenville, SC ) 
by aspiration and then loaded into one barrel of a pre-fused 4-barrel glass (Part # 4FB100-
75-100, 1.0 mm OD, 0.75 mm ID, 100 mm L, 4-barrel omega dot tubing with filament, 
Friedrich and Dimmock, Millville, NJ).  The 4-barrel glass with attached heat shrink (to 
prevent microfractures in the glass) was pulled on a vertical micropipette puller (Narashige, 
Tokyo, Japan).  When pulling, it is important that the multi-barrel glass capillary is 
completely centered and straight within the coil of the puller.  If the glass moved at all from 
the center of the coil when the chuck was rotated, the probe moved the same way when 
lowered into the brain.  This greatly increased the likelihood of chipping or breaking the 
probe on the guide cannula or otherwise damaging the electrode seal. 
In experiments described here, one iontophoresis barrel was filled with 5 mM 
dopamine dissolved in 5 mM NaCl.  The additional two barrels were filled with either 5 mM 
of the D2-antagonist raclopride, 5 mM of the D1 antagonist SCH-23390, or 5 mM of the 
dopamine uptake inhibitor nomifensine.  All drugs were dissolved in 5 mM NaCl containing 5 
mM acetaminophen (Herr et al., 2010).  Acetaminophen served as the electroactive marker 
that allowed ejections to be monitored and quantitated with FSCV the amount of 
electroinactive drug ejected was calculated indirectly from relative electrophoretic mobilities 
with respect to acetaminophen as done previously (Herr et al., 2008).  Capillary 
electrophoresis and previously established methodology were used to determine that the 
relative electrophoretic mobilities of raclopride and SCH 23390 and nomifensine are 1.68, 
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1.90, and 2.24, respectively, compared to acetaminophen.  Positive current was used to 
eject all drugs.  The current was adjusted to during ‘priming’ (Herr et al., 2010) to deliver the 
appropriate micromolar concentration (detected with FSCV at the carbon-fiber) of dopamine 
or acetaminophen during a 15 s ejection.  Between probes and from barrel to barrel, the 
amount of current required to achieve a desired concentration varied from 10 nA to 450 nA.  
During experiments, drug application was randomized.  
After barrels were loaded with drug solutions, the probe was inserted connection side 
first, into the modified Biela manipulator and fastened to the manipulator with a strip of 
parafilm.  A gold pin was then soldered to the end of the silver wire connected to the carbon-
fiber electrode; separate silver wires were inserted into each pre-loaded iontophoresis barrel 
and all connections were secured to the probe with parafilm.  A final check occurred to 
ensure that the electrode tip was centered and only moved straight up and down, not in 
circular motions, with turning of the manipulator.   
For the range of acetaminophen concentrations used in these experiments, 
acetaminophen toxicity is considered unlikely.  The first step in acetaminophen metabolism 
is its oxidation by cytochrome P450 2E1, which is predominately found in the liver (Lee et 
al., 1996).  The enzyme is present in the brain but in smaller amounts (0.5 to 2% of liver 
concentration) (Upadhya et al., 2000; Hedlund et al., 2001) .  This enzyme metabolizes 
acetaminophen into a toxic, reactive intermediate that under normal conditions is 
immediately broken down into a non-toxic compound by glutathione.  The reactive 
intermediate can cause damage if there is an overexpression of the enzyme (normally due 
to chronic ethanol treatment) or if the glutathione concentration is low (Dong et al., 2000).  
Here, however, the plasma concentrations of acetaminophen were below 2 mM (the level for 
hepatoxicity) (Rumack and Peterson, 1978).    
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Cannula and Manipulator Modifications 
 
Biela manipulators designed for 4-barrel glass were obtained commercially (Crist 
Instrument Co, Part# 3-MMB-3D).  Before surgical implantation of the guide cannula, the 
custom made adapter was used to stretch the guide cannula (Bioanalytical Systems, West 
Lafayette, IL) slightly to ensure that the manipulator could easily slide into the cannula.  
Without this step, insertion of the manipulator into the cannula took more force which may 
stress the animal or electrode.   
Combined Electrochemistry/Electrophysiology Instrumentation 
 
A version of the custom build headstage (Takmakov et al., 2011a) with pins to 
connect the iontophoresis barrels to the current source was constructed by the UNC 
Electronics Facility.  An iontophoretic constant current delivery system (NeuroPhore BH-2 
System, Harvard Apparatus, Holliston, MA) was used for all iontophoretic ejections.  All 
electrical signals were passed through an electrical swivel (Med-Associates, St. Albans, VT) 
that allowed the animal unrestrained movement within the behavioral chamber (Cheer et al., 
2005).    
Surgeries 
 
For recovery surgeries, male Sprague-Dawley rats (225-350g; Charles River, 
Wilmington, MA) were anesthetized with isofluorane (rats were induced at 4% and 
maintained at 1.5 to 2.0% during surgery) and placed in a stereotaxic frame (Kopf, Tujunga, 
CA).  Surgeries were performed as previously described (Cheer et al., 2004; Roitman et al., 
2004; Owesson-White et al., 2008).  The stretched guide cannula was implanted with the 
hub extending 2.5 mm into the brain directly above the NAc core (1.3 AP, 1.3 ML) or shell 
(1.7 AP, 0.8 ML, N = 4 animals and n = 8 cells) (Paxinos and Watson, 2007) and a bipolar 
stimulating electrode (Plastics One, Roanoke, VA) was lowered into the VTA (5.2 mm AP, 
1.0 mm ML, and 7.8 mm DV).  Coordinates for the bipolar stimulating electrode ensure 
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activation of the neurons projecting to the NAc (Ikemoto et al., 1997).  A Ag/AgCl electrode 
was placed in the contralateral hemisphere to act as both reference for the carbon-fiber 
electrode and a ground for the iontophoresis barrels.  All items were secured to the skull 
with stainless steel screws and dental cement.  Rats inhaled 100% oxygen for a few minutes 
at the end of the surgery and were given ibuprofen (15mg/kg) to aid in their recovery.   
Experiments with anesthetized animals were similar except for anesthesia used.  
Rats were anesthetized with 1.5 g/kg urethane (50% urethane/50% saline, w/w).  Identical 
coordinates were used for implantation of electrodes.  All procedures were approved by the 
Institutional Animal Care and Use Committee of the University of North Carolina. 
Data acquisition 
 
After at least a 3-day recovery period, rats were anesthetized in an isofluorane 
chamber (4% for ~2 minutes).  Once lightly anesthetized, rats were removed from the 
chamber and the implanted cannula rinsed with 0.9% bacteriostatic saline (Animal Health 
International, Greely, CO).   Isofluorane anesthetization lasts only for a few minutes and it 
has no measureable effect on an animal’s ability to perform ICSS or on electrically 
stimulated [DA]max (Robinson and Carelli, 2008; Robinson et al., 2009).  The loaded 
manipulator was then attached to the cannula, and the rat was placed into a behavioral 
chamber (Med Associates, St Albans, VT).  Once in the chamber, the electrode and 
iontophoresis connections were made to the custom built headstage (Chemistry Department 
Electronics Facility, University of North Carolina, Chapel Hill).  
The probe was slowly lowered to 6.0 mm in the brain (1 turn of the manipulator 
moved the electrode 0.4 mm).  The electrode was then cycled for 15 min at 60 Hz from -0.4 
to 1.3 V and back at 400 V/s (Heien et al., 2003) using custom-built software (Tarheel CV, 
LABVIEW, National Instruments, Austin, TX), and then cycled for 10 minutes with the same 
waveform applied at 10 Hz.  The iontophoresis barrels were primed as described previously 
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(Herr et al., 2010) and pump currents to deliver the desired amount of each drug were 
determined at a depth of 6.2 mm into the brain.  The electrode was then lowered into the 
NAc (7.0 mm DV) and the waveform was altered to allow FSCV and electrophysiological 
recordings (Owesson-White et al., 2008).  Figure 5.1 shows the circuitry that allowed this 
switching to occur along with the simultaneous outputs from each circuit.  A solid-state relay 
in the headstage alternated between the current amplifier for voltammetric scans and a 
voltage follower for unit recording. This complementary metal–oxide–semiconductor 
(CMOS) switch (MAX 319CSA) was chosen due to its low leakage, low charge transfer, low 
and matched input capacitance, low resistance (10 Ω), and fast (<1 µs) switching time 
(Takmakov et al., 2011b).  The unit-recording interval had a 20-ms gap every 180 ms when 
voltammograms were collected.  In the first 5 ms of this interval, a potential of -0.4 V was 
applied.  The potential sweep for voltammetry remained the same as during the initial 
cycling.   
Once in the NAc, data collection occurred at sites where a single unit was isolated. A 
single unit was classified as an MSN if baseline firing frequency was below 15 Hz and the 
waveform duration was less than 1.2 ms (Kish et al., 1999; Carelli and Ijames, 2001). After 
unit activity was monitored for 30 minutes to ensure a constant firing rate, drug was applied 
to the unit.  The probe configuration allowed a maximum of three drugs applied per cell, so 
separate experiments were carried out prior to reported experiments where cell firing was 
monitored during ejections of 5 mM acetaminophen in 5 mM NaCl in rats during and prior to 
ICSS. Cell firing was not modulated by ejections of the neutral marker acetaminophen (N = 
4 rats, n = 6 cells).  Drugs were applied in a randomized order from cell to cell within an 
animal and from animal to animal to ensure affects were not due to the drug sequence.  
Positive currents were used for all ejections (10 to 450 nA).  Multiple recording locations 
were used in a single animal provided they were at least 300 µm apart to ensure a new 
MSN was being recorded.  Units recorded at carbon-fiber electrodes were amplified (x 
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1,000) and band-pass filtered (300–3,000 Hz).  All signals were digitized with commercially 
available software (DIGITIZER, Plexon, Dallas, TX) and isolation of a unit was accomplished 
with principal component analysis in commercially available software (OFFLINE SORTER, 
Plexon, Dallas, TX).  Med-Associates software (St. Albans, VT) controlled iontophoresis 
ejections and provided digital outputs synchronized to behavioral cues that were recorded in 
both Tarheel CV (fast-scan voltammetry) and Plexon (electrophysiology) records.   
Data Analysis 
 
Dopamine was identified from the background subtracted cyclic voltammograms 
(Michael et al., 1999).  Current traces showed changes in dopamine concentration over time 
at the oxidation potential of dopamine from the cyclic voltammograms collected every 200 
ms.  Neural activity was characterized with raster displays and peri-event histograms (PEHs) 
across distinct time domains that bracketed the iontophoretic ejections. Each PEH was 
partitioned into three parts [baseline (15 s before the ejection), response (15 s during 
ejection), and recovery (15 s after the ejection)] to allow measurement of changes relative to 
the drug application.  We use N to indicate number of animals and n to equal the number 
units. 
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Chapter 6 
Role of medium spiny neurons in intracranial self-stimulation 
 
INTRODUCTION 
 
Dopaminergic neurons exhibit a transient increase in firing rate (or bursting) in 
response to unexpected rewards and cues that predict reward (Schultz et al., 1997).  These 
changes in firing rate are accompanied by transient increases in extracellular dopamine in 
terminal regions revealed by in vivo voltammetric recordings (Robinson et al., 2002; Phillips 
et al., 2003; Day et al., 2007; Sombers et al., 2009).  Consistent with the mediation of 
reward, animals will self-administer dopaminergic agonists directly into brain regions that 
contain dopaminergic terminals (Ikemoto, 2007).  Dopamine deficient mice will starve even 
though food is readily available indicating that dopamine is associated with the reward 
aspects of feeding behavior (Szczypka et al., 1999; Szczypka et al., 2001).  Furthermore, 
genetically altered mice, whose dopaminergic neurons lack the ability to burst fire, show 
impaired ability to learn associations between cues and a reward (Zweifel et al., 2009).  
Taken together, these data indicate that dopamine is a neuromodulator that exerts profound 
effects on reward-based behaviors (Wise, 2004).   
The dopaminergic neurons associated with reward are termed mesolimbic 
projections and extend from the ventral tegmental area (VTA) to several regions including 
the nucleus accumbens (NAc) core (Ikemoto, 2007).  In the NAc, dopaminergic neurons 
synapse on the necks of medium spiny neurons (MSNs), GABAergic neurons, that also 
receive glutamatergic inputs from the cortical and thalamic regions of the brain (Hersch et 
al., 1995).  Three dopamine receptor populations are expressed on MSNs (Gerfen and 
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Surmeier, 2011):  in the NAc the majority express either D1- or D2-like dopamine receptors 
exclusively, while a minority (5-10 %) of MSNs have both D1- and D2-like dopamine 
receptors (Valjent et al., 2009).  The family of D1-like receptors (D1Rs) include D1 and D5 
dopamine receptors while the D2-like family of dopamine receptors (D2Rs) includes D2, D3, 
and D4 receptor subtypes (Neve et al., 2004).  The D1-like MSN’s are referred to as the 
direct pathway because they project back to dopamine cell bodies where they provide an 
inhibitory input (Gerfen and Surmeier, 2011).  In contrast, MSN containing the D2-family of 
receptors comprise the indirect pathway that projects to the ventral pallidum (for a review 
see (Sesack and Grace, 2010)).  Cholinergic neurons in the ventral pallidum project back to 
dopamine cell bodies via the subthalamic nucleus and thus provide an excitatory influence 
as a consequence of disinhibition (Gerfen and Surmeier, 2011).   
The modulation by dopamine of glutamatergic neurotransmission at MSNs has been 
the subject of considerable investigation.  The prevalent view is that activation of D2Rs on 
MSNs (Gerfen and Surmeier, 2011) or on the glutamatergic corticostriatal terminals (Wang 
and Pickel, 2002) suppress excitation of MSNs.  Consistent with this, glutamatergic 
transmission in the striatum is facilitated in D2R-deficient mice (Cepeda et al., 2001).  
Activation of D1Rs in the striatum potentiates NMDA receptor function (Gerfen and 
Surmeier, 2011).  Here, we investigated the role of dopaminergic receptors in a reward 
based behavior, intracranial self-stimulation (ICSS).  In ICSS, an animal depresses a lever 
to deliver an electrical stimulation to select regions of the brain.  This paradigm has been 
characterized extensively and is often used to investigate brain reward (Wise, 2002).  We 
used a single carbon-fiber electrode that is concurrently used to measure cyclic 
voltammograms, providing measurements of local dopamine concentrations, and single-unit 
activity arising from adjacent neurons (Millar and Barnett, 1988; Takmakov et al., 2011).  
When iontophoretic barrels attached to the carbon-fiber electrode are filled with specific 
receptor agonists or antagonists, the roles of dopamine receptor subtypes on MSNs can be 
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determined in behaving animals (Belle et al., 2013).  In prior work we demonstrated that this 
approach can be used to identify D1-like and D2-like MSNs in the NAc, and that their 
incidence is similar to that obtained by traditional anatomical characterization.  Here we 
show that specific cue-mediated changes in neural activity are associated either with D2- or 
D1-like receptors. 
 
METHODS 
 
Electrode Preparation 
 
Iontophoresis probes were fabricated, filled with drugs, and loaded into a modified 
Biela manipulator as previously described (Belle et al., 2013).  Combinations of the following 
drugs were loaded into the three iontophoresis barrels of the probe: 5 mM raclopride, 5 mM 
SCH 23390, 5 mM SKF 38393, or 5 mM quinpirole.  All drugs were dissolved in 5 mM 
acetaminophen containing 5 mM NaCl, a vehicle shown to have no effect on stimulated 
dopamine release or MSN cell firing (Herr et al., 2010; Belle et al., 2013).  Acetaminophen 
serves as an electroactive marker to indicate the performance of the iontophoretic barrels.  
The electrophoretic mobility of each compound relative to acetaminophen was used to 
determine ejected drug concentrations (Herr et al., 2010).  Positive current was used to eject 
all drugs.  Between probes and from barrel to barrel, the amount of current required to 
achieve a desired concentration varied from 10 nA to 450 nA.  During experiments, the 
order of drug application was randomized.  
 
Combined Electrochemistry/Electrophysiology Instrumentation  
 
A custom built headstage (Takmakov et al., 2011) with pins to connect the 
iontophoresis barrels to the current source was constructed by the UNC Electronics Facility.  
An iontophoretic constant current delivery system (NeuroPhore BH-2 System, Harvard 
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Apparatus, Holliston, MA) was used for iontophoretic ejections.  Electrical signals were 
passed through an electrical swivel (Med-Associates, St. Albans, VT) that allowed the 
animal unrestrained movement within the behavioral chamber (Cheer et al., 2005).    
Surgeries 
 
For recovery surgeries, male Sprague-Dawley rats (225-350g; Charles River, 
Wilmington, MA) were anesthetized with isoflurane (induced with 4% and maintained at 1.5 
to 2.0% during surgery) and placed in a stereotaxic frame (Kopf, Tujunga, CA).  Surgeries 
were performed as previously described (Owesson-White et al., 2008).  The guide cannula 
was implanted with the hub extending 2.5 mm into the brain directly above the NAc core 
(1.3 AP, 1.3 ML) or shell (1.7 AP, 0.8 ML) (Paxinos and Watson, 2007) and a bipolar 
stimulating electrode (Plastics One, Roanoke, VA) was lowered into the VTA (5.2 mm AP, 
1.0 mm ML, and 7.8 mm DV).  A Ag/AgCl electrode in the contralateral hemisphere served 
as both the reference electrode for electrochemistry/electrophysiology and the return for the 
iontophoresis barrels.  Implanted items were secured to the skull with stainless steel screws 
and dental cement.  Rats inhaled 100% oxygen for a few minutes at the end of the surgery 
and were given ibuprofen orally (15 mg/kg) to aid in recovery.  All procedures were 
approved by the Institutional Animal Care and Use Committee of the University of North 
Carolina. 
Training 
 
After at least 3 days of recovery, rats were trained on a fixed-ratio (FR-1) schedule, 
with the lever continuously presented.  Upon lever press, a stimulus train (24 biphasic 
pulses, 60 Hz, 125-150 μA, 2 ms per phase) was delivered to the stimulating electrode on 
average 200 ms later.  Once rats learned this association, they were trained to lever press 
on a variable-time out (VTO) schedule, FR-1.  For the first 50 trials the audiovisual cue was 
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presented at the same time as the lever, with a VTO of 9-16 s between trials.  For trials 
51-200, the audiovisual cue preceded lever availability by 2 s (Figure 6.1A).  The animal 
then pressed 50 times on an extended VTO (eVTO) paradigm with 16-25 s between trials 
(Figure 6.2A).   
 
Data acquisition 
 
Once fully trained, rats were briefly anesthetized with isoflurane (4% for ~2 minutes, 
shown to have no effect on ICSS performance (Robinson and Carelli, 2008; Robinson et al., 
2009)) for insertion of the iontophoresis assembly and micromanipulator into the implanted 
cannula.  The iontophoresis probe was slowly lowered to 6.2 mm in the brain.  The electrode 
was cycled for 15 min at 60 Hz from -0.4 to 1.3 V and back at 400 V/s (Heien et al., 2003) 
using custom-built software (HDCV, LABVIEW, National Instruments, Austin, TX).  After this 
the waveform was applied at 10 Hz during priming of the iontophoretic barrels as described 
previously (Herr et al., 2010).  
Following priming, the electrode was lowered into the NAc (7.0 mm DV) and the 
same waveform applied at 5 Hz to allow electrophysiological recordings in between potential 
scans (Owesson-White et al., 2008; Belle et al., 2013).  Data collection occurred at sites 
where a single unit was isolated; multiple recording locations were used in a single animal 
provided they were at least 300 µm apart.  Single units were amplified (x 1,000), band-pass 
filtered (300-3,000 Hz), and digitized with commercially available software (DIGITIZER, 
Plexon, Dallas, TX).  Isolation of units employed principal component analysis with 
commercially available software (OFFLINE SORTER, Plexon, Dallas, TX).   
Single units were considered MSNs if they had a baseline firing rate below 15 Hz 
and a waveform duration of less than 1.2 ms (Carelli and Ijames, 2001).  Baseline firing rate 
was measured during 30 trials of the eVTO paradigm.  Next, trials occurred where a drug 
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was iontophoresed for 15 s during the extended time-out period.  Iontophoretic barrels were 
used with a randomized order of drug application.  The firing pattern of a MSN was defined 
as responsive to the lever or the cue based on the magnitude of the z-score to each event.  
It was classified as increasing in firing rate if the firing rate during the baseline ICSS period 
had a z-score of +1.65 with respect to the cue onset or lever availability period.  MSNs were 
considered to decrease in firing rate if the z-score was less than -1.65.  For MSNs that had 
z-scores fitting multiple response categories, the MSN was classified based on the z-score 
of greatest magnitude.  MSNs without significant changes in firing rate were termed non-
phasic.  Med-Associates software (St. Albans, VT) controlled iontophoresis ejections and 
provided digital outputs synchronized to behavioral cues that were recorded in both HDCV 
(fast-scan cyclic voltammetry) and Plexon (electrophysiology) records.   
Data Analysis 
 
Dopamine was identified from the background subtracted cyclic voltammograms with 
principal component analysis (Michael et al., 1999).  Neural activity was characterized with 
raster displays and peri-event histograms (PEHs) across distinct time domains that 
bracketed the iontophoretic ejections.  We use N to indicate number of animals and n to 
equal the number of units. 
 
RESULTS 
Neuronal Responses during Behavior 
 
In trained animals executing an ICSS program, we simultaneously measured 
dopamine release and neuronal firing at sites within the NAc where MSNs were isolated.  
The animals expected lever extension into the behavioral chamber 2 s after the initiation of 
an audiovisual cue that was delivered at random times (Figure 6.1A).  Pressing the lever 
activated an electrical stimulation of dopamine cell bodies in the VTA.  MSNs showed four   
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Figure 6.1.  Neuronal responses seen during VTO ICSS.  A) Timing diagram for VTO ICSS 
(Upper) The audiovisual cue (house light and tone) turns on and (Middle) 2 s later the lever 
is presented to the animal. (Lower) The stimulation was delivered (black triangle) 200 ms 
following lever press (white triangle) and the lever retracted after press.  After a variable time 
out of 9-16 s the audiovisual cue was presented and the cycle reinitiated.  B & C)  4 distinct 
MSN firing responses seen during behavior in (A):  increase in cell firing to cue presentation 
(i), increase in cell firing to lever press (ii), decrease in cell firing to lever press (iii), no 
change in cell firing during behavior (iv).  The black vertical dashed line marks the time of 
cue onset (i) or lever press (ii-iv).   B)  Average PEH for each MSN type.  Firing events are 
collected in 200 ms bins.  PEHs are the average of 6 MSNs (i), 17 MSNs (ii), 38 MSNs (iii), 
or 9 MSNs (iv).  C)  Colorplot representation of voltammetric data collected over the 10 s 
including cue presentation and lever press.  Each colorplot is the average of 30 trials within 
a single location.  The white dashed line indicates the potential at which the dopamine is 
oxidized.    
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different responses (Figure 6.1C).  Firing rate increased immediately following cue 
presentation (9 %), increased immediately before the lever press (24 %), or decreased 
immediately before the lever press (54 %).  In 13 % of locations firing rate did not change in 
response to the cue or lever extension, and these were locations where dopamine release 
timelocked to the behavior was not observed.  At the other locations, a transient increase in 
dopamine concentration occurred following lever presentation, followed by a second 
dopamine surge at the electrical stimulation, consistent with our prior findings 
(Owesson-White et al., 2008). 
Identification of MSNs by Dopamine Receptor Subtype 
 
 MSNs were classified as D1, D2 or D1/D2 cells based on their firing rate changes 
during iontophoretic introduction of D1R and D2R antagonists.  The VTO interval was 
increased to 16-25 s, and the predrug firing rate was taken over a 15 s interval 1 s prior to 
cue onset for 30 consecutive trials (Figure 6.2A).  Next, the D1R antagonist raclopride or 
D2R antagonist SCH 23390 were iontophoresed during the 15 s interval 1 s prior to cue 
onset in each trial.  Average changes during antagonist application relative to predrug firing 
rate were taken as an indicator of the specific dopamine receptor subtype present.  The 
majority (76%) of MSNs showed altered cell firing to only one receptor antagonist, 5% 
responded to both D1R and D2R antagonism, and 19% of MSNs were unresponsive to 
either antagonist.  As seen previously (Belle et al., 2013), D2 responsive MSNs increased 
their firing rate in response to raclopride while D1 responsive MSNs decreased their firing 
rate in response to SCH 23390 (Figure 6.2B).  D1 responsive MSNs also showed the 
highest predrug firing rate, while non-phasic cells had the lowest baseline firing rate 
(Figure 6.2B).   
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Figure 6.2.  Firing rates for MSNs sorted by dopamine receptor subtype.  A) Timing diagram 
for eVTO with highlighted region showing the period during which firing rates in (B) are 
compared.  Timing is the same as in Figure 6.1, but with a variable time out between trials of 
16- 25 s, to allow a collection of baseline firing rate or iontophoretic ejection (Top).  B) 
Baseline firing for D1, D2 and D1/D2 MSNs along with firing during application of receptor 
subtype specific antagonists, SCH 23390 for D1 MSNs, raclopride for D2 MSNs, and both 
for D1/D2 MSNs.  Baseline cell firing is significantly different between all cell types (one-way 
ANOVA, Tukey post test, p<0.001).  All pharmacological manipulations significantly alter 
baseline firing rates (paired t-test, *** p<0.001 * p<0.05).  
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Dopamine modulation of MSN firing patterns 
 
We investigated whether iontophoresis of dopamine receptor antagonists affected 
firing patterns of MSNs during ICSS.  MSNs were sorted by both dopamine receptor type 
and ICSS response.  Interestingly, cells that were unresponsive to pharmacological 
challenge also were not timelocked in their firing during ICSS responses.  All MSNs that had 
a timelocked increase in cell firing following the cue responded only to D2R antagonism 
(Table 6.1).  Most of the cells timelocked to (but proceeding) the press were D1 responsive 
cells.  Populations of D1, D2, and D1/D2 responsive MSNs showed decreases in firing rate 
timelocked, but preceding, the press.  
Role of D2 Receptors in Increased Firing Rate of MSNs to Cue Presentation  
 
 MSNs that show excitations immediately after the cue all respond solely to D2R 
antagonism.  In addition to their response to raclopride, the increase in firing rate was 
depressed by D2R agonist quinpirole (Figure 6.3A) and was unaffected by D1R selective 
drugs (Figure 6.3B).  The relative increase in firing rate (i.e. signal-to-baseline) after cue 
onset remained constant following raclopride but decreased following quinpirole (Figure 
6.3C).   
Role of D1 Receptors in Increased Firing Rate of MSNs in Anticipation of Lever Press  
 
The majority (86%) of MSNs that showed an increased firing rate in anticipation of 
the lever press responded exclusively to D1R antagonism as reported in Table 6.1.  But, the 
six cells showing this behavior do not show statistically significant differences in firing rate 
during ICSS when averaged together (Figure 6.4) due to the variation in predrug MSN firing 
frequencies between cells.  Further collection of MSN responses will hopefully create a 
statistically significant depression of the anticipatory increase in MSN firing with SCH 23390   
164 
 
 
 
 
 
 
 
 
 
 
Table 6.1.  MSN Cell-type and Firing Pattern During ICSS 
 
Type of 
Response 
Number of Cells (%)a 
D1 D2 D1+D2 
Excitatory to cueb  0 (0) 16 (36) 0 (0) 
Excitatory to pressc 6 (14) 1 (2) 0 (0) 
Inhibitory to pressd  4 (9) 4 (9) 2 (5) 
TOTAL 10 (23) 21 (47) 2 (5) 
aPercentages are calculated from N = 44 cells (units) from 14 rats. 
11 (25%) non-phasic units are not listed in the table.  These units did not 
respond to either antagonist and showed no time-locked response to 
behavior 
bz-score of ≥1.65 for the 1.8 s cue firing period compared to 2.4 s baseline, 
when all firing is aligned to cue presentation  
cz-score of ≥1.65 for the 0.6 s lever anticipation firing period compared to 
2.4 s baseline when firing was aligned to lever presentation 
d z-score of ≤-1.65 for the 0.6 s lever anticipation firing period compared to 
2.4 s baseline when firing was aligned to lever presentation 
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Figure 6.3.  Pharmacological manipulation of cue cells during behavior.  A) Manipulation of 
cell firing with D2R selective drugs.  Average cell firing of MSNs during control sessions 
(black boxes, n=27), a session where the D2R antagonist raclopride (rac) was 
iontophoresed before cue presentation (blue trace, n=27) and a session where the D2R 
agonist quinpirole (quin) was iontophoresed before cue presentation (green trace, n=11).  All 
session conditions showed a significant change in cell firing with the cue, and there was a 
significant change in cell firing between session conditions (two-way ANOVA, p<0.001).  B) 
Manipulation of cell firing with D1R selective drugs. Average cell firing of MSNs during 
control sessions (black boxes, n=27), a session where the D1R antagonist SCH 23390 was 
iontophoresed before cue presentation (orange trace, n=13) and a session where the D1R 
agonist SKF 38393 was iontophoresed before cue presentation (purple trace, n=11). All 
session conditions showed a significant change in cell firing with the cue but no significant 
change in cell firing between conditions (two-way ANOVA, p<0.001).   C) Summary average 
firing rate before onset of the cue and during the 1.8 s cue presentation window (-cue) for all 
pharmacological manipulations of cue responsive cells (one-way Anova P < 0.001 *** 
(df=9)). 
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Figure 6.4.  Pharmacological manipulation of D1 MSNs that increased firing frequency 
immediately before lever press.  Average cell firing of MSNs during control sessions (black 
boxes, n=6), a session where the D2R antagonist raclopride was iontophoresed before cue 
presentation (blue trace, n=6) and a session where the D1R antagonist SCH 23390 was 
iontophoresed before cue presentation (orange trace, n=6).  CURRENTLY: There was no 
statistical difference in the firing patterns between session conditions, but within each 
session condition there was a significant change in cell firing to the lever press (two-way 
ANOVA, p<0.001). 
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application and no alteration with raclopride.  The MSNs that showed inhibition immediately 
before the press responded to both D1R and D2R agents. 
 
DISCUSSION 
 
In this work we examined the electrochemical and electrophysiological events that 
occur in the NAc during execution of the operant, rewarding behavior, ICSS.  We combined 
these measurements with a novel iontophoretic procedure that allows delivery of known 
amounts of pharmacologically active substances (Belle et al., 2013).  Iontophoresis of 
dopamine antagonists enable the distinction of MSNs modulated by D1-like receptors, the 
direct pathway, from MSNs that are modulated by D2-like receptors, the indirect pathway.  
Consistent with prior work (Day et al., 2007; Owesson-White et al., 2008; Howe et al., 2013), 
we find that cues that predict impending reward availability induce a transient dopamine 
concentration surge that is followed by a second dopamine surge evoked by the electrical 
stimulation.  Simultaneous single-unit recordings reveal that these neurochemical events 
coincide with electrophysiological changes in firing rate.  MSNs that increased their firing 
rate to cue onset exclusively responded to a D2R agonist or antagonist.  Less than two 
seconds later, but prior to the lever press, a population of MSNs, primarily D1 responsive, 
exhibit a more rapid increase in firing rate.  Another distinct (but heterogeneous) population 
of MSNs exhibits a transient decrease in firing immediately preceding the lever press.   
The major glutamatergic inputs to NAc MSNs are from the ventral hippocampus, 
basal lateral amygdala, and prefrontal cortex (Sesack and Grace, 2010).  Dopamine in the 
NAc modulates the effects of these excitatory inputs rather than directly driving neuronal 
activity (O'Donnell et al., 1999; Nicola et al., 2000).  Thus, when dopamine is transiently 
introduced into the NAc of an awake but quiescent animal, either exogenously with 
iontophoresis or endogenously with electrical stimulation of dopaminergic neurons, it is 
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relatively ineffective in causing an immediate change in the firing of MSNs (Belle et al., 
2013).  In contrast, in active reward-seeking, glutamatergic terminals are activated and the 
modulatory effects of dopamine are apparent.  Indeed, there was sufficient neuronal activity 
in the time in between behavioral trials that we could evaluate the effects of dopamine 
antagonists on firing rate.  From the results in Figure 6.2B we conclude that dopamine 
predominantly increases the firing rate of D1 responsive MSNs and decreases the firing of 
D2 responsive MSNs.  These data are consistent with measurements of the modulatory 
effects of dopamine at MSNs that are in the “up” state as determined with patch clamp 
recording in brain slices or anesthetized preparations (Bamford et al., 2004; Brady and 
O'Donnell, 2004; Andre et al., 2010; Wang et al., 2012). 
Even though it only has a modulatory role, considerable evidence shows that 
dopamine release is critically important for optimum performance of reward related 
responses (Schultz, 2007; Tripp and Wickens, 2012).  In particular, evidence from ICSS 
experiments strongly supports the view that dopamine release is an important component of 
this behavior (Wise, 2004).  For example, genetically modified rats that express opsin in 
dopamine neurons will work to deliver optical pulses that evoke the neuronal release of 
dopamine in much the same way as the animals described here work for electrical 
stimulation to the VTA (Witten et al., 2011).  However, subsequent research using 
optogenetics has also revealed that mice will work to receive optical excitation of MSNs 
containing opsin (Britt et al., 2012).  These optogenetic results concur with the previous 
neurochemical result that ICSS can occur without  dopamine release (Garris et al., 1999).  
Rather, dopamine appears to filter the responses of NAc MSNs to cortical (O'Donnell, 2003), 
hippocampal, and amgydalar inputs (Mogenson et al., 1988; Pennartz et al., 1994; 
O'Donnell et al., 1999; Floresco et al., 2001).  One proposal is that dopamine modulates 
these different inputs via alteration of the signal-to-baseline ratio of MSN firing (Kiyatkin and 
Rebec, 1996; O'Donnell and Grace, 1996; Nicola et al., 2000).  Our combined 
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neurochemical and electrophysiological results in the NAc of a rat pressing for ICSS reward 
directly confirm this hypothesis.  In the presence of a D2R antagonist, both the baseline 
firing rate and the burst immediately following the cue increase their firing rate, thus resulting 
in a decreased signal (the burst) relative to the noise (the baseline, Figure 6.4A).  Overall 
firing frequency also changes, suggesting that changes in MSN firing modulate behavior. 
During ICSS a minority of MSNs show no phasic changes in firing rate.  These cells 
are in locations lacking detectable dopamine release during ICSS (Figure 6.1Biv), a 
previously reported phenomenon (Owesson-White et al., 2009; Cacciapaglia et al., 2011).  
In this behavioral paradigm, non-phasic cells have significantly suppressed baseline firing 
rates compared to phasic MSNs, supporting the idea that the circuit containing these NAc 
MSNs is not activated during ICSS. 
There have been prior attempts to separate the roles of D1R and D2R containing 
MSNs on behavior.  Kravitz and coworkers used selective optogenetic activation of 
dopamine D1R- or D2R–expressing striatal MSNs to evaluate their influence on 
reinforcement learning in mice (Kravitz et al., 2012).  Stimulating D1R–expressing neurons 
induced persistent reinforcement, whereas stimulating D2R–expressing neurons induced 
transient punishment.  Additionally, microinfusion of the D2R agonist quinpirole into the NAc 
(Yawata et al., 2012) inhibited acquisition of aversive behaviors.  In agreement with these 
findings we observed that increased MSN firing at the cue was suppressed with D2R 
agonism while D2R antagonism decreased the signal-to-baseline ratio for the increase in 
firing rate by increasing baseline firing (Figure 6.4).  In contrast, we hope to find that MSNs 
showing an anticipatory increase to the lever press show enhanced firing in the presence of 
D1R agonists.  The concept that activation of both types of MSNs is required to coordinate 
responses during reward seeking is supported by the work of Cui and coworkers.  Using 
viral expression of a calcium indicator selective for D1 or D2 MSNs, they showed that both 
pathways are activated in mice executing an operant task (Cui et al., 2013).   
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D1 MSN responses are required for behavioral reinforcement (Kravitz et al., 2012) 
and increased cell firing during reward based behaviors involves D1R activation of the direct 
pathway (Cheer et al., 2007).  Our experiments reveal that the dopamine surge following the 
cue does not result in a D1R mediated response until almost 2 seconds later in anticipation 
of lever availability.  This is consistent with the initiation of MSN firing by glutamatergic 
inputs while dopamine serves a modulatory role.  Indeed, dopamine is known to exert its 
effects 2 to 3 seconds after its release (Schultz, 2007).   
Consistent with our findings, microinfusions of D2R antagonists into the NAc block 
responding to reward predicting cues (Yun et al., 2004).  Using a second order 
reinforcement schedule for cocaine self-administration, Di Ciano and coworkers found that 
cue evoked reinstatement of drug seeking was attenuated by a selective D3R antagonist 
given systemically (Di Ciano et al., 2003) and lever pressing was inhibited by microinfusions 
of the D3R antagonist directly into the basal lateral amygdala (Di Ciano, 2008).  These 
results were replicated by Gal and coworkers who also showed that haloperidol, a 
nonspecific D2R antagonist blocked reinstatement of cocaine taking (Gal and Gyertyan, 
2006).  In both studies, cue-controlled responding for sucrose was unaffected by these 
antagonists.  Others have shown that D2 MSNs are linked to motivation (Trifilieff et al., 
2013) or updating a learned response (Yawata et al., 2012).   
The occurrence of increased firing rate at cue presentation exclusively in D2 MSNs 
indicates an inhibition of the indirect circuit.  Consistent with this, the effects of glutamate 
release on D2R responsive MSNs in the slice preparation is attenuated by dopamine (Wang 
et al., 2012).  D2 MSNs also have been shown to participate in long term depression 
(Grueter et al., 2010).  Stimulating D2R–expressing neurons induced transient punishment, 
indicating that activation of these circuits is sufficient to modify the probability of performing 
future actions (Kravitz et al., 2012).  Suppression of D2 MSN firing by dopamine (or 
quinpirole, Figure 6.4) would attenuate this affect.   
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In conclusion, the dopamine surge following the cue has a dual role.  First, it 
prevents responding or encoding of aversive circuits to cue presentation by inhibiting the 
firing frequency of D2 MSNs.  Second, 2-3 s later dopamine activates low affinity D1Rs in 
anticipation of the press.  With further experiments to examine alteration of MSN firing 
patterns with D1R agonism and in behavioral extinction paradigms the measurements made 
here will help provide a clarified view of the interplay between the direct and indirect 
pathways in reward driven behavior. 
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